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Corticosteroid Effects and Senescence in Cultured 
Endothelium 
ABSTRACT 
A dissertation submitted in partial fulfillment of the 
requirements for the degree Doctor of Philosophy at 
Virginia Commonwealth University 
Stephen A. Gudas 
Virginia Commonwealth University 
Advisor: Milton M. Shelley 
Cultures of human umbilical vein endothelial cells 
were treated with heparin-corticosteroid combinations to 
determine effects on cellular growth. Standard 
proliferation assays, colony formation assays, and 
cytoflourometric analysis were the methods employed. 
Dexamethasone (DEX) and hydrocortisone (HC) were 
inhibitory to growth of HUVEC when EtOH was used as a 
solvent and fully supplemented medium (20% serum) was 
employed. When DMSO was the solvent, growth enhancement 
sometimes occurred when (DEX) was the test steroid; growth 
inhibition occurred with this steroid when a reduced (1%) 
serum component was used. Since significant inhibition of 
cell colony formation in response to DEX administration 
was observed, the results suggest that low density growth 
of HUVEC was inhibited by steroid treatment, w!1ile higher 
density growth was faci�itated. cytoflourometric analysis 
of HUVEC treated with DEX-heparin combinations indicated 
that this treatment increased cellular size and possibly 
increased the number of endothelial cells in the s and/or 
G2-M phases of the cell cycle in early passage HUVEC. 
Senescent expression was studied in HUVEC using a 
cell counting method to determine the percentage of 
senescent cells in these cultures. The effects of culture 
gender and passage number on senescent expression were 
determined for various plating densities and passage split 
ratios. When primary cultures of HUVEC were passed at a 
1:10 split ratio and subsequently passed at a 1:5 split 
ratio, male cultures expressed a greater degree of 
cellular senescence than to female cultures. 
When differences in confluent cell density between male 
and female primary cultures were corrected for by plating 
at standard density (1.25 x 10 5 cells/flask), there were 
no significant differences in total cells, total senescent 
cells, or percentages of senescent cells between male and 
female cultures, a phenomenon which was true in both five 
and seven day assessments. When cultures of both male and 
female HUVEC were passed at high density (l:4 split 
ratio), significantly greater senescent expression 
occurred in later passages vs. earlier passages, a1 effect 
not seen when the cultures were passed at a lower density 
(1:16 split ratio). There was a trend for both male and 
female cultures passed at a lower density to express less 
X 
senescence when contrasted with male and female cultures 
passed at a higher density. The results suggest that 
cellular density at passage may be more important than 
gender in the expression of senescence in HUVEC. 
xi 
Part I 
Effect of Corticosteroids on Cultured Human Umbilical Vein 
Endothelial Cells 
Introduction 
This study addresses the in vitro growth 
characteristics of human umbilical vein endothelial cells 
(HUVEC} subjected to treatment with corticosteroids and 
heparin. The rationale for the studies using steroids and 
heparin is based on in vivo studies; it has been 
demonstrated that tumor suppression by inhibition of tumor 
angiogenesis can be effected by combined treatment with 
heparin and selected corticosteroids (Folkman, 1985a). 
The mechanism by which angiogenesis is inhibited is 
unknown, although a recent report has suggested that the 
mechanism is related to heparin-corticosteroid induced 
dissolution of the vascular basal lamina (Ingber et al., 
1986). In reviewing the literature, however, it becomes 
apparent that the effects of steroids, or steroid-heparin 
combinations, on proliferation of endothelial cells (EC) 
are not completely documented. Since cellular 
proliferation, along with cellular migration, is a major 
cellular kinetic process necessary for the formation of 
blood vessels, studies of the effect of steroids and 
heparin on the proliferation of endothelial cells in 
culture were initiated. The rationale for the in vitro 
experiments is that these studies may help to define the 
mechanism of the anti-angiogenic effect seen in vivo. 
1 
Review of Literature 
The following review is divided into four sections. 
The first section describes the results of in vivo studies 
which have examined the effect of corticosteroids and 
heparin upon angiogenesis. The second section summarizes 
findings regarding the effect of various corticosteroids 
upon cellular growth in general. The third section 
introduces the history and methodology of culturing HUVEC, 
the cells used in the present study. Lastly, the fourth 
section delineates the research addressing the in vitro 
effect of corticosteroids upon functional parameters of 
endothelial cells, with emphasis on HUVEC. 
Corticosteroids and angiogenesis in vivo 
Angiogtnesis or neovascularization, the formation of 
new blood vessels from the established microvasculature, 
occurs in response to various pathologic or physiologic 
stimuli. Pathologic angiogenesis includes vessel growth 
occurring in response to inflammation, wound healing, 
tumors, and other disease processes such as psoriasis and 
sclerodern,a (Furcht, 1986). It is well recognized that 
�eovascularization of tumors is necessary for their 
2 
continued growth. In fact, cell populations which acquire 
the ability to induce angiogenesis, but are normally 
devoid of this capacity, have an increased risk of 
neoplastic transformation (Zilch & Gullino, 1982). 
The process of angiogenesis involves both 
proliferation and migration of EC lining the 
microvasculature (Shelley et al., 1984). Factors, then, 
which influence endothelial cellular proliferation and/or 
migration are of immediate interest in the study of new 
blood vessel formation. Intriguing recent reports have 
demonstrated that angiogenesis can be inhibited in vivo 
by selective treatment with heparin and various 
corticosteroids (Folkman, 1985a,b; Folkman et al., 1983; 
Crum et al., 1985). In vitro studies examining the 
positive or negative influence of various corticosteroids 
on the proliferation of EC would assist in understanding 
the cellular kinetics involved with the anti-angiogenic 
phenomenon. Any pharmacologic agents which might 
influence the proliferation and/or migration of EC could 
alter the growth of new blood vessels. 
Proliferation of EC is an important component of 
many pathological reactions, such as inflammation, wound 
healing, and the formation of atherosclerotic lesions. 
Factors affecting the migration of vascular cells are also 
3 
central to both the repair of damage and pathological 
changes in the vascular structure (Gee & Minta, 1984). 
Due to the fact that endothelial damage and the extent of 
repair can affect the integrity of the existing 
endothelial barrier, determinants of endothelial cellular 
proliferation and migration are also integral aspects in 
the process of atherosclerosis, which may develop after 
injury to the endothelium (Schwartz et al., 1981). Factors 
which maintain viability of the vascular endothelium and 
protect it from injury may indirectly prevent or 
attennuate the atherosclerotic process (Folkman, 1984). 
The identification of pharmacological agents which 
suppress proliferation of EC is of interest regarding 
possible therapeutic manipulation of diseases involving 
angiogenesis, such as growth of malignant tumors, diabetic 
retinopathy, neovascular glaucoma, corneal inflammation, 
and scleroderma. Corticosteroids are already used 
clinically to suppress ocular neovascularization, but 
their effectiveness is thought to be related largely to 
their anti-inflammatory properties. Whether these 
steroids directly affect proliferation of EC is uncertain, 
and information concerning their possible effects on the 
proliferation of EC would greatly facilitate understanding 
of the mechanism of corticosteroid suppression of 
neovascularization. 
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The concept of anti-angiogenesis as a means of 
controlling tumors by regulating their blood supply is not 
new. Recently Folkman (1985a) summarized studies in this 
area. Despite evidence that heparin alone can promote and 
facilitate angiogenesis, heparin in the presence of 
cortisone or hydrocortisone could inhibit angiogenesis, 
when used in the mouse skin or lung, in the rabbit cornea, 
or on the chick chorioallantoic membrane (CAM). The 
results of these studies utilizing in vivo models 
demonstrated that under certain conditions, heparin could 
become a negative regulator of angiogenesis. The 
possibility was also raised that the anti-angiogenic 
effect of hydrocortisone was independent of its 
glucocorticoid activity. Folkman (1985a) employed 11-
alpha epicortisol, a stereoisomer of hydrocortisone having 
no glucocorticoid or mineralocorticoid activity, and found 
that anti-angiogenic activity was sustained. 
Crum et al. (1985), in further studies, 
characterized seven corticosteroids with heparin dependent 
anti-angiogenic (angiostatic) activity but no 
glucocorticoid or mineralocorticoid activity, 
demonstrating the existence of a class of steroids for 
which inhibition of angiogenesis appears to be the 
principal function. They suggested that angiostatic 
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activity appears to be associated with certain alterations 
of the pregnane structure and is governed mainly by 
specific structural configurations on the D ring. The 
absence of either the 17-hydroxyl or both the 17-hydroxyl 
and carbons 20 and 21 on the D ring led to successive 
decreases in angiostatic activity. Also, Crum et al. 
(1985) found that dexamethasone, which originally 
exhibited no anti-angiogenic activity when used at 
concentrations maximally effective for hydrocortisone, 
displayed a potent angiostatic effect when given at a 
lower concentration. This finding stresses the importance 
of determining a broad and inclusive dose-response 
relationship in establishing optimally effective 
corticosteroid-heparin combinations in angiostatic 
activity. 
Ingber et al. (1986) suggested that induction of 
capillary basement membrane dissolution may be involved in 
the mechanism of anti-angiogenesis observed in the 
heparin-corticosteroid treated chorioallantoic membrane 
(CAM). The CAM, when treated with combinations of 
angiostatic steroids and heparin, exhibited capillary 
basement membrane fragmentation and eventually complete 
loss of fibronectin and laminin from regions of capillary 
involution. The authors, however, admittedly pointed out 
that it could not be clearly determined whether the 
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basement membrane breakdown was a primary effect of 
corticosteroid treatment or secondary to the loss of 
endothelial cell viability. Thus, the necessity of 
ascertaining the effect of heparin-corticosteroids on 
proliferation of EC is further supported. 
Corticosteroids and Cellular Growth in Vitro 
There is a wide body of literature which explores 
the effect of corticosteroids, both natural and synthetic, 
upon the growth characteristics of various cultured cells. 
Many of the studies have been performed upon fibroblast 
cell lines in culture. The results of these in vitro 
studies have been equivocal. Some cell lines exhibit 
enhanced proliferation, DNA synthesis, and increased 
metabolism when treated with steroids; while others show 
an inhibition of cellular growth. It is thought that 
target cells may biotransforrn the molecular structure of 
corticosteroids in a specific unique way; a particular 
steroidal molecular structure is apparently essential for 
eliciting a particular biologic response (Berliner, 1965). 
Cells more resistant to cortisol effects, for example, 
will selectivity inactivate the hormone in greater 
quantities than will more sensitive cells. 
Ponec et al. (1977) added various corticosteroids to 
logarithmically growing cultures of primary human skin 
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fibroblasts, and determined their effect on cellular 
growth using a cell counting assay. These steroids 
inhibited proliferation of the human fibroblasts at 
concentrations (lo-5 M to 10-8 M) which fell in a range 
expected to occur during the topical treatment of skin 
disorders. Inhibition was independent of the source (baby 
foreskin or adult arm skin) and cell passage number of the 
fibroblasts. Building on this study, Ponec et al. (1979) 
found that when steroids were added at a later stage of 
cellular growth, when cell density was increased, 
fibroblasts showed a reduced sensitivity or even an 
insensitivity to growth inhibition. The inhibition in 
early growth stages was transient and mo�t pronounced when 
the culture medium was not renewed. In contrast, Rosner & 
Cristafalo (1979), using the Coulter counter method to 
examine the effect of hydrocortisone on the proliferative 
activity of various vertebrate fibroblast-like cell lines, 
found that addition of hydrocortisone to human fetal 
foreskin and human fetal lung-derived cell lines (W-138) 
was growth enhancing. Serum was required in the medium 
for this enhancement to occur. However, they also found 
that steroids caused growth inhibition in a number of 
other vertebrate cell lines. Their results suggested that 
the proliferative response to hydrocortisone demonstrated 
a cell-type specificity, as well as steroid-molecular 
structure specificity, mediated by high affinity 
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glucocorticoid binding sites. That hydrocortisone acted 
to conserve the cycling state of human embryonic lung 
fibroblasts was suggested by Ban et al. (1980), who 
supported previous findings of Cristafalo (1972). They 
noted that hydrocortisone extended the population life 
span of these cells, without changing the maximum 
population doubling potential. It appeared that 
hydrocortisone delayed the progression of fibroblasts to a 
non-cycling state. 
Baker et al. (1978) reported that dexamethasone, 
maximally effective at 0.25 uM, enhanced the mitogenic 
response of human diploid foreskin fibroblasts to 
epidermal growth factor (EGF). Binding studies with 1251-
labeled EGF suggested that dexamethasone caused this 
permissive effect by modulating cell surface receptors for 
EGF. Thus, glucocorticoids may modulate cell growth 
indirectly by altering cell responsiveness to growth 
factors or serum. Cristafalo (1979) delineated 
experiments looking at the specific binding of 
glucocorticoid hormones in human fibroblast WI-38 cells. 
They concluded that the stimulation of WI-38 cell 
proliferation by hydrocortisone involved specific 
glucocorticoid receptors whose concentration per cell is 
under cell cycle control. They also compared cells with a 
cumulative population doubling level (CPDL) of 30 with 
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cells with a CPDL of 57, and found that there was an age­
associated decrease in specific glucocorticoid binding 
sites. The latter might explain a previously observed 
loss of responsiveness to hydrocortisone observed in aging 
cultures (Kalimi & Seifter, 1979; Rosner & Cristafalo, 
1979). Also, significantly, hydrocortisone effected an 
increased life span for WI-38 cells, in terms of 
cumulative population doublings and chronological time. 
Because the effect of hydrocortisone was serum-dependent, 
it was suggested that the steroid was an amplifier of the 
serum stimulation of growth. It was later shown that the 
responsive period of WI38 cultures is limited to a brief 
period (up to 12 hours) following subcultivation, although 
cultures may remain responsive to glucocorticoid­
conditioned medium throughout the growth cycle (Finlay et 
al., 1985). 
Barrack & Hollenberg (1981) showed that the growth 
promoting action of serum in human skin fibroblast 
cultures can be attributed to the presence in the serum of 
a number of specific growth factors, and outlined their 
finding that glucocorticoids that had an 11 beta hydroxyl 
group (e.g., dexamethasone) enhanced several fold the 
mitogenic activity of synthetic polypeptides on 
fibroblasts. Supporting the findings of Rosner & 
Cristafalo (1979) above, Conover et al. (1983) 
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demonstrated that the increased ( 3 H]thymidine 
incorporation caused by insulin-like growth factor 
(somatomedin-C) in combination with human hypopituitary 
serum could be dramatically increased with further 
addition of dexamethasone or hydrocortisone. This 
synergistic effect was corroborated by cell replication 
studies. Wu et al. (1981) found that hydrocortisone 
enhanced cell growth in HeLa cells in serum free medium, 
yet inhibited cell growth in serum-supplemented cultures. 
Hydrocortisone increased twofold the 125r-labeled EGF 
binding within 24 hours after the addition of 
pharmacological concentrations of this steroid. Since a 
higher concentration of steroid was needed to affect the 
binding capacity of labeled EGF than was required to 
elicit the growth response, the growth response appeared 
to be independent of EGF. 
Further regarding glucocorticoid-serum-growth factor 
interactions, it is held that glucocorticoids can either 
sensitize or desensitize various cell types to the action 
of serum or growth factors added to cell cultures. 
Gospodarowicz and Moran (1975) found that at plateau 
values of fibroblast growth factor (FGF) (between 2.5 and 
5 ng/ml), FGF, dexamethasone, and insulin added to 
cultures of BALB/c 3 T3 fibroblasts were 82% as effective 
as saturating concentrations (10%) of serum in stimulating 
11 
DNA synthesis. Quinlan and Hochstadt (1977) extended 
these findings, demonstrating that FGF, dexamethasone, and 
insulin could induce mitogenesis and mitosis in quiescent 
3T3 cells in 0.8% serum induced G0-arrest. In contrast, 
Rubin (1977) found that hydrocortisone inhibited yet 
insulin stimulated the coordinate response of uridine 
uptake and thymidine incorporation into DNA in chick 
embryo fibroblasts. 
Jarvelainen et al. (1982) determined the 
proliferative effects of hydrocortisone on cultured human 
aortic smooth muscle cells. At concentrations of 10 uM or 
greater, hydrocortisone retarded cell growth markedly, as 
judged by decreased incorporation of [ 3H] thymidine by the 
cells, and decreased DNA content of the cultures. 
Longenecker, Kilty, & Johnson (1982) found that 
dexamethasone inhibited the growth of bovine smooth muscle 
cells (BSMC) in vitro when FGF was absent from the growth 
medium. Curiously, this inhibition was abolished when FGF 
was present. Thus, it again appears that glucocorticoids 
indirectly modulate cell growth in this cell type by 
changing the cellular responsiveness to various growth 
factors or serum. Dexamethasone inhibited maximal 
obtainable saturation densities in BSMC, but this effect 
could apparently be overcome by FGF. 
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Glucocorticoid induced inhibition of cell 
proliferation in murine growth cartilage in vitro was 
shown to be receptor-mediated (Silberman & Maor, 1985). 
Berliner et al.(1978) found that hydrocortisone could 
induce cell spreading in rat glial cells 24 hours after 
its addition to the culture medium; this spreading 
correlated with an increase in the fraction of the 
peripheral cytoplasm occupied by microfilaments. 
As pointed out in this review, many authors have 
examined the effects of various steroids upon cellular 
growth in a variety of cells in vitro, although the 
majority of these studies have been performed upon 
fibroblasts. These studies have demonstrated that 
corticosteroids, both natural and synthetic, can either 
stimulate, inhibit, or have no effect on cellular growth 
in various non-endothelial human and animal cell lines 
(Finlay et al., 1985). The presence of various 
concentrations of serum, and stage of cellular growth 
(i.e. passage number in vitro) are important variables 
which can alter the response of a particular cell line to 
corticosteroid influence, and they should be entertained 
in studies measuring the effect of corticosteroids upon 
cellular proliferation. The concentration of steroids, 
the time frame of steroid administration, and the presence 
of various additional growth factors all appear to be 
13 
modulating factors in the expression of proliferation 
effects upon cultured cells. 
HUVEC in Culture 
The human umbilical vein has been used as a source 
of endothelial cells for over two decades. Mayuma (1963) 
reported the use of this vessel as a source of endothelial 
cells in culture, and became the first individual to 
describe a pure culture of human endothelium. Using a 
trypsin incubation method for cell removal, he grew HUVEC 
in 20% umbilical cord serum or horse serum, 80% YLH 
medium, and 200 ug/ml streptomycin. Cells came to lie 
flat in 3-4 days, and spread out, forming an epithelial 
like sheet at 7-14 days. Unfortunately, Mayuma (1963) 
could not get the EC to replicate in vitro, and the cells 
began to degenerate in 14-21 days. Mitotic figures were 
rarely seen; there was some contamination with 
"fibroblast-like cells'' (which, one can speculate, could 
have been smooth muscle cells or fibroblasts); and, 
curiously, some cells were binucleate or multinucleate. 
This pioneer investigation led to many subsequent 
researchers using the human umbilical vein as a source of 
uncontaminated and uniform cells for study. Mayuma (1963) 
described the beneficial reasons for using HUVEC as a 
source of EC for study: they are of fetal origin; they can 
be obtained fairly easily; the human umbilical vein has no 
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tributaries, making it easy to cannulate and handle; and 
the lumen of the vessel has an adequate volume for trypsin 
to dislodge the endothelia. Gimbrone (1976) summarized 
methods utilized in culturing endothelial cells, and 
agreed that the recovery of EC from the human umbilical 
vein was technically uncomplicated, and could provide a 
continuously available supply of normal human vascular 
tissue for experimental use. 
Expanding on Mayuma's work, Fryer, Birnbaum, & 
Luttrell (1966) examined sections of the umbilical cord 
after trypsinization of the umbilical vein, and found that 
the endothelial cells detached readily, leaving the 
internal elastic lamina of the vein intact. The cells, 
grown on double cover slips and Rose chambers, were 
polygonal or slightly elongated in shape, and 40 to 50 um 
at their longest axis. These authors also did not observe 
replication or migration of the cells in culture. They 
also cultured the umbilical artery, outlining the 
difficulties in perfusion of this relatively smaller 
vessel. EC derived from the umbilical artery initially 
differed from those of the vein only by the presence of a 
small number of fibroblasts, which, in older cultures, 
overgrew the endothelial cells. 
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Jaffe et al. (1972) were the first authors to use 
collagenase rather than trypsin, and were able to obtain 
EC that grew to confluence in primary cultures. Saba, 
Zucker, & Mason (1973 ), following the method of Jaffe et 
al. (1972), also utilized collagenase to isolate EC from 
the human umbilical vein. The cells were exposed to 
platelets, neoplastic cells, or both to determine possible 
interactions. Although platelets did not adhere to EC, 
degenerating EC produced a slight aggregation of 
platelets. They concluded that, in response to certain 
stimuli, the EC release an activity or factor which 
inhibits platelet aggregation. But even more importantly, 
it was underscored that the availability of uniform EC 
grown in tissue culture would open numerous new avenues 
for investigation of the function and properties of these 
cells. 
Gimbrone et al. (1974) found that control of 
digestion time and concentration of collagenase were 
critical for successful cell isolation and culture. Using 
standard cell proliferation studies utilizing ( 3 HJ 
thymidine, they further characterized EC as behaving as a 
density dependent population with respect to DNA 
synthesis, and for this reason, stated that HUVEC could be 
used for studies examining the mechanism of endothelial 
cellular growth and regeneration. Using HUVEC with a 
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controlled scraping model to effect a wounded monolayer, 
Shelley et al. (1977) demonstrated that small defects in 
the endothelium could be repaired with migration alone, 
without proliferation of cells. Henrikson et al. (1975) 
found that the replicative ability of HUVEC was correlated 
with cell density at the time of seeding. Paradoxically, 
high cell seeding densities (greater than 1 x 104 
cells/cm2) inhibited cellular proliferation. They 
determined that the optimum cell seeding density for 
success in cellular proliferation was in the range of 500-
700 cells/mm2. 
Wall et al. (1978), in order to more fully 
understand vascular repair mechanisms following 
endothelial injury, studied the proliferative response of 
HUVEC to cell free plasma derived serum, whole blood 
serum, fibroblast growth factor (FGF), and macrophage 
conditioned medium in vitro. They concluded that 
proliferation of EC in pre-confluent cultures was 
dependent on plasma factors, since all four parameters 
above enhanced EC proliferation. Interestingly, in HUVEC, 
proliferation, migration, and repopulation of irradiated 
and/or wounded cultures appeared to be independent of 
platelet factors. DeGroot et al. (1983) defined 
experimental conditions allowing HUVEC to grow in serum 
free medium. Although serum was needed for a short period 
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of time to allow attachment and spreading of EC after 
trypsinization, the cells could be grown in Medium RPMI-
1640, supplemented with transferrin, insulin, and human 
serum albumin. Although ECGF enhanced growth, these 
authors concluded that it was not absolutely required for 
proliferation and subcultivation of HUVEC. 
Cultures of HUVEC have the following 
characteristics: monolayer formation, production of Factor 
VIII antigen, production of prostacyclin, and the presence 
of Weibel-Palade (WP) bodies (Zetter, 1981). The 
ultrastructure of human umbilical vessel endothelium in 
situ was studied in detail by Parry & Abramovich (1972). 
There was a paucity of glycogen in the venous EC. Rough 
endoplasmic reticulum (RER) was more abundant than in the 
umbilical artery EC. The latter was particularly well 
developed in the 15 week fetus; almost all RER at that 
time was in the form of widely dilated channels and 
cisternae. Weibel Palade bodies, endothelial cell 
specific organelles (Weibel & Palade, 1964), were numerous 
throughout pregnancy in human umbilical vein EC, and the 
Golgi are well developed. These findings correlate well 
with studies of HUVEC ultrastructure in vitro 
(Haudenschild et al., 1975). These authors described WP 
bodies in abundance, peripheral pinocytosis vesicles, and 
• • 
both thick (100 A) and thin (60-70 A) filaments in HUVEC 
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in culture. McDonald et al. (1973) also described primary 
and subcultured HUVEC as consisting of closely apposed 
large polygonal cells, 20-50 uM in diameter; under EM, 
they were phenotypically similar and revealed features 
consistent with EC in situ. 
Cultured EC have provided a powerful approach to 
study the characteristics and function of the endothelium 
(de Groot et al., 1983). Mechanistic studies of the 
biology of HUVEC have been facilitated by the 
establishment of accepted in vitro cell culture 
conditions, the definition of endothelial cellular 
phenotypes, and the identification of polypeptide growth 
factors which promote the growth of EC. These advances in 
techniques have afforded methods which allow serial 
cultivation of HUVEC over many passages (Maciag et al., 
1981; Thornton et al., 1983). The discovery of 
endothelial cell growth factor (ECGF) was a major 
breakthrough in culture methodology (Maciag et al., 1979). 
ECGF, originally a partially purified growth factor 
derived from bovine hypothalamus, is used by researchers 
to stimulate replication of EC (Maciag et al., 1979, 
1981,1982; Gordon et al., 1983; Knaver & Cunningham, 
1980). ECGF was found to contain a significant level of 
mitogenic activity when tested in a HUVEC growth assay 
(Maciag et al., 1979). Recently, the structure of ECGF 
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and the gene coding for ECGF have been described (Jaye et 
ai., 1986). These authors showed that ECGF was an acidic 
form of fibroblast growth factor. 
It was found that angiogenic basic FGF and FGF-like 
growth factors had a strong affinity for heparin (Shing 
et al., 1984). Apparently, these growth factors acted in 
a synergistic fashion with heparin (Thornton et al., 
1983), and are protected and stabilized by heparin 
(Gospodarowicz and Cheng, 1986). It was suggested that 
heparin could be involved in the modulation of growth 
factor activity, thus indirectly participating in the 
control of cellular growth (Schreiber et al., 1985). 
These authors felt that ECGF induced a conformational 
change in the heparin molecule which increased or 
stabilized the biological activity of the growth factor 
mitogen. Exactly how heparin participates in the 
mitogenic events induced by ECGF is unknown. Since EC 
possess high affinity binding sites for ECGF, it was 
proposed that these same binding sites could be activated 
by an ECGF-heparin complex (Maciag et al., 1984). It is 
of interest that heparin binding angiogenic factors are 
found in both normal tissues and tumors (Shing et al., 
1985). Folkman & Klagsburn (1987) have summarized the 
intense research productivity regarding angiogenic factors 
in the past few years, tracing the discovery of these 
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factors and describing their significance in understanding 
growth regulation of the vascular system jn vivo. 
Effect of Steroids upon EC in vitro 
Maca et al. (1978a) studied the effects of various 
steroids, including dexamethasone, hydrocortisone, and 
prednisone on the morphology and growth characteristics of 
cultured HUVEC grown in serum-containing media, but in the 
absence of ECGF and heparin. They found that 
corticosteroids caused an increase in cell surface area 
and protein synthesis and content, without an increase in 
DNA synthesis or cellular replication. Dexamethasone was 
approximately 10 times more effective than hydrocortisone 
in causing these changes; prednisone was least effective. 
Other steroids that were tested, including aldosterone, 
testosterone, progesterone, estradiol, and estriol were 
ineffective in this manner. Maca et al. (1978b) also 
found that dexamethasone decreased adhesiveness of 
cultured leukemia and lymphoma cells to confluent cultured 
endothelium; hydrocortisone was also effective in this 
manner. The effects of corticosteroids on HUVEC have also 
been examined by Piovella et al. (1982), who found that 
dexamethasone-treated cells displayed larger cytoplasms 
and larger nuclei, the latter with more prominent 
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nucleoli. Preliminary studies in our laboratory using 
dexamethasone with HUVEC have corroborated these findings. 
Piovella et al. (1982) also observed that dexamethasone 
increased the amount of fibronectin matrix in cultured 
HUVEC, suggesting that this increased matrix was 
responsible for the more flattened aspects of cells and 
their better spreading on the culture dish. 
Using the HUVEC culture system, Almasio et al. 
(1984) also found that dexamethasone induced production of 
a more cohesive and complete extracellular matrix, causing 
the EC to assume a more polygonal shape, with abundant 
cytoplasm. There was a greater degree of confluence and 
each cell covered a greater area. Earlier, Piovella et 
al. (1980) cultured HUVEC in the presence or absence of 
dexamethasone, and with daily counts reported a greater 
number of cells in the steroid-treated cultures in 
comparison to control cultures for the first five days. 
However, by day six both control and dexamethasone­
treated cultures reached confluence without significant 
differences in cell counts. In comparison to the non­
treated cultures, the confluent monolayer appeared 
tighter in the steroid treated cultures (Piovella et al., 
1980). The preservation of adhesion in the dexamethasone 
treated cultures was possibly related to the increased 
fibronectin extracellular matrix observed, the latter 
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demonstrated by immunofluorescence. It is well known that 
the extracellular matrix plays a pivotal role in the 
modulation of EC behavior in vivo (Madri & Pratt, 1986). 
Within this conceptual framework, the same preservation of 
adhesion might have affected the cell counts in the 
experiment, with the relatively less adhesion in the non­
steroid treated cultures reflected in a lower cell count, 
thus making the early increased cell number observed in 
the dexamethasone treated cultures more apparent than 
real. The availability of space into which cells can 
replicate is also an important factor, and crowded near­
confluent EC cultures will necessarily have a lower growth 
rate if evaluated at that time (Goldsmith et al., 1984). 
Although it appears that dexamethasone initially 
accelerated growth in cultured EC, this finding was 
neither repeated nor corroborated by others, nor were 
other corticosteroids tested. 
Goldsmith et al. (1984) used cytofluorometric 
techniques and found that approximately 2-8% of EC in 
primary confluent HUVEC were in the proliferative phases 
(S, G2 and M) of the cell cycle. Unfortunately, the 
proliferative characteristics of later passage HUVEC were 
not examined with cytofluorometry; no author has utilized 
this technique to assess the effects of corticosteroids on 
endothelial cellular kinetics. 
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Berliner (l981), repeating her earlier studies 
concerning the effect of hydrocortisone upon HUVEC, 
developed a defined medium which supported maximum levels 
of cell division. She found that both insulin and FGF 
increased the incorporation of 3H thymidine in HUVEC when 
hydrocortisone was present- the steroid alone did not 
increase incorporation of the radionuclide. 
Hydrocortisone also increased cell spreading in serum 
containing medium. Although her defined medium did not 
contain serum, it was pointed out that plating and 
maintenance of cells in serum containing medium was 
necessary before transfer to defined medium, otherwise the 
cells would not divide. In this, she supported the 
findings of De Groot et al. (1983), who found serum 
containing medium necessary for initial plating before 
serum-free medium could be used to support growth of the 
cells. 
Hoshi & McKeehan (1984) tested various hormones and 
growth factors, including steroids, on HUVEC 
proliferation. Although they inferred that steroids 
examined at concentrations reported to be active for other 
cells were not mitogenic for HUVEC, they did not indicate 
which steroids or concentrations were tested, nor were 
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quantitative data offered. Very little concerning steroid 
effects on HUVEC could be concluded from their report. 
Longenecker, Kilty, & Johnson (1982) tested primary 
and cloned strains of bovine aortic endothelial cells 
(BAEC) for their response to glucocorticoids. The growth 
of EC was inhibited by dexamethasone in the presence of 
FGF. Since there was no inhibition of proliferation of EC 
in the absence of FGF, it is possible that 
glucocorticoids mildly inhibit the maximal response of EC 
to FGF. However, these influences were corticosteroid­
specific and concentration dependent, but independent of 
serum concentration. Also, when deprepsion of growth did 
occur, it was relatively mild (i.e., less than 20% of 
controls), and growth depression was inconsistent. 
Perhaps even more important, the authors pointed out that 
the steroid responses observed were due to relatively 
acute treatment periods (up to five or six days), and for 
that reason may potentially differ from responses that 
might occur to chronic exposure of EC to glucocorticoid 
excess throughout a culture life span, or from responses 
that might occur in the endothelium in vivo over the 
course of many months or years. Longenecker et al. (1983) 
later studied four clones of BAEC and found that the EC 
exhibited a rather striking clonal heterogeneity with 
regards to their sensitivity to glucocorticoid treatment. 
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Only one clone exhibited an FGF dependent dexamethasone 
induced inhibition of cellular growth, and that inhibition 
was abolished by the use of extracellular matrix (ECM) 
derived from bovine aortic smooth muscle cells (BASMC) as 
a growth substratum. The authors suggested that clonal 
variability, among other variables commonly encountered in 
the culture of endothelial cells, could be eliminated by 
the use of ECM coated culture dishes. 
Harrison & McKee (1981) found that 17-beta estradiol 
caused an increased rate of replication in HUVEC, as 
measured by greater DNA content and [ 3 H] thymidine 
incorporation in the treated cultures. Corvazier et al. 
(1984), in contrast, found that 17-beta estradiol had no 
effect on endothelial cell proliferation, nor did 
progesterone. The latter authors did report that ethinyl­
estradiol increased cellular proliferation when the 
plating density was 4 x 10 4 cells/flask or greater. 
Using a 51cr release assay, Jarvelainen et al. 
(1985) tested hydrocortisone, dexamethasone, and 
prednisolone on HUVEC. All corticoids stabilized the EC 
monolayer as demonstrated by a decrease in the release of 
51cR. Paralleling other research studies employing 
dexamethasone, this particular steroid was maximally 
effective at a lower concentration than the other 
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steroids. They proposed that the beneficial effect of 
glucocorticoids observed empirically in the treatment of 
certain hemorrhagic disorders such as purpura might 
partially be explained by the strengthened endothelial 
integrity observed in their assay system. 
A number of authors have studied the effect of 
corticosteroids upon prostaglandin release from EC. 
Rosenbaum et al. (1986), using cultured rabbit 
microvascular EC, found that dexamethasone effected a time 
and concentration dependent decrease in prostaglandin 
accumulation in the culture media, and a reduced basal and 
ionophore stimulated PGE2 release. Hydrocortisone and 
corticosterone were less potent inhibitors of PGE2 
secretion, while aldosterone, progesterone, and 
dihydrotesterone did not inhibit PGE2 release. Lewis et 
g.J,.. (1986) corroborated this finding in HUVEC, outlining 
the effects of dexamethasone and hydrocortisone on 
prostacyclin (PGI2) and PGE2 release. Dexamethasone 
reduced prostaglandin formation in cells stimulated by 
histamine, bradykinin, calcium ionophore, or mechanical 
agitation. Hydrocortisone had less potent, but similar 
effects. Here again, since neither testosterone nor 
progesterone affected prostaglandin production, the effect 
seemed to be glucocorticoid specific. Decaterina & 
Weksler (1986), also studying HUVEC, found that inhibition 
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of PGI2 production in the presence of hydrocortisone 
averaged 15% less than the inhibition seen in the 
presence of dexamethasone. Corvazier et al. (1984) tested 
the natural sex hormone 17-beta estradiol and the 
synthetic hormone ethinyl-estradiol on prostacyclin 
release in HUVEC and found no effect with either steroid. 
Since vasodilatation precedes migration and proliferation 
of EC in angiogenesis in vivo (Folkman, 1984), and since 
prostacyclin (PGI2) is a potent vasodilator as well as a 
platelet aggregation inhibitor, perhaps the inhibition of 
prostacyclin activity by corticosteroids may be partially 
responsible for the antiangiogenic effect of these 
corticosteroids observed in vivo. Sei�lan et al. (1983) 
stimulated secretion of prostaglandins from cultured 
female porcine EC by using the sex steroids 17 beta­
estradiol and testosterone; male EC could not be 
stimulated in this manner. Since female, but not male, EC 
could convert testosterone to estradiol, the latter's 
induced stimulation of prostacyclin production may explain 
in part the beneficial role generally attributed to 
naturally occurring estrogens in cardiovascular diseases. 
Mendsolsohn et al. (1982a, 1982b) studied the 
glucocorticoid induction of angiotensin converting enzyme 
(ACE) production in BAEC. Using confluent monolayers of 
BAEC, they found that dexamethasone increased ACE activity 
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six to seven fold over control cultures. Since ACE 
converts angiotensin I to angiotensin II, the latter a 
strong vasoconstrictor, the process might be facilatory to 
angiostasis (see above). Also, since ACE plays a role in 
the inactivation of bradykinin, a vasodilator, an increase 
in ACE activity would further contribute to the 
vasoconstrictive effect of corticosteroids, and favor the 
phenomenon of angiostasis. Lam et al. (1985) supported 
these findings, and reported that dexamethasone (1 uM) 
increased ACE activity in BAEC in a time-dependent 
fashion, and that this steroid and irradiation interacted 
to raise cellular ACE activity. However, dexamethasone 
and increased cellular ACE activity unfortunately did not 
appear to modify the endothelial cytotoxcity induced by 
irradiation. 
In summary, due to the tremendous importance of the 
endothelium in inflammation and repair, tumor and other 
disease mediated angiogenesis, and permeability, a large 
body of literature has examined the effects of 
corticosteroids on endothelial cell function. Inhibition 
of prostacyclin release by EC and facilitation of ACE 
activity by corticosteroids, dexamethasone in particular, 
are processes whose single or combined effect would be to 
induce vasoconstriction in local vascular beds. Whether 
these mechanisms play a role in corticosteroid-heparin 
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induced angiostasis is not known. However, few published 
reports have explored the influence of corticosteroids 
upon endothelial cellular proliferation, a basic component 
of angiogenesis, and the results of these reports have 
been inconclusive. In addition, no authors have used 
cytofluorometry to address these effects upon HUVEC 
population kinetics. Experiments using cellular growth 
assays and cytofluorometry on heparin-corticosteroid 
treated EC will increase our understanding of the role of 
these substances in endothelial cell proliferation and 
hopefully provide a rationale for the clinical use of 
these pharmacological agents in pathological processes and 
disease syndromes in which endothelial cellular 
proliferation plays a significant role. 
The primary aim of this research was to establish 
the effects of heparin and selected corticosteroids upon 
growth characteristics of HUVEC in culture. Monolayer 
cultures of HUVEC were used in these studies. Direct 
cellular proliferation studies, utilizing cell counting 
and analysis of population doubling, were performed in 
order to determine the effect of heparin and 
corticosteroids on the growth characteristics of EC. 
Specifically, corticosteroids known to be antiangiogenic 
in vivo were added to culture media at various times after 
culture plating to determine the effect on cellular 
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proliferation. A variable response by EC to 
corticosteroids was found, depending on a number of 
. factors, including type of steroid solvent, time frame of 
steroidal administration, and length of time of 
corticosteroid exposure. Our results suggest that EC are 
influenced by many factors when responding to heparin­
corticosteroid administration. The results do not lend 
unequivocal support to the hypothesis that heparin and 
corticosteroids induce angiostasis partly due to the 
suppression of endothelial cellular proliferation. 
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Materials and Methods 
Experimental Methodology 
Culture of HUVEC. Harvest of endothelial cells from 
umbilical cord veins was based on the method of Gimbrone 
et al. (1974). Term umbilical cords, detached from the 
placenta, were obtained from the Labor and Delivery Room 
of the Department of Obstetrics and Gynecology at the 
Medical College of Virginia. Using sterile technique, 
unclamped umbilical cord segments of at least 10 cm. in 
length were cannulated at bot� ends using one way 
stopcocks and blood was flushed by a perfusion of 200-400 
ml. of phosphate buffered saline solution (PBS), pH 7.20. 
The lumen of the vein was filled with 0.1% collagenase 
(Clostridium histolyticum, type I, Sigma Chemical Company, 
St. Louis, MO) in PBS with calcium and magnesium [Cacl2 
(anhyd), 0.10 gm/L, and MgC12·6 H2o, 0.10 gm/LJ, and the 
stopcocks closed. The cord segment was then incubated in 
a bath of PBS at 37 degrees centigrade for 15 minutes. 
The collagenase solution was collected in a 15 ml. conical 
centrifuge tube with an equal volume of Hank's Balanced 
Salt Solution (HBSS) without calcium or magnesium. The EC 
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were then pelleted by centrifugation at 200 x g for five 
minutes. 
Defined fetal bovine serum (FBS, Hyclone 
Laboratories, Logan, UT) was used in media preparation, as 
this serum is supplied with an analysis so that the types 
and amounts of endogenous steroids in the serum would be 
known. Other media and reagents were obtained from Gibco 
Laboratories (Grand Island, NY) or Meloy Laboratories 
(Springfield, VA). The pelleted EC were resuspended in 
complete Medium 199 (CM-199) containing the following 
ingredients: Medium 199 with Earle's Salts and L­
glutamine, lOOU/ml penicillin, 100 pg/ml streptomycin, 
0.25 pg/ml Fungizone, 20% FBS, 90 µg/ml heparin (sodium 
salt, grade 1, from porcine intestinal mucosa, Sigma 
Chemical Co., St. Louis, MO), and 20 ug/ml endothelial 
cell growth factor (ECGF, Tissue Culture Grade, Meloy 
Laboratories, Springfield, VA. ECGF was also a generous 
gift of Dr. Thomas Maciag of Jerome Holland Research 
Center of the American Red Cross, Rockville, MD). 
Thornton et al. (1983) described the use of low 
concentrations of ECGF along with heparin, since heparin 
potentiates the effects of ECGF. Cultures were grown in 
gelatin coated T-25 flasks (Corning). Gelatin (0.2% 
wt/vol) promotes the attachment and growth of HUVEC 
(Gordon et al., 1983; Folkman et al., 1979; Thornton et 
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g,l., 1983; Walker et al., 1984). Cultures were then 
continuously incubated at 37 degrees C in a  humidified 
atmosphere of 95% air, 5% co2 • 
Identification of HUVEC. The endothelial nature of the 
cultured cells was determined by observing the typical 
"cobblestone" morphological appearance of the monolayer 
when viewed under phase contrast microscopy (Nikon 
Inverted Phase Contrast Microscope, Model M), and by 
immunofluorescent staining for the factor VIII antigen. 
Direct immunofluorescent staining for factor VIII antigen 
was performed on selected confluent cultures using 
fluorescein-conjugated rabbit anti-human factor VIII 
related antigen (Atlantic Antibodies, Scarborough, ME) 
according to the protocol of Maciag et al (1981). 
Addition of Corticosteroids. Dexamethasone (DEX), 
dehydroepiandrosterone (DHEA), and hydrocortisone (HC) 
(Sigma Chemical Co., St. Louis, MO) were dissolved in 
either absolute ethyl alcohol (EtOH} or dimethyl sulfoxide 
(DMSO). The corticosteroid dilutions were adjusted so 
that the DMSO concentration in the media was standardized 
at 0.1%. When EtOH was used as a steroid solvent, the 
maximum concentration was 0.2% Control cultures were also 
run at these concentrations. For each steroid dosage, 
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triplicate flasks were evaluated; for control cultures, 
quadruplicate flasks were evaluated. 
Trypsinization and Cell Counting. At selected times after 
subculturing, depending on the experimental paradigm being 
used, cultures were washed with HBSS without calcium or 
magnesium, rinsed briefly with 0.025% trypsin-0.01% EDTA, 
and incubated at 37 degrees C for six minutes. Either CM-
199 or counting medium (Medium 199 plus 20% FBS, and 
antibiotic-antimycotic solution) was added and a single 
cell suspension was obtained by repeated aspiration. The 
cells were counted in quadruplicate using a hemacytometer. 
A trypan blue exclusion procedure (0.4% trypan blue mixed 
with the cell suspension at a 1:5 ratio) was used to 
determine the viability of harvested cells. 
Percentage of Attachment and Population Doubling. For 
percentage of attachment (PA) determination, quadruplicate 
flasks for the selected experimental manipulation were 
seeded at established cell densities (1.25 x 105 
cells/flask). After incubation at 37 degrees C and 5% co2 
for 24 or 48 hours, several flasks were washed with 
appropriate media and the cells harvested and counted. 
The PA is the number of cells harvested divided by the 
number of cells seeded. This value determined the number 
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of cells present on the day steroids were added to the 
culture system, and was used in calculating growth rates 
and population doublings of HUVEC between either two and 
five or between two and seven days. The remaining flasks, 
after washing with media, were returned to the incubator 
until harvested according to the particular experimental 
protocol. The number of population doublings (PD) between 
seeding and ultimate harvesting was determined as follows: 
PD= log 
log 2 
When corticosteroids were tested, the control flasks 
contained EC from the same subculture as the experimental 
flasks, and were subsequently handled in identical 
fashion, using medium including either EtOH or DMSO 
without corticosteroid. Control cultures without steroids 
or solvent were also studied. Population doublings were 
compared using ANOVA and a Duncan Multiple Range Test to 
test for significant differences. 
Fixation of EC. Cultures were fixed for preservation of 
morphology according to the following procedure. After 
removing the medium from the flasks, each flask was washed 
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twice in fresh phosphate buffered solution with calcium 
and magnesium. Then, 2.5% glutaraldehyde in 0.1 M sodium 
cacodylate (pH = 7.3) was added to each flask, and the 
flask fixed at room temperature for one hour. After 
fixation, the flasks were rinsed once with 0.1 M sodium 
cacodylate buffer containing 7% sucrose. The cultures 
were then stored in the sucrose-cacodylate buffer at 4 
degrees C until further evaluation was undertaken. 
Absorbed Serum. Hyclone FBS was absorbed with a a 
charcoal-dextran mixture to remove endogenous steroids by 
the following procedure. The absorption material was 
prepared by mixing 3.75 gm. of activated charcoal with 
0.375 gm. of dextran, and dissolving both in 100 ml. of 
deionized-distilled water. After thorough mixing, 10 ml. 
of the absorption preparation was removed and centrifuged 
at 2,000 g for five minutes. The pellet was recovered, 
and then added to 100 ml. of FBS. The serum-charcoal­
dextran mixture was then refrigerated at 4 degrees C for 
24 hours with constant, gentle stirring. At the end of 
this time period, the mixture was removed from 
refrigeration and centrifuged at 10,000 g for 20 minutes. 
The clear supernatant was collected and this absorbed 
serum immediately frozen at -16 degrees C until use in the 
appropriate experiment. 
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Colony Forming Assay. As an alternative method for 
assessing proliferation capacity of selected endothelial 
cell cultures, subcultured EC from a selected passage were 
harvested, counted, and seeded into T-25 flasks at clonal 
densities (1,000 cells/flask). After sufficient time to 
allow colony formation (eight to eleven days), the colony 
containing flasks were fixed as described above. Fixed 
cultures were rinsed twice in distilled water, and stained 
with 0.5% azure II and 0.5% methylene blue in 0.5% sodium 
borate. The number of colonies (at least 50 cells per 
colony) were counted for each flask, and experimental 
flasks and control flasks were compared using an ANOVA and 
a Duncan Multiple Range test to determine significant 
differences. 
Cytofluorometry. The EC were prepared for cell cycle 
analysis according to the following procedure: The cells 
were trypsinized as described and suspended in 4 to 10 ml. 
of CM-199 in a gelatin-free plastic centrifuge tube, and 
counted. The cells were then centrifuged at 1000 x g for 
5 minutes, and after removing the supernatant, the cells 
were vortexed and resuspended in 1.5 ml. of PBS without 
calcium or magnesium. While vortexing, 3 ml. of 95% 
ethanol was added dropwise. The cells were allowed to fix 
in this ethanol solution for one hour on ice. If desired, 
the cells could remain in this fixative up to one week 
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before additional processing. After centrifugation and 
supernatant removal, 10 to 20 ml. of staining solution 
(3.8 x 10-3 M sodium citrate, 2 mg/ml RNase, 0.05 mg/ml 
propidium iodide in distilled water) was added, and the 
cells stained on ice for three hours. The cells were then 
centrifuged, the supernatant removed, and the pellet 
resuspended in PBS at a concentration of 1 x 106 cells/ml. 
After filtering the cells through several sizes of nylon 
mesh (74 pm, 44 pm, 37 pm), the suspension underwent cell 
cycle analysis in a Coulter EPICS V Cell Sorter (Coulter 
Diagnostics, Hialeah, Fl.). DNA histograms were generated 
and the percentages of cells in the G0 + G1, S, and G2 + M 
phases of the cell cycle were determined using a computer 
algorithm designed for the EPICS V System (Parametric 
Analysis I, by c. Bruce Bagwell, Coulter Diagnostics, 
Hialeah, Fl.). Light scatter analysis using the cell 
sorter provided relative information on the average size 
of the cells in the cell population tested. The main 
purpose of using cytofluorometry was to determine the 
effect of corticosteroids on endothelial cellular size. 
The claim that corticosteroid administration increases the 
size of the EC (Maca et al., 1978) was addressed by 
obtaining cell size information from the cell sorter. 
Early experiments indicated that a dose related increase 
in EC size occurs after subculturing the cells in the 
presence of dexamethasone. Although limited flow 
39 
cytometric data regarding EC from the human umbilical vein 
were reported by Goldsmith et al. (1984), there are no 
reports in the literature describing the effects of 
corticosteroid treatment upon the cell cycle kinetics of 
HUVEC. 
Experimental Designs 
Effect of Corticosteroids Dissolved in EtOH. In order to 
determine the effects of corticosteroids, as well as the 
effects of ETOH as a solvent on the log phase growth of 
HUVEC, flasks were plated with first, second, or third 
passage HUVEC at standard density (1.25 x 105 cells/ 25 
cm2 flask). CM-199 containing corticosteroids dissolved 
in EtOH at various doses (DEX (1 pM, 0.5 VM) or HC (1 �M)} 
were added to the culture flasks at two days after 
plating, just as the cells were about to enter the 
logarithmic phase of cellular growth. Three separate 
control groups were also examined: no EtOH, 0.2% EtOH, and 
0.1 % EtOH. Cultures were refed with either control or 
steroid containing media on the fourth or fifth day after 
plating. The flasks were subsequently trypsinized and 
counted on the seventh day after plating. Cellular growth 
determinations between two and seven days after plating 
were made for the various control and corticosteroid 
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concentrations. The population doubling which occurred 
between two and seven days, which takes into account the 
number of cells present on the day of steroid 
administration, was calculated for each corticosteroid 
dosage. 
Effect of Corticosteroids Dissolved in DMSO. In order to 
determine the effects of DMSO as a solvent, as well as a 
single steroid feeding on the second day on the log phase 
growth of HUVEC, flasks were plated with second or fourth 
passage HUVEC at standard density. DEX (5 µM, 1 µM, 0.5 
µM, 0.1 µM); HC (20 µM, 10 µM, 5 µM, 1 µM); or DHEA (50 
µM, 20 µM, 10 µM, 5 µM) dissolved in DMSO were added to 
the culture flasks at two days after plating. The DMSO 
concentration was adjusted to 0.1% in all steroid­
containing media. HUVEC in CM-199 alone or CM-199 with 
0.1% DMSO served as control groups. After this initial 
feeding with steroids or control media, the cultures were 
not fed for the remainder of the experiment. At seven 
days, the flasks were trypsinized, cells were counted, and 
cellular growth and population doublings between two and 
seven days were determined. 
Effect of Charcoal Filtered FBS. In order to determine 
the effects of filtered FBS upon the growth of steroid 
treated HUVEC, CM-199 was prepared using Hyclone FBS which 
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was filtered twice through activated charcoal to remove 
endogenous steroids. All other media ingredients were 
identical to those used in preparing CM-199. Second 
passage HUVEC were plated at standard density, and DEX, 
HC, or DHEA dissolved in DMSO at the same doses as 
outlined immediately above were added to the culture 
flasks at two days after plating. Control flasks were 
plated with and without the DMSO solvent at the standard 
final concentration of 0.1%. The cultures were not refed 
during the experiment, and the flasks were trypsinized and 
counted on the seventh day after plating. 
This experiment was repeated for DEX alone at the 
same dosages (5 µM, 1 µM, 0.5 µM, 0.1 µM) utilizing cells 
from the same cord but at a later passage (passage 4). In 
this experiment, both unabsorbed and charcoal filtration 
absorbed FBS containing media were employed and the 
results compared. 
Comparison of Male and Female HUVEC. In order to compare 
the effects of corticosteroids on male and female HUVEC, a 
wider dosage range of DEX was used. Second passage 
cultures derived from paired male and female HUVEC 
harvested on the same day and passaged under identical 
conditions were used in these experiments. DEX (5 µM, 1 
µM, 0,5 µM, O.l µM, 0.01 µM, or 0.002 jlM) dissolved in 
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DMSO was added to either male or female cultures of HUVEC 
at two days after plating. There was no refeeding step 
involved. Since these cultures grew fairly rapidly, 
confluence was reached in many flasks by the sixth day. 
Due to this, the decision was made to evaluate the 
experiment on the sixth, rather than the seventh, day, 
lest cells be lost to the culture media. 
Effect of Reduced (1%) FBS. DEX at the same doses used in 
the male-female comparison experiments was tested using 
media with a reduced serum component. One percent instead 
of the usual 20% FBS was used in preparing culture media 
for this experiment; all other media ingredients were 
identical to those used in CM 199. The six dosages of 
DEX, dissolved in DMSO, were added to second passage HUVEC 
at two days after plating. Again, the final DMSO 
concentration was 0.1%. The flasks were trypsinized and 
counted on the seventh day after plating with no refeeding 
step following the initial steroid administration. This 
experiment was repeated for 0.1 �M DEX and 0.001 pM DEX 
utilizing fourth passage cells derived from the same cord 
as cells used for the reduced serum experiments above. In 
this experiment, media containing either 1% FBS or 20% FBS 
was employed and the results compared. The experiment was 
again repeated for DEX at a slightly wider dose range (5 
43 
µM, 1 pM, 0.1 pM, or 0.01 pM), utilizing third passage 
cells obtained from a different cord. 
Effect of Repeated Steroid Dosing. In all above 
experiments employing DMSO as a steroid solvent, cultures 
were fed only on the second day, with final count 
performed on the sixth or seventh day. In order to 
determine the effect of a second steroid feeding on the 
log phase of growth of HUVEC when treated with DMSO 
dissolved steroids , DEX (1.0 }lM, 0.5 pM, 0.1 µM, or 0.01 
}lM) was dissolved in DMSO and added to second passage 
cultures of HUVEC on the second and fourth day after 
plating at standard density. The cultures were 
trypsinized and counted on the seventh day to ascertain 
the effect of a second steroid feeding on the log phase 
growth of HUVEC. This experiment was repeated for the 
same four DEX doses utilizing fourth passage endothelial 
cells derived from a different cord. 
Effect of Steroids on Proliferation of HUVEC at Four Days. 
In order to determine if corticosteroid administration had 
an earlier effect on endothelial cellular proliferation 
than was seen at seven days, DEX at the same four doses 
used in the repeated steroid dosing experiments above was 
dissolved in DMSO and added to the culture flasks on the 
second day after plating. Without any further refeeding, 
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the flasks were trypsinized and counted on the fourth day, 
two days after steroid administration. The purpose of 
these interventions was to determine if DEX had any early 
effect on the proliferation of HUVEC that might be masked 
after growing for seven days as in preceding experiments. 
This four day cell counting experiment was repeated using 
the same four doses of DEX utilizing fourth passage 
endothelial cells derived from a different cord. 
Dexamethasone and Colony Formation of HUVEC. Employing an 
alternate method of proliferation assessment, DEX (1 pM or 
0.1 }l-M) was used in a colony forming assay to determine 
the effect of this steroid upon growth of HUVEC. Four 
variations were used in these experiments, in order to 
determine the influence of DEX on both plating and growth 
of HUVEC. Seventh passage HUVEC were used in all colony 
formation assay experiments. The first variation tested 
the effect of DEX on growth only as measured by colony 
formation. Triplicate flasks for the two DEX doses and 
for the control group were plated at colony formation 
density (1,000 cells/flask). At four hours after plating, 
the flasks were washed in plain medium 199, and 
immediately thereafter fed with CM-199 containing the 
desired DEX concentration or with CM 199 with 0.1% DMSO 
alone (control). The cultures were fed twice more at 
three day intervals with the appropriate steroid or DMSO 
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media, and fixed and evaluated on the ninth day after 
plating. 
The second variation tested the effect of DEX on 
plating only. Triplicate flasks for 1 uM DEX or 0.1 uM 
DEX and control flasks were plated at colony formation 
density in CM 199 with the appropriate DEX dosage or CM 
199 with 0.1% DMSO alone, respectively. At four hours 
after plating, the cultures were washed with plain medium 
199, and immediately thereafter fed with CM-199. The 
cultures were fed twice more at three day intervals with 
CM-199, and fixed and evaluated on the ninth day after 
plating. The third variation tested the effects of 
dexamethasone on both plating and growth. In this 
experiment, triplicate flasks were plated at colony 
formation density in CM-199 with either 1 µM DEX or O.lyM 
DEX, or CM-199 with 0.1% DMSO alone. At four hours after 
plating, the cultures were washed with plain medium 199 
and immediately thereafter fed with CM containing the 
desired DEX concentration or with CM-199 with 0.1% DMSO 
(control). The cultures were fed twice more at three day 
intervals with the appropriate steroid or DMSO medium, and 
fixed and evaluated on the ninth day after plating. 
The fourth variation was designed to test the effect 
of the wash step four hours after plating. In this 
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experiment, the cultures were plated and fed in CM-199 
exclusively. Two groups were evaluated, one with and one 
without the wash step with plain medium 199 at four hours 
after plating, prior to the first feeding with CM-199. 
Otherwise, the treatment of the groups was the same: the 
cultures were fed twice more with CM-199, and fixed and 
evaluated on the ninth day after plating. 
Cytoflurometry Experiments. In order to determine the 
effect of corticosteroids on the percentage of cells in 
the various phases of the cell cycle and on cellular size 
in HUVEC, cultures were plated at standard density. DEX 
(1 ).lM, 0.5 ).lM) was dissolved in EtOH and added to the 
culture flasks on the second and fourth day after plating. 
The final concentration of EtOH in the steroid-containing 
media was 0.2% for 1 µM DEX and 0.1% for 0.5 µM DEX. Two 
control groups were also examined: no EtOH and 0.2% EtOH. 
Cells were harvested on the seventh day and prepared for 
flow cytometry as described. The percentages of cells in 
the G0 + G1, S, and G2 + M phases of the cell cycle were 
determined; light scatter analysis provided information 
concerning the relative size of the control and steroid 
treated cells. 
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Results 
Effect of Glucocorticoids Dissolved in Alcohol 
The purpose of our experiments was to determine if 
dexamethasone-heparin or hydrocortisone-heparin 
combinations affected the log phase of cellular growth in 
HUVEC. In early experiments in our laboratory, EtOH was 
used as a corticosteroid solvent, and its final 
concentration in the medium was 2.0%, 0.2% or 0.1%. When 
2.0% EtOH was used as a solvent, it was toxic to the 
cells, and the concentration was lowered for subsequent 
experiments. For 1 }lM DEX, the EtOH concentration was 
0.2%; for 0.5 pM DEX, it was 0.1%. Controls were run at 
both concentrations, and the cultures were fed with 
corticosteroid-containing media on the second and fifth 
day after plating. The cell number harvested at seven 
days and the number of population doublings between two 
and seven days are shown in Figures la and lb 
respectively. The graphs illustrate the pooled cell 
counts and population doublings from four experiments at 
the above steroid doses and control conditions. An ANOVA 
and Duncan's multiple range test were the test statistics 
used to examine the population doublings in this and all 
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other experiments reported here. Both steroid doses were 
associated with inhibition of cellular growth at seven 
days. Regarding population doublings, DEX at 1 pM caused 
a significant decrease in population growth compared to 
the control. DEX at lJlM also effected a significant 
inhibition of population doubling when compared to either 
0.1% or 0.2% EtOH solvents, which both caused slight, but 
not significant, inhibition of population doubling when 
compared to controls. Thus, alcohol was only slightly 
toxic to the cells at the concentrations employed, causing 
some minor growth suppression. The results indicate that 
1 uM DEX demonstrated a greater inhibition of growth than 
0.5 uM DEX, suggesting a dose response. However, only two 
doses were tested; a wider dose range was needed to 
substantiate a graded, dose-related inhibition of cellular 
and population growth. 
Hydrocortisone (HC) was tested at 1 pM, in 0.2% 
EtOH. Controls were run at this alcohol concentration, 
and also without alcohol. Cultures were fed with steroid 
containing or control medium on the second and fifth day 
after cell plating, with cell harvest on the seventh day. 
The results from pooled cell counts and population 
doublings from three experiments conducted at 1 pM HC and 
control conditions are shown in Figures 2a and 2b, 
respectively. Cultures exposed to alcohol at 0.2% 
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displayed only slightly suppressed cellular growth at 
seven days. At the 1 µM concentration, HC caused growth 
inhibition, but this was not significant. Although 1 µM 
HC effected a slight decrease in the number of population 
doublings at seven days, it was not significant (Figure 
2b). Since only one dose was tested, it cannot be 
ascertained whether there was a dose response. In a 
single experiment, 10 JlM HC dissolved in a final media 
concentration of 0.1% EtOH was tested. Both 0.1% EtOH 
control and HC at 10 pM led to a significant inhibition of 
population growth, compared to the EtOH-free control 
group, so it could not be concluded that HC at this 
relatively high dose was growth inhibitory to HUVEC (data 
not shown). 
A limited number of doses were used initially, 
especially for HC. It was clear from these findings that 
more extensive dose-response information was needed. In 
these initial experiments, the cultures were fed twice 
with steroid containing medium, and this factor may have 
potentiated the inhibitory effect of corticosteroids upon 
HUVEC. Also, the use of EtOH as a solvent was questioned. 
Although used by previous researchers (Almasio et al., 
1984; Maca et al., 1978a; Piovella et al., 1980;), it was 
possible that EtOH as a solvent might affect the response 
of HUVEC to corticosteroid intervention. 
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Dimethylsulfoxide (DMSO) was proposed as a better solvent, 
due to its relative non-reactivity with steroids, and its 
lack of effect upon various cellular functions (M.Y. 
Kalimi, personal communication). All subsequent 
experiments reported in this paper were performed with a 
uniform DMSO concentration (0.1%) in the media used for 
the DMSO-control and all steroid doses. Each experiment 
also contained a control group not exposed to DMSO or 
steroids. In addition, all experiments were performed 
with heparin included in the media. 
Effect of Corticosteroids Dissolved in DMSO 
To determine the effect of DMSO as a solvent, of a 
single feeding with steroids on day two, and of a wider 
range of doses on the growth of HUVEC in the log phase, 
several experiments were carried out. In addition to DEX 
and HC at a wider dose range, another corticosteroid­
dehydroepiandrosterone (DHEA) - was tested. Unlike DEX 
and HC, DHEA is not a glucocorticoid. DHEA is a 
quantitatively major steroid secreted by the adrenal 
cortex (15-30 mg/day in humans), and plays a role in 
adrenal androgen metabolism. DHEA is converted to 
androst-4-ene 3,17, dione, which in turn is converted to 
either testosterone or estrogen or is excreted as 
androsterone and etiocholanolone in the urine. 
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CM-199 containing DEX at four doses, containing DMSO 
(0.1%) without steroid, or containing no added steroid or 
solvent, was administered to HUVEC in culture on the 
second day after plating, with cellular harvest and 
counting performed on the seventh day. The additional 
steroid feeding used in the EtOH solvent experiments was 
omitted. The data represent the pooled results of two 
experiments conducted under identical parameters and 
conditions. For flasks receiving HC and DHEA, which were 
run simultaneously and are reported below, the basic 
experimental procedure regarding cell plating, steroid 
addition, and cell harvest was the same. There was little 
difference between control and 0.1% DMSO control cultures, 
suggesting that DMSO as a solvent had little effect on the 
growth of HUVEC. The control groups served as controls 
for all three steroids. The data illustrating the cell 
number for DEX at seven days are depicted in Figure Ja. 
All four doses of DEX (5 _µM, 1 µM, 0.5 pM, & 0.1 �M) 
effected a paradoxical increase in cellular growth. The 
population doublings are shown in Figure Jb. Compared to 
DMSO control, all four DEX doses caused a significant 
increase in population growth at seven days, although 
there was not a dose response. 
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The four doses of HC employed in DMSO solvent 
experiments were relatively higher than those used for 
DEX. Since HC is a less potent glucocorticoid than DEX, 
slightly increased doses of the former were used. Also, 
since 1 µM HC in a previous experiment (Figure 2b) 
effected a decrease in growth, albeit non-significant, 
higher doses might have been expected to manifest a 
similar inhibitory effect. However, as was the case with 
DEX, all four HC doses demonstrated a paradoxical increase 
in cellular growth at seven days (Figure 4a). All four HC 
doses caused a significant increase in population 
doublings at seven days, compared to DMSO control (Figure 
4b) . 
The significant increases in population doubling 
observed following both DEX and HC treatment led to the 
idea that the cells possibly overcome the initial 
inhibitory effects of the corticosteroid, and rebound 
strongly, therefore leading to a relative increase in 
growth at seven days. This conceptual question was 
addressed in later experiments, when the proliferation of 
steroid-treated HUVEC was measured at four days. 
As with DEX and HC, DHEA at the doses tested caused 
an increase in cell number (Figure 5a). Statistical 
analysis of the population doublings (Figure 5b) indicated 
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that the PD achieved with DHEA 50 µM, 20 µM, and 5 µM were 
significantly higher than those attained by the DMSO 
control group. A dose response was not found. DHEA at 10 
p.M, although causing growth enhancement, was not 
significantly different from the DMSO control group. 
In the first set of corticosteroid-heparin treatment 
experiments using DMSO as a solvent, all three steroids 
tested caused growth enhancement in HUVEC. Since the same 
two cell lines derived from the same two umbilical cords 
were used for all three steroids, it could be possible 
that these cell lines responded to corticosteroid 
treatment by growth facilitation. It cannot be ruled out, 
however, that an initial decrease in cellular growth may 
have occurred, and was overcome by a subsequent increase 
in cellular growth as the cells recovered from the 
pharmacological treatment by seven days. Note these 
findings are in contrast to those found by Piovella et al. 
{1980) and Maca et al. (1978a), who reported an early 
increase in cell numbers under the influence of DEX which 
stabilized by the sixth day after plating so that cell 
numbers in control and treatment flasks were comparable. 
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Effect of Absorbed Serum 
The purpose of charcoal-dextran absorption of the 
Hyclone FBS used in these experiments was to remove 
endogenous steroids that might affect the interaction of 
the cells with the test steroid. Theoretically, freeing 
the media of endogenous steroids would free receptors on 
the endothelial cell, and make it more responsive to 
exogenously added steroids. Both absorbed and unabsorbed 
FBS were used in a final concentration of 20%. In the 
first of these experiments, DEX was tested in this 
absorbed medium and compared to DEX administered to HUVEC 
in CM-199 with unabsorbed serum. DEX at the same doses 
used in the initial DMSO solvent experiment was added to 
HUVEC growing for two days. As in previous experiments 
using the DMSO solvent system, only one steroid feeding 
was done. At seven days, the cell number and population 
doublings (Figures 6a and 6b respectively) were compared 
between the absorbed and the unabsorbed group. 
In comparison to absorbed serum, obviously greater 
growth in the HUVEC occurred when the unabsorbed serum was 
used. This could suggest that endogenous steroids in the 
serum used in routine media preparation might be 
facilitative to cellular growth in HUVEC. Alternatively, 
other growth factors in serum might be altered by the 
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charcoal filtration process. Using absorbed serum, very 
little variation from the DMSO control was observed when 
DEX was added to the cultures. For the absorbed group, 
DEX at 5 JlM and 1 }lM was associated with a significant 
decrease in population doublings compared to controls, but 
not to DMSO controls. Therefore, it cannot be concluded 
that the relative decrease seen in the DEX treated flasks 
was due to the corticosteroid alone. The difference 
between control and DMSO control is greater for the 
absorbed group than for the unabsorbed group. Apparently 
the charcoal filtered serum, with its endogenous steroids 
removed, allowed DMSO to exert a more suppressive effect 
on cellular growth. 
In the unabsorbed group, all four doses of DEX 
caused a significant decrease in population doublings at 
seven days (Figure 6b). This is an interesting finding, 
since DEX at the same doses was growth enhancing in 
previous experiment (Figures Ja and 3b). Growth 
inhibition occurred in some DEX doses in absorbed serum­
containing media, although it was significant only in the 
media containing unabsorbed serum. 
Since the use of absorbed serum suggested a possible 
trend toward inhibition of growth, it was decided to 
retest DEX, and, in addition, to examine the effects of 
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absorbed serum upon RC-heparin and DHEA-heparin 
administration. In followup experiments, DEX, HC, and 
DHEA were again tested using the dosages employed in the 
initial DMSO solvent experiments, but this time employing 
media containing absorbed serum. A simultaneous 
comparison with unabsorbed serum was not done in this 
experiment. The results using DEX are shown in Figures 7a 
and 7b, which display the cell number and population 
doublings at seven days, respectively. In this 
experiment, DEX at 5 µM and at 1 p.M caused growth 
inhibition and population growth inhibition while DEX at 
0.5 pM and at 0.1 J..1M caused growth facilitation. These 
differences are not significant. DEX at 5 pM and 1 JlM 
doses caused population doublings to be significantly 
lower than controls, but not lower than DMSO controls 
(Figure 7b). As in Figure 6b, then, the decrease in 
population doublings observed was not due to 
corticosteroid intervention alone. As they did in the 
preceding absorbed FBS experiment, the two highest doses 
of DEX again caused growth inhibition. It is interesting 
that in both experiments, the higher DEX doses (5 µM, 1 
µM) caused growth levels that were significantly lower 
than controls, but not DMSO controls. Again, the results 
may well reflect a greater suppression of cell and 
population growth by DMSO in the absorbed serum. 
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When HC was used (20 pM, 10 µM, 5 pM, 1 pM) with 
absorbed serum, all four doses effected an increase in 
cellular and population growth at seven days (Figures 8a 
and 8b). A dose response was not observed. The 
population doublings for all HC doses except 10 pM were 
significantly greater than the DMSO control group. 
However, the 10 )lM dose of HC still caused an increase in 
population growth. Apparently, the facilatory effect of 
HC upon cellular growth of HUVEC, demonstrated for 
unabsorbed serum (Figure 4b), does not appear to be 
influenced by using absorbed serum. 
When DHEA (50 pM, 20 pM, 10 yM, and 5 pM) was used 
with absorbed serum, a variable response was found. 
Figures 9a and 9b display the cellular and population 
growth respectively at seven days for the various doses of 
DHEA. In absorbed serum, 10 µM DHEA inhibited population 
growth which was significantly less than control, but not 
DMSO control groups; therefore this inhibition was not due 
solely to corticosteroid intervention. Addition of DHEA 
(20 µM) caused a non significant increase in cellular and 
population growth at seven days, compared to DMSO control, 
but the population growth observed at this dose was still 
less than that for the control group. For two doses of 
DHEA, 50 µM and 5 µM, neither growth inhibition nor 
facilitation occurred. This is in contrast to the 
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facilitory effect of DHEA when unabsorbed serum was used 
(Figures 5a and 5b). Since the experiments with absorbed 
serum were run simultaneously for DEX, HC, and DHEA, 
comparison for each steroid was to the same control and 
DMSO control treatment groups. 
In summary, when DEX, HC, and DHEA were tested in 
media containing absorbed serum, the inhibitory effect of 
DEX, at least at higher doses, appeared to be somewhat 
sustained, while the facilitory effect of HC seen in DMSO 
solvent experiments (albeit with unabsorbed medium) was 
unaffected by the absorbed serum. DHEA at the doses used 
resulted in a variable response. In this second group of 
experiments employing medium containing absorbed FBS, a 
non significant difference between control and DMSO 
control groups was again observed (Figure 6b). This 
difference was relatively greater than that observed when 
unabsorbed serum was used. 
Comparison of Male and Female HUVEC 
For some time in our laboratory, it had been 
observed that female and male HUVEC appeared to grow quite 
differently in culture. It was noticed that female HUVEC 
tended to grow more rapidly yet enter the senescent phase 
of a culture's life span later, and overall senesce at a 
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slower rate when compared to male HUVEC. Experiments to 
assess this observation quantitatively are in progress. 
It was decided to compare the cellular and population 
growth response of DEX-heparin treated female and male 
HUVEC. Also, two additional doses of DEX (0.01yM and 
0.002 pM) were examined for their effects in both the 
female and male cultures. Steroids were dissolved in DMSO 
and added to the cultures on the second day after plating. 
For both the female and male treatment and control 
cultures, cell harvest was on the sixth, instead of the 
customary seventh, day. The cellular and population 
growth was thus assessed slightly earlier than previous 
assays. However, the cultures were confluent at the time 
of trypsinization and further delay would have resulted in 
lost cells. Cell lines for the female and male HUVEC used 
in this experiment were derived from cords started on the 
same day, and passed identically. The male and female 
cells utilized were of the same age and passage number. 
For the female HUVEC (Figures lOa, 10b), there was 
no dose-response effect when six doses of DEX were used. 
However, the trend was again noticed that the higher doses 
of DEX (5 µM, 1 µM, and 0.5 )lM) caused a slight decrease 
in population growth (Figure 10b), while the lower doses 
of DEX (0.1 µM, 0.01 µM, and 0.002 JlM) caused a slight 
increase in population growth. These differences, 
60 
however, were not significant. Again, it was also 
observed that when using unabsorbed serum there was very 
little difference between control and DMSO control flasks 
regarding cellular or population growth assays. 
It can be pointed out that the cell number and 
population doublings in the male treatment and control 
groups (Figures lla, llb) were somewhat lower than the 
corresponding values in the female treatment and control 
groups (Figures lOa, 10b). This observation lends support 
to the suggestion that female and male HUVEC grow at 
different rates. There was little difference between the 
control and DMSO control groups when male cells were 
utilized. Apparently, the slight inhibition of cellular 
and population growth that occurs in 0.1% DMSO alone in 
the medium, when compared to DMSO-free control groups, is 
not sex-specific and is a property shared by cells derived 
from either gender umbilical cord. A variable response 
was found among the male HUVEC treated with the six DEX 
doses. DEX at doses of 0.5 µM and 0.002 pM caused a 
slight (n.s.) inhibition in cellular growth at six days. 
The remaining DEX doses (5 pM, 1 µM, 0.1 µM and 0.01 yM) 
caused a facilitation in cellular growth at six days. DEX 
at 0.01 pM caused a significantly greater increase in 
population doubling when compared to DMSO control. In 
addition, the increase in population growth effected by 
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DEX at 0.01 µM was significantly different from control, 
0.5 )lM, and 0.002 µM DEX. Here, compared to female HUVEC, 
the higher doses of DEX (5 pM, 1 �M) caused an increase, 
rather than a decrease in cellular growth. However, a low 
dose of DEX (0.01 pM) caused a significant increase in 
cellular and population growth, which corroborates 
previous findings with lower doses of DEX (Figures 6b, 
7b) • 
To summarize, in female HUVEC, the differences 
between treatment and DMSO control groups were not 
significant, but it was observed that the higher doses of 
DEX were manifested in a slight decrease in population 
growth, while the lower doses of DEX in a slight increase. 
The results for male HUVEC were less clear, but 
nonetheless DEX at 0.01 fM caused a significant increase 
in population growth, which supports a trend for lower 
doses of DEX enhancing growth, a finding suggested by 
previous experiments. 
Effect of Dexamethasone in Reduced (1%) Serum 
Growth of HUVEC in culture does not occur when serum 
is omitted from the media, unless serum substitutes are 
used. While optimal growth of these rather fastidious 
cells occurs with heparin, ECGF, and 20% FBS, reduction of 
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the serum component in the medium to a concentration as 
low as 1% can support low level growth of the cells. In 
order to determine whether DEX could affect cells under 
suboptimal growth conditions, six doses of DEX were used 
in combination with 1% FBS. As in all previous 
experiments using DMSO as a solvent, the cultures were fed 
with experimental media on the second day. The cell 
numbers (Figure 12a) demonstrated that all six doses of 
DEX caused a decrease in cell number at seven days, when 
compared to the DMSO control group. All doses of DEX 
except 0.5 pM caused a population growth that was 
significantly lower than DMSO control and control. The 
results are similar to our earlier experiments with DEX 
when ETOH was the steroid solvent. Apparently, using 
medium with a reduced serum component (1%) allows the 
inhibitory effect of DEX treatment to be more fully 
expressed. 
Next, two doses of DEX (0.1 JlM and 0.01 pM) were 
employed in a comparison experiment using fully 
supplemented media (20% FBS) or reduced serum medium (1% 
FBS). The same cell line as used in the 1% FBS experiment 
immediately preceding (Figures 12a, 12b) was used in the 
comparison experiment, except that the cells were at a 
later passage. A regular control group was not run, and 
all statistical comparisons were made with the DMSO 
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control group. Figures 13a and 13b depict the effect of 
DEX in media containing 20% and 1% FBS upon cellular and 
population growth, respectively. There was much greater 
growth in 20% FBS as expected. With 1% FBS in the culture 
medium, a non-significant decrease in cellular and 
population growth was observed for both DEX doses. With 
20% FBS, growth enhancement at seven days was observed. 
Both the 0.1 pM and the 0.01 pM doses of DEX caused a 
significant increase in the number of population 
doublings, when compared to DMSO controls. A dose 
response over this range was not observed. Again, the 
reduced serum (1%) appeared to unmask an inhibitory effect 
of DEX or to prevent the stimulation observed with 20% 
FBS. The growth enhancement seen with 20% FBS was 
consistent with that found earlier when DMSO was used as a 
solvent (Figures 3b, llb). 
The 1% vs. 20% FBS comparison experiment was 
repeated using a slightly wider dose range of DEX (5 )lM, 1 
)lM, 0.5 pM, 0.01 �M) using third passage cells from a 
different cord. There was little difference in cellular 
or population growth between 0.1% DMSO controls and 
controls when either the 1% or the 20% FBS was used 
(Figure 14a, 14b). Using 1% serum, growth was slightly, 
but not significantly, facilitated at seven days at the 
lower doses of DEX (0.1 �M, 0.01 �M); however, DEX at 
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doses of 5 pM and 1 µM had no effect. When 20% FBS was 
used, a relatively high dose of DEX (5 pM) caused a 
significant increase in population growth compared to DMSO 
controls (Figure 14b). Actually, all doses of DEX when 
used with 20% FBS enhanced population growth. This was 
consistent with earlier DEX experiments when 20% serum 
containing medium was used (Figures 3b,llb,13b). 
In summary, a dose response was not observed in the 
above three experiments employing a reduced serum 
component in the culture medium. Using 1% serum allowed 
DEX to exert an inhibitory effect on the growth of HUVEC 
in two of three experiments, although this was not 
significant in one of them. When 20% FBS was used in 
comparison experiments, cellular growth and population 
growth were enhanced, much as it was in the initial DMSO 
solvent experiments. Even when using higher doses of DEX 
(5 )lM, 1 pM) that had proven inhibitory previously 
(Figures 3b,7b,9b), growth enhancement occurred with 20% 
FBS containing medium. Since DEX in medium containing 20% 
FBS either facilitated or inhibited growth, depending on 
the cell line used, these findings can be related to the 
clonal specificity theory of Longenecker et al. (1982), 
who reported that EC exhibited a clonal heterogeneity 
regarding their response (inhibitory or facilitory) to 
glucocorticoid treatment. 
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Effect of Repeated Steroid Dosing 
When EtOH was used as a solvent in our early 
experiments, the cultures were fed twice, at two and five 
days, with corticosteroids. In all previous experiments 
employing corticosteroid-heparin combinations and DMSO as 
a solvent, the cells were fed with steroid containing 
medium only once on the second day after plating. Cells 
were counted at seven days. The purpose of the next 
experiments was to determine the effect of a second 
steroid feeding on the log phase growth of HUVEC when DMSO 
was used as a solvent. In these experiments, cultures 
were fed on the second and fourth day after plating, and 
counted on the seventh day. DEX at doses of 1.0 pM, 0.5 
y.M, 0.1 }lM, 0.01 J1M was used. Table 1 shows that at seven 
days, all four doses of DEX caused a decreased cell count. 
Apparently the second steroid feeding at four days after 
plating sustained the inhibitory effect of DEX seen in 
some previous experiments. However, while all four doses 
of DEX caused a decreased population growth at seven days, 
none were significantly different from DMSO controls. 
When the experiment was repeated using later passage 
cells from a different cord, growth enhancement occurred 
(Table 2) despite the second steroid feeding. Three of 
the four doses of DEX caused a significantly greater 
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population growth (Table 2) when compared with DMSO 
control. Thus, it was observed that when cultures of 
HUVEC were fed twice with steroid medium, a non­
significant inhibition occurred in one experiment, while a 
significant enhancement of cellular and population growth 
occurred in a second experiment. Since these experiments 
were conducted under identical conditions (except for the 
passage number), the clonal specificity response again 
appears to be supported (Longenecker et al., 1982). 
Effect of Steroids on Proliferation of HUVEC at Four Days 
Following the observations of Piovella et al. 
(1980), who noticed an enhancement of growth for the first 
five days of steroid treatment of HUVEC but level growth 
at seven days, and our own conflicting findings using 
seven day assays, it was decided to determine if steroids 
had an earlier effect on cellular proliferation and 
population growth than could be seen at seven days. These 
experiments were run simultaneously with those examining 
the effects of a second steroid feeding, using the same 
cultures at the same passage numbers. The purpose of 
these lines of inquiry was to determine if DEX had any 
early effect on the growth of HUVEC that might be masked 
after the cultures were allowed to grow for several 
additional days. DEX at doses used for the second steroid 
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feeding experiment just described were employed; cells 
were steroid-fed at two days and harvested at four days. 
All four doses caused inhibition of cellular growth at 
four days (Table 3); of these doses, 1 yM and 0.1 pM were 
significantly different from DMSO controls. The 
relatively less inhibition caused by the lower steroid 
dose (0.01 JlM) was noted. It was possible, then, that DEX 
caused an early inhibition of cellular growth in HUVEC 
that might well have been overcome and not be evidenced at 
a later time, say seven days. 
The four day cellular and population growth assays 
were repeated using the same steroid doses, but with later 
passage cells from a different cord. Early growth 
inhibition was again observed (Table 4), as all doses of 
DEX effected a decrease, albeit non-significant, in cell 
number and consequently in population doublings at four 
days. Again there appeared to be less inhibition of 
cellular and population growth at the lower DEX dose (0.01 
uM). The conclusions from this second experiment were 
similar to those made above: DEX at the doses tested 
causes an early inhibition of cellular growth in HUVEC 
that might well be overcome, and not be evident, if the 
cultures are harvested at a later time (seven days). 
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Colony Forming Assay 
A colony forming assay, an alternate method of 
cellular proliferation assessment, was used to test DEX at 
doses of 1 µM and 0.1 µM HUVEC. A colony forming assay 
may be a more sensitive growth assay, since it measures 
the ability of single cells to grow and form a colony of 
cells following plating at low density. In the first 
colony formation variation, the effect of DEX upon growth, 
and not upon attachment, was examined. The cells were 
plated at colony formation density (1,000 cells/ 2 5 cm2) in 
CM- 199, and after four hours were washed and then fed 
with the appropriate steroid containing medium. The 
cultures were fed a total of three times with either 
steroid or DMSO control medium. Both DEX doses caused 
effective and significant inhibition of colony formation, 
i.e. there were significantly fewer colonies in the DEX 
treated flasks after nine days of growth (Figure 15). 
In the second colony formation variation, the effect 
of DEX on attachment only was examined. In this 
experiment, the cultures were plated at colony formation 
density for four hours in CM-199 with the appropriate DEX 
dosage (1 µM or 0.1 pM) or CM-199 with 0.1% DMSO alone. 
After the four hour incubation with steroid, the cultures 
were washed and then fed with CM-199 without steroids or 
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DMSO. After a total of three such feedings, the cultures 
were fixed and evaluated at nine days. No difference in 
the number of colonies of HUVEC was observed at nine days, 
suggesting that a short attachment period in steroid 
medium would not affect subsequent colony growth. If 
possibly there was a slowing of the growth of HUVEC in 
this initial four hour period, it did not effect the 
number of viable colonies observed at nine days. 
In the third variation, the effect of DEX on both 
attachment and growth was determined. In this experiment, 
cells were plated in steroid or DMSO containing medium for 
four hours, washed, and subsequently fed three more times 
with the steroid or DMSO control medium. The steroid 
treatment caused significantly fewer colonies to form when 
compared to the DMSO control group (Figure 15). There 
appeared to be a dose-response, but this assertation is 
made cautiously. Note the lower number of colonies in the 
steroid treated flasks both plated in and subsequently fed 
with steroid containing media (Variation 3), when compared 
to steroid treated flasks in the first experiment 
(Variation 1), when the effect of DEX was assessed for 
growth alone. These data suggest that plating with 
steroid media even for the relatively short period of four 
hours further inhibits colony formation in HUVEC, when 
steroid treatment is then continued. 
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Cytofluorometry 
Phase contrast microscopy revealed that the 
dexamethasone-treated cultures contained EC with larger 
cytoplasmic and nuclear areas and more prominent nucleoli, 
supporting the observation of Piovella et al. (1982). The 
increase in cellular size was confirmed by light scatter 
analysis using the cytofluorometer. Figures 16, 17, 18, 
and 19 show the effect of dexamethasone on relative 
endothelial cellular size for control, control plus 0.2% 
ETCH, 0.5 JlM dexamethasone, and 1 )111 dexamethasone, 
respectively. From these data, it can be seen that an 
increase in concentration of dexamethasone paralleled an 
increase in cellular size. This effect may be dose 
related (Figures 18, 19). 
Goldsmith et al. (1984) used flow cytometric 
analysis of both bovine aortic endothelial cells (BAEC) 
and HUVEC to examine the proliferative characteristics of 
repeatedly subcultured endothelial cells. They found that 
confluent primary HUVEC had approximately 2-8% of the 
cells in the proliferative phases (S,G2, and M) of the 
cell cycle. Although the authors evaluated the effect of 
cell passage upon cell cycle profiles for BAEC, only 
primary HUVEC were studied. Preliminary work in our 
laboratory, utilizing cytofluorometric analysis of EC 
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cultures treated with dexamethasone in the presence of 
heparin, demonstrated that this treatment increased the 
number of EC in the S and/or G2-M phases of the cell cycle 
in early passage HUVEC (Table 5). The decreased 
population doubling observed when certain cultures were 
treated with DEX-heparin combinations was paradoxical, 
then, since greater population growth would have been 
anticipated with more cells in the proliferative cell 
cycle phases. 
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Discussion 
Since angiogenesis can be inhibited in vivo by 
treatment with heparin and various corticosteroids 
(Folkman, 1985a,b; Folkman et al., 1983: Crum et al., 
1985), in vitro experiments examining the effect of 
corticosteroids on cultured HUVEC were undertaken to 
determine if the mechanism of anti-angiogenesis involves 
suppression of cellular proliferation. Several papers 
(Maca et al., 1978; Piovella et al., 1980, 1982; 
Longenecker et al., 1983) have dealt with steroid effects 
on cultured EC. In order to elaborate further the effect 
of these steroids upon growth characteristics of HUVEC, 
the current study has extended previous research by 
testing the glucocorticoids DEX and HC in the presence of 
heparin and ECGF under a variety of conditions. This 
study has also examined the effects of DHEA, a 
corticosteroid not used by previous researchers, upon 
cellular proliferation and population growth in HUVEC. In 
our study, a variable response of HUVEC to corticosteroids 
was found, depending on a number of factors, including the 
time frame of steroidal administration, the type of 
steroid solvent, and the length of exposure to 
corticosteroids. These equivocal findings involving HUVEC 
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were similar to those of Longenecker et al. (1983), who 
suggested that bovine aortic endothelial cells (BAEC) 
exhibit a rather striking clonal heterogeneity regarding 
their sensitivity to glucocorticoid treatment. 
Using HUVEC grown under optimal conditions with FBS, 
ECGF, and heparin {Thornton et al., 1983), our results 
have corroborated some aspects of previous inquiries 
involving steroid effects; in other areas the findings are 
in contrast to earlier reports. The increased growth 
observed in HUVEC in many of our experiments (when 
steroids were dissolved in DMSO) was also reported by 
Piovella et al. {1980, 1982), who found that DEX caused 
an initial increase in cell number, but that the confluent 
density of HUVEC matched controls at six days. However, 
the increases we observed were sustained at confluence 
(seven days). Growth inhibition, as observed in some of 
our experiments, was also noted by Longenecker et al. 
(1983) in DEX-treated BAEC. However, they found that DEX 
inhibited cellular growth in only one of four clones that 
they studied. Growth inhibition of HUVEC treated with DEX 
and HC, which occurred consistently when EtOH was used as 
a steroid solvent in this study, stands in contrast to the 
findings of Piovella et al. (1980) as well as to our 
findings when DMSO was the solvent. The present study 
also has corroborated and, by employing cytofluorometric 
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light scatter analysis, added a quantitative dimension to, 
earlier reports (Maca et al., 1978; Piovella et al., 1980, 
1982) that dexamethasone increases cellular size in HUVEC. 
It was clear that when EtOH was used as a solvent 
for corticosteroids in the HUVEC culture system employed 
here, growth inhibition occurred that was reproducible in 
several experiments terminated at seven days. Growth 
inhibition significantly greater than the slight amount 
caused by the EtOH solvent was evident using two doses of 
DEX, (1 pM, 0.5 pM), and was consistently, although not 
significantly, inhibited when HC at 1 µM was used. The 
fact that the cultures were fed twice with steroid 
containing media in contrast to a single feeding when DMSO 
was the solvent may have sustained early growth 
inhibition, but we cannot conclude this unequivocally, 
since an earlier (four day) growth assessment was not done 
in experiments utilizing EtOH as a solvent. Also, since 
single feeding treatment regimens were not employed in the 
EtOH solvent experiments, we cannot ascertain whether 
recovery from early growth inhibition or even subsequent 
enhancement might have occurred if the cultures were fed 
once and harvested at seven days, as in most of the DMSO 
solvent experiments. 
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When DMSO was used as a solvent for DEX, HC, and 
DHEA, cellular and population growth enhancement was 
frequently observed. In these experiments, there was a 
slight and insignificant depression cf growth caused by 
the DMSO solvent itself, suggesting that this solvent did 
not stimulate growth of HUVEC. In contrast to the growth 
inhibition seen when DEX was used with EtOH as a solvent, 
when four doses of DEX dissolved in DMSO were used, 
significant growth enhancement was initially seen at seven 
days. Subsequently, when unabsorbed and absorbed serum 
were compared regarding responses to DEX treatment, the 
unabsorbed group, which was comparable to the first DMSO 
solvent experiment except that a different culture was 
used, exhibited growth inhibition. And in a later 
experiment comparing 20% and 1% FBS containing media, 
growth enhancement occurred when the 20% FBS containing 
media was used. Thus, it seems clear that DEX is not 
consistent in its effect on cellular and population growth 
at confluence (seven days) in HUVEC when fully 
supplemented media, a DMSO solvent, and a single steroid 
feeding are employed. 
Since 1 pM HC (Figure 2b) effected a non-significant 
decrease in growth when ETOH was the solvent, higher doses 
might have been expected to manifest a similar inhibitory 
effect. However, when DMSO was the solvent, all four HC 
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doses demonstrated a paradoxical increase in cellular 
growth at seven days. This enhancement with HC was 
significant, and was sustained when absorbed serum was 
used in the media. Thus, the growth facilitory effects of 
HC upon HUVEC when DMSO was used as a solvent did not 
appear to be affected by using absorbed serum. This 
finding suggests that hydrocortisone, a natural 
glucocorticoid, might be more consistent than 
dexamethasone, a synthetic glucocorticoid, under different 
experimental conditions in enhancing growth in HUVEC. 
When DHEA was used with DMSO as a solvent, 
significant growth enhancement also occurred. In 
contrast, when DHEA was tested using absorbed serum in the 
media, a variable response was found. Since neither 
growth facilitation or inhibition occurred when two doses 
of DHEA were used, it appeared that DHEA had little 
definitive effect on the growth characteristics of HUVEC 
when absorbed serum was used. 
To summarize, in contrast to the experiments 
employing EtOH as the solvent, when DMSO was used as the 
solvent, there was a tendency for growth enhancement to 
occur, but this was not observed in all experiments. In 
earlier research (Piovella et al., 1980), an early 
increase in cell number was seen but this enhancement was 
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not sustained at seven days. In the present study, this 
enhancement was sustained at least for five days after 
steroid administration on the second day of culture. 
However, Piovella et al. (1980) administered steroids at 
the time of cell plating; that is, two days earlier than 
in the present experiments, so the steroid-treated cells 
may have reached confluence earlier, allowing the control 
cultures to catch up by the end of the six day assessment 
period, therefore causing the cell numbers in control and 
steroid treated cultures to be comparable. In comparison, 
in our culture system, the cells were exposed to steroids 
for shorter periods of time, allowing early growth 
stimulation to still be operational at the end of the 
seven day assessment; thus growth enhancement was 
observed. However, since only a seven day assessment was 
carried out in these experiments, the possibility of an 
early growth inhibition occurring during the first few 
days following steroid treatment followed by a later 
growth enhancement manifesting at seven days cannot be 
completely ruled out. The results of our four day 
assessment experiments, which showed steroid-induced 
cellular growth inhibition two days after steroid 
treatment, support this contention. 
It should be noted that in the first experiments in 
which DMSO was used as a solvent, cells derived from the 
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same umbilical cord were used for all three steroids 
tested. It may be that these cells respond to 
corticosteroid treatment by facilitation of growth, and 
that this response might be culture specific, much like 
the clonal variability responses seen in BAEC by 
Longenecker et al. (1983). One might speculate that the 
majority of cells from this cord would respond to steroid 
treatment with growth facilitation, and that a minority of 
cells would respond with inhibition, yielding an overall 
increase in culture growth following treatment with DEX, 
HC, or DHEA. 
There was a consistent lack of a dose response in 
most of the experiments reported in this study. This was 
particularly true for experiments which employed media 
containing a full serum supplement (20% FBS) and steroids 
dissolved in DMSO. The full serum supplement in the media 
possibly may serve to down regulate steroid receptors on 
the endothelial cellular surface; the receptors may then 
not be in a propitious state to respond to exogenously 
administered steroids. Possibly for this reason, at the 
steroid doses that we employed, a dose response regarding 
proliferative effects was not observed. In addition, 
cells more resistant to steroid effects might selectively 
inactivate these steroids in greater quantities than more 
sensitive cells (Berliner, 1965). Since the human 
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umbilical vein cell populations used in these studies were 
uncloned, it is likely that our cultures contained groups 
of cells with varying sensitivity to steroid effects. 
This may partially explain the lack of a dose response, as 
well as the variable and equivocal nature of our findings, 
concerning the effects of steroids on endothelial cellular 
proliferation in vitro. 
When the effects of corticosteroids in medium 
containing absorbed serum were compared to those in medium 
containing unabsorbed serum, the slight inhibition caused 
by the DMSO solvent was somewhat greater for the former 
than for the latter group. Apparently, the use of 
absorbed serum in the growth media allows the DMSO solvent 
to exhibit a greater degree of inhibition upon cellular 
and population growth. 
Although our data suggest that endogenous steroids 
in the serum used in routine media preparation might be 
facilitative to cellular growth of HUVEC, the use of media 
containing absorbed serum appears to modify somewhat the 
response of HUVEC to corticosteroid intervention. The 
mechanism underlying this modification might concern the 
regulation of steroid receptors on the endothelial 
cellular surface, alluded to above in partially explaining 
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the lack of a dose response regarding proliferation in 
steroid-treated EC. 
In using media containing unabsorbed serum, the 
already high steroid (ligand) concentration present in the 
serum might serve to down regulate steroid receptors on 
the endothelial cellular surface. Therefore, exogenously 
added steroids may further down regulate the steroid 
receptors. On the other hand, a lower steroid (ligand) 
concentration, as would be the condition when media 
containing absorbed serum was used, would serve to up 
regulate the steroid receptors on the cell surface. Thus, 
added steroids would have an effect on cellular 
proliferation, as the up regulated steroid receptors would 
then be more apt to bind the hormone, internalize it, and 
effect a growth response. According to Evans (1988), in 
steroid-cellular interactions, transcriptional regulation 
of cellular DNA derives from the binding of the hormone­
receptor complexes to hormone response element sites on 
the DNA. Apparently the hormone binding region normally 
prevents the domain for DNA binding and transcriptional 
activation from functioning. The addition of steroid 
apparently relieves this inhibition (Evans, 1988). One 
can speculate that the use of media containing absorbed 
serum would increase the likelihood of this disinhibition 
occurring. 
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In the experiments using absorbed serum, there was a 
trend for higher doses of DEX(> 0.5 µM) to inhibit 
growth, and lower doses of DEX (<.5 µM) to facilitate 
growth. It is possible that the higher doses of DEX, 
added to cells whose steroid receptors were up regulated 
due to the presence of media containing absorbed serum, 
were more effective than the lower doses in engaging a 
greater number of steroid receptor sites, thus resulting 
in net inhibition of growth. In comparison, the lower DEX 
doses might not have been as effective in engaging as many 
steroid receptor sites on the endothelial cellular 
surface, thus even though the steroid receptors were in an 
up regulated state due to the presence of media containing 
absorbed serum, the binding of added steroids to cellular 
receptors was insufficient to effect a growth inhibition 
response; neutral growth or even slight growth enhancement 
occurred. 
Alternately, the use of absorbed serum might 
modulate the number or character of ECGF and other growth 
factor binding sites on EC, and thus it would be the 
altered response by EC to growth factors per se, and not 
to corticosteroids, that would ultimately effect the level 
of cellular or population growth that was observed. 
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In the male vs. female experiments, the cell harvest 
was on the sixth day post plating, slightly earlier than 
in other experiments in this study. Although 
dexamethasone had one day less to exert any effect, this 
probably was not a significant factor in the responses 
observed, as the cells were tightly confluent when they 
were trypsinized and counted. When female and male HUVEC 
were compared regarding the effect of DEX on cellular and 
population growth, no consistent inhibition or stimulation 
of growth was observed in either group. It was not 
possible to definitively conclude from these experiments 
that gender plays a crucial role in the response of HUVEC 
to exogenous steroid administration. 
In comparing the responses of female and male cells 
(Figures 10a and lla), it was noted that there was a trend 
for cellular and population growth of control cultures for 
female cells to be greater than that for male cells. This 
observation lends support to the suggestion that female 
and male HUVEC grow at different rates. Further evidence 
for this phenomenon can be found in the four day growth 
experiments. When the four day assessments were carried 
out, two experiments were performed. Although these 
experiments were not designed to test cellular gender as a 
factor in steroid response, it is informative to examine 
the results for control cultures here also. The results 
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in Table 3 are those for male cells, and in Table 4, for 
female cells. The greater population growth of HUVEC 
under control cultures for female cells compared to male 
cells is noted. Also, from these tables, it can be 
observed that for each steroid dosage, the cell number for 
female cells was approximately twice as great as that for 
male cells, with both types of cells responding to steroid 
treatment with growth inhibition. In these experiments, 
all culture flasks were plated at standard density two 
days prior to steroid administration. The results seemed 
to indicate a trend for female HUVEC to exhibit a greater 
growth ability than male cells. However, more culture 
pairs will have to be tested specifically for the gender 
effects upon cellular growth to substantiate this trend. 
DEX appears to be inhibitory when greatly reduced 
FBS (1% vs. the usual 20%) is employed in the media used 
to feed the cultures. When 1% FBS was used in the media, 
DEX consistently, but not always significantly, inhibited 
population growth. The use of medium containing 1% serum 
might lead to up regulation of the steroid receptors on 
the endothelial cellular surface in the same manner as 
when media containing absorbed serum was employed. The 
reduced serum component in the medium would effectively 
lower the concentration of steroid (ligand) available to 
the steroid receptors; added steroid would then be more 
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likely to engage the available receptors, thereby possibly 
exerting an effect on cellular proliferation. In this 
way, a reduced serum component in the media might make the 
HUVEC more susceptible to the possible inhibitory effects 
of heparin-corticosteroid combinations. 
The response characterized by higher doses of DEX 
leading to growth inhibition and lower doses of DEX 
leading to growth enhancement, observed in two experiments 
when the absorbed serum paradigm was employed, was not 
seen with media containing reduced FBS except in one 
experiment. But when culture medium containing a full 
serum supplement (20% FBS) was used, either growth 
facilitation or inhibition could occur depending on the 
cell line used. These results as displayed in the 
comparison experiments could be related to the clonal 
specificity theory of Longenecker et al. (1982), who 
reported that EC exhibited a clonal heterogeneity 
regarding glucocorticoid sensitivity. Further testing 
employing medium with a full serum supplement, using 
cultures derived from cloned cells might confirm this or 
perhaps demonstrate a more definitive relationship of 
either growth inhibition or enhancement in cloned HUVEC 
treated with corticosteroids. Also, other steroids, in 
addition to DEX, should be studied using both a full and a 
reduced serum supplement in the media to determine if a 
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trend toward cellular and population growth inhibition 
observed with DEX would be expressed. 
In the study of Longenecker et al. (1983), who 
emphasized clonal variability of BAEC, it was interesting 
that inhibition of proliferation of EC occurred only in 
the presence of FGF. It is possible also in our study 
that the response to glucocorticoids was also growth 
factor dependent. It might be that steroids mildly 
inhibit the maximal response of EC to growth factor, in 
our case, ECGF. Since ECGF is believed to be the acidic 
form of FGF (Jaye et al., 1986), it would be interesting 
to determine if FGF would cause the same effects, i.e. 
inhibition of the endothelial cellular proliferation 
response to the growth factor in HUVEC as well as BAEC. 
Alternately, different cultures or clones of HUVEC may 
display different responses to steroid-heparin 
combinations. Moreover, it cannot be ruled out that a 
given cell clone of HUVEC can simply respond to 
corticosteroid administration by either growth enhancement 
or inhibition. 
Based on the results from two separate experiments 
where cultures of HUVEC were fed twice with medium 
containing DEX dissolved in DMSO, a non-significant 
inhibition in one experiment and a significant enhancement 
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of cellular and population growth in a second experiment, 
occurred. Since these experiments were conducted under 
identical conditions, the clonal specificity response 
again appears to be supported (Longenecker et al., 1983). 
However, in early experiments using EtOH as a solvent, a 
second steroid feeding was routinely employed, and 
cellular and population growth inhibition was rather 
constant. Perhaps then, the solvent is as important a 
factor as the steroid effects themselves. 
It is conceivable that certain cultures of HUVEC 
could overcome the growth inhibition that was seen at four 
days of culture, that is, two days after steroid 
treatment. At this point, after cessation of inhibition, 
the inhibited cultures (at a lower density) might proceed 
to grow more rapidly during the final days of culture than 
the more dense controls, with ultimate confluent density 
consisting of similar numbers of cells in treated and 
control flasks. In experiments that employed a seven day 
growth assay, a cellular and population growth enhancement 
was a frequent finding, suggesting that if an initial 
steroid induced growth inhibition did occur, it could be 
overcome. Further support for this contention is 
supplied by the observations in the four day growth 
experiments and repeated steroid dosing experiments (DMSO 
solvent). Table Two and Table Four illustrate findings 
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that were observed using the same cell line, at the same 
passage number, and run simultaneously. The cultures 
exhibited cellular and population growth inhibition at 
four days, but enhancement at seven days. Even with a 
second feeding (Table Four), significant cellular and 
population growth enhancement was seen at seven days; 
replicate cultures had displayed inhibition of growth just 
three days previously. 
The findings employing a second steroid feeding 
support the suggestion made above that a given culture of 
EC can respond to steroid treatment with either growth 
facilitation or growth inhibition. This is further 
evidence in support of the clonal specificity theory 
regarding endothelial cellular response to steroid 
treatment (Longenecker et al., 1983). However, even in a 
controlled in vitro experiment there are a number of 
factors that can determine the type of response by the EC. 
It is also possible that, depending on other factors, such 
as cellular density and medium composition, HUVEC may 
reach a point in their growth cycle when they are less 
responsive to any steroid induced inhibition of their 
growth characteristics. Alternately, exogenously 
introduced steroids may continue to bind to the surface of 
the EC, and when this is reinforced and further maintained 
by a second steroid feeding, the response of the EC may be 
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one of increased growth. This might explain the growth 
enhancement observed when the cultures were trypsinized 
and counted on the seventh day after plating. 
Henriksen et al. (1975) found that the replicative 
ability of HUVEC was correlated with cell density at the 
time of cell seeding. Colony formation is an alternate 
method of growth assessment in culture systems and is a 
way of examining clonal growth of cells plated at very low 
density. Colony formation was employed to determine if 
corticosteroids administered to sparsely plated HUVEC had 
a possibly different effect than when administered to a 
denser, yet still subconfluent and growing culture of 
HUVEC. In the first colony formation variation, the 
effect of DEX upon growth only was assessed; a 
significantly lower number of colonies was observed in 
DEX-treated cultures compared to controls. In the second 
variation, HUVEC were plated in steroid containing media 
for four fours only, then subsequently fed with CM-199 
without steroids; there was no difference in the number of 
colonies between DEX-treated and control cultures. In the 
third variation, the effect of DEX on both plating and 
growth was determined. Compared to the control, there 
were significantly fewer colonies in the steroid treated 
flasks when the cells are both plated in and fed with 
steroid containing media. It is noted, in comparing the 
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DEX-treated cultures in the first and third variations, 
that there were fewer colonies in the DEX-treated cultures 
in the latter. The data suggest that plating with steroid 
media even for a relatively short period of time can 
potentiate the inhibition of colony formation in HUVEC 
seen if the cells continue to be grown in the steroid 
containing media. 
Since steroid-induced inhibition of growth was 
prominent in the colony formation experiments, where 
plating density is only 1,000 cells/flask (vs. 1.2 5 x 105 
cells/flask in the usual growth assay experiments), low 
density growth of HUVEC may be inhibited by heparin and 
DEX, whereas high density growth is unaffected or slightly 
increased. A low number of cells, given a uniform steroid 
dosage, may not be able to metabolize it as rapidly; 
therefore, growth inhibition may ensue when cell density 
is low, the relatively higher steroid concentration acting 
on a smaller number of cells. This might be a possible 
mechanism for the inhibition seen with the four day growth 
assessments and the colony formation experiments. Now, at 
a later time, say seven days after plating, when the 
culture may be approaching confluence, there are more 
cells to metabolize the steroid and the concentration of 
the steroid has been reduced, so that an effect on growth 
does not occur. This could possibly explain the lack of a 
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consistent response to a second steroid feeding when DMSO 
was used as a solvent. Any inhibitory effects that might 
have resulted if the cellular density were lower might be 
minimized if the steroids were added at five days, as 
during the second steroid feeding experiments. 
High density cultures of HUVEC seem to respond 
differently to steroid intervention. It should be noted 
that in several experiments the cultures were crowded and 
postconfluent at the termination of the experiment at 
seven days. It was for this reason that the experiments 
comparing the response of male and female HUVEC to 
corticosteroid administration were terminated at six, 
instead of seven, days. A crowded, densely populated 
culture of HUVEC may exhibit a deceleration of the 
cellular growth rates in the later period just prior to 
cell harvest; growth during this period may not be 
responsive to exogenous steroid administration. In our 
experimental paradigms involving administration of fresh 
steroids during later growth periods (i.e., experiments 
employing a second steroid feeding) there might have been 
little effect on growth rates during this crowded period. 
It appears then that the density of a culture during the 
later stages of steroid treatment may have a considerable 
effect on cell number assessed at a postconfluent time. 
Since the availability of physical space in the monolayer 
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into which the EC can replicate is an important factor in 
the growth of EC in vitro, crowded near confluent cultures 
will have a lower growth rate than less dense, younger 
cultures exhibiting the characteristic numerous mitotic 
figures indicative of rapid growth. 
Another possible mechanism for the inhibition at low 
density might be related to the proportion of the 
endothelial cellular surface mechanically available to 
exogenously administered steroids. It is possible that 
crowded, more confluent cultures may be less responsive to 
inhibitory effects of steroid treatment because only the 
receptors on the apical surface of the cell would be 
exposed directly to exogenous steroids. Therefore only a 
limited number of receptors on the endothelial cellular 
surface would be likely to respond to steroid treatment. 
In the intact endothelium in vivo, this may be a factor 
where perhaps only the luminal surface of the EC would be 
exposed to circulating steroids. The clonal specificty 
hypothesis (Longenecker et al., 1983) could also be 
related to the inhibitory effects of DEX on colony 
formation. In colony formation, clones that are inhibited 
and do not grow are therefore not counted; in a mixed 
culture, loss of the cells contributed from a clone that 
is totally inhibited could be compensated for by the 
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greater growth potential of a neighboring clone allowed to 
grow to confluence. 
On the other hand, steroids administered to low 
density, rapidly growing EC under in vitro experimental 
conditions might prove to be too artificial a situation to 
compare the responses to those which might possibly occur 
during in vivo conditions. However, when corticosteroid 
preparations are administered pharmacologically to treat 
various diseases where angiogenesis is an ongoing process, 
the effect on open, rapidly growing microvessels where 
migrating and dispersed EC are present might consequently 
differ from that seen in an intact e�dothelium where 
angiogenesis is not occurring. 
Cell cycle analysis by cytoflourometry revealed that 
1 uM DEX (EtOH solvent) almost doubled the percentage of 
HUVEC in the G2-M phase of the cell cycle (Table 5). 
Since the number of population doublings was significantly 
suppressed by 1 uM DEX in these early growth experiments, 
it is possible that the mechanism of suppression involved 
arrest in the G2 phase of the cell cycle and therefore 
delay of division (Goldsmith et al., 1984). Running 
additional cytofluorometric analysis simultaneously with 
growth studies could enable further correlation of the 
level of growth enhancement or suppression with the 
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relative distribution of cells in the various phases of 
the cell cycle. This may provide more information to 
answer questions concerning the cell cycle dependency of 
the growth response of HUVEC to corticosteroid-heparin 
treatment. Light scatter analysis of DEX treated cells 
revealed that this steroid caused an increase in cellular 
size. It is known that glucocorticoid treatment increases 
protein content of cultures of HUVEC (Maca et al., 1978); 
therefore, increased structural protein synthesis could be 
responsible for this increase in cellular size. 
Alternatively, although the exact mechanism for this 
phenomenon is unclear, it may be related to an increase in 
microfilament formation in association with the cell 
membrane, as reported for steroid treated C6 glial cells 
by Berliner et al (1978). Quantitative studies employing 
electron microscopic procedures might reveal whether a 
relative increase in microfilament formation occurs in 
steroid treated EC. 
Rosner and Cristafalo (1979) studied a number of 
non-endothelial cell lines and observed both growth 
enhancement and growth inhibition when hydrocortisone was 
used in the medium. Perhaps in EC also, in this case 
HUVEC, the proliferative response of the cells to 
corticosteroids demonstrates a cell-line specificity, as 
well as a steroid-molecular structure specificity. In 
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this light, it cannot be concluded that a given culture or 
clone of HUVEC will respond with either growth 
facilitation or inhibition to all steroids. 
Steroid-endothelial cell reactions are conceivably 
mediated by high affinity glucocorticoid binding sites on 
the endothelial cellular surface (Berliner, 1981). If the 
binding sites are altered in some way, the endothelial 
cellular response to corticosteroids will also be altered. 
Perhaps the study of factors which can compete, either 
positively or negatively, with the steroid binding sites 
would yield more fruitful information concerning cellular 
growth responses to corticosteroids than study of the 
corticosteroids per se. It is conceivable that various 
growth factors and media components can affect the 
function or regulation of these corticosteroid binding 
sites on the endothelial cellular surface. Berliner 
(1981) found that although HC did not appear to have a 
direct effect on thymidine incorporation in EC, the 
presence of the steroid was permissive for the effects of 
insulin and FGF. Although the mechanism of action of the 
steroid induced enhancement of the growth factor and 
insulin interaction is not completely understood, Baker et 
al. (1978) felt that it might be related to the increase 
in insulin binding observed when EC were treated with HC. 
It is entirely possible, according to the work of Baker et 
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al. (1978), that corticosteroids, dexamethasone in this 
case, cause a permissive effect on growth by modulating 
cell surface receptors for the growth factor. To this 
effect, DEX may enhance the mitogenic response of HUVEC to 
growth factors, and this may be the mechanism by which 
growth enhancement occurs. Therefore, the modulation of 
growth by steroids may be indirect. One might speculate 
that the level of corticosteroids in the blood exerts some 
control over the growth or quiescent state of the 
endothelium in vivo. Such an effect may be mediated by 
alteration of the character or structure of binding sites 
for heparin and growth factors on the surface of the 
endothelial cell. 
Glucocorticoids can either sensitize or desensitize 
various cell types to the action of serum or growth 
factors added to the cell cultures, and the role of these 
growth factors needs to be further understood. Perhaps a 
time factor is relevant, with growth factors being more 
inhibitory in some phases of the cell cycle than others. 
However, the possible interaction of added steroids and 
growth factors is even more intriguing. Longenecker et 
al. (1982) reported that DEX inhibited the growth of 
bovine smooth muscle cells (BSMC) but only when FGF was 
absent from the medium. This suggests that the inhibition 
of cellular growth following exogenous steroid 
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administration may be dependent on the absence of FGF. 
However, smooth muscle cells were tested above; when 
steroids were administered to BAEC (Longenecker et al., 
1983), growth inhibition was dependent on the presence of 
FGF. It is conceivable, then, that the steroids and 
growth factors may be competing with the same or 
interdependent binding sites on EC, sites which are 
responsible for the modulation of cellular growth. 
Whether steroids compete with growth factors for binding 
sites or render the latter inactive by binding to separate 
but physiologically related sites is unknown. Alterations 
of the location, size and/or character of these binding 
sites would also be important factors in determining 
endothelial cellular responses to steroid treatment. 
Since heparin was utilized in all experiments in our 
cultures system, its role in steroid induced proliferative 
effects in EC needs further delineation. It is known that 
heparin interacts structurally with ECGF and potentiates 
the mitogenic activity in EC by altering immunological 
epitopes within the structure of ECGF, stabilizing its 
polypeptide structure, and increasing the affinity of ECGF 
for its cell surface receptors (Schreiber et al., 1985). 
The interaction and possible interdependence of these 
three factors (ECGF, heparin, steroids) in modulating 
proliferation of EC are topics for future study. 
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Note that Longenecker et al. (1983) also found that 
the steroid induced inhibition seen in one clone of BAEC 
was FGF dependent. In our culture system, we did not test 
whether the inhibition seen in some experimental 
conditions was ECGF dependent, as this growth factor was a 
component in all experiments conducted. It may be that 
the responses of HUVEC to steroid intervention would 
differ if ECGF were omitted from the culture media. 
However, without ECGF, cultures of HUVEC grow slowly and 
sporadically, and impaired growth could affect the 
response to steroid treatment. Further, regarding culture 
conditions, an alternative to completely eliminating the 
growth factor would be to modify the amount of heparin in 
the media. However, for optimal growth of HUVEC, this 
would necessitate increasing the amount of ECGF (Thornton 
et al., 1983). If it is indeed true that the mechanism 
behind steroid-induced inhibition or enhancement of growth 
lies in the interaction of the steroid with the growth 
factor, then increased concentrations of ECGF could play a 
role in any growth response to exogenously administered 
steroids. 
Indirect support for steroid induced enhancement of 
proliferation comes from the work of Jarvelainen et al. 
(1985), who found that DEX and HC stabilized the monolayer 
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of EC, strengthening the adhesion of cells to the 
extracellular matrix, reducing their susceptibility to 
separation by enzymatic agents. stabilization of the 
structural integrity of the endothelial cellular monolayer 
might render the cells less susceptible to factors that 
would inhibit growth via several mechanisms. Pursuant to 
this concept, since an increase of migratory activity 
precedes proliferation of cells in stimulated cultures of 
EC (Shelley et al., 1977), then the steroid induced 
stabilization of the monolayer observed with steroid 
treatment could play a role in the inhibition of 
proliferation by preventing the antecedent migration or 
chemokinesis. 
Since angiotensin converting enzyme (ACE) activity 
is increased in steroid-treated cultures of EC (Mendelsohn 
et al., 1982a, 1982b; Lam et al., 1985), an in vivo role 
may exist for this phenomenon in steroid induced 
inhibition of cellular proliferation. Since the ACE 
converts angiotensin I to angiotensin II, the latter a 
potent vasoconstrictor, an in vivo correlation can be 
theorized. ACE induced vasoconstriction might constrict 
vessels in vivo, altering the cellular surface area, and 
consequently modifying the character of steroid or growth 
factor binding sites, making the cells less sensitive to 
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positive growth factors. Thus vasoconstriction would 
support the phenomenon of angiostasis. 
The role of extracellular matrix (ECM) is an 
additional variable that should be explored in examining 
factors which may be operative in effecting in vivo anti­
angiogenesis. Concerning this, three studies are 
relevant. Piovella et al. (1982) found that DEX increased 
the amount of fibronectin matrix in cultured HUVEC, and 
suggested that the phenomenon was responsible for better 
spreading of the cells on the culture surface. Whether 
this increased spreading affects cellular proliferation is 
not known. Longenecker et al. (1983) reported that the 
FGF dependent DEX induced inhibition of cellular growth in 
BAEC could be abolished by employing ECM derived from 
bovine aortic smooth muscle cells. Whether the gelatin 
matrix used in our culture system or the ECM laid down by 
HUVEC affects the response of the cells to steroid 
treatment is unclear, but certainly is a factor that 
deserves further consideration. Lastly, Ingbar et al. 
(1986) stated that basement membrane dissolution played a 
role in anti-angiogenesis mediated by angiostatic steroids 
in vivo. However, exactly when this degradation of 
basement membrane occurred in the sequence of events in 
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steroid induced angiostasis was not pinpointed in their 
study. 
It must be remembered that the steroid responses 
seen in the present in vitro studies were observed during 
relatively acute treatment periods, and, as pointed out by 
Longenecker et al. (1983), might differ significantly from 
responses which might ensue due to more chronic exposure 
of EC to excess glucocorticoids, such as would occur in 
cells treated throughout a culture lifespan. They 
speculated that responses of the endothelium in vivo, 
exposed to exogenous glucocorticoids for months or years, 
would also be potentially different from those seen in 
cultures treated with steroids in more acute time 
periods. Perhaps also, in the in vivo situation, a 
homeostatic environment prevails in the endothelium, that 
is, there is a balance between growth facilitation and 
growth inhibition, and the response to physiological doses 
of glucocorticoids might be such so as to provide 
conditions favorable to the maintenance of endothelial 
integrity. 
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The following major findings in the present study 
regarding the effect of heparin-corticosteroids on HUVEC 
can be summarized as follows: 
1. Both DEX and HC were inhibitory to growth of HUVEC 
when EtOH was used as a solvent and fully supplemented 
media was employed. The fact that these cultures were fed 
twice with steroids prior to harvest might have 
potentiated the effects of DEX and HC upon the growth of 
HUVEC. 
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2. When a full supplement of CM-199 was used as the media 
and DMSO was used as a solvent, there was a tendency 
toward enhancement of cellular growth when DEX was used. 
3. The cellular and population growth enhancement seen 
when HC was used {DMSO solvent) was significant and was 
sustained when absorbed serum was used in the media. 
4. Employing absorbed serum in the media, treatment with 
DEX and DHEA, but not HC, led to inhibition of cellular 
and population growth. The inhibition seen when absorbed 
serum is used may not be due solely to corticosteroid 
intervention. 
5. Although gender does not appear to be a factor in the 
proliferative response of HUVEC to corticosteroid and 
heparin treatment, there was a trend for female EC to 
display better growth rates than their male counterparts. 
6. Using a reduced serum component (1% FBS), inhibition 
of cellular and population growth was observed following 
treatment with DEX, but this was not always significant. 
7. There was a trend for higher doses of DEX to effect 
cellular and population growth inhibition, while lower 
doses effected cellular and population growth enhancement. 
This was true for HUVEC grown in absorbed media and for 
female HUVEC. 
8. There was a trend for DEX to effect an early 
inhibition of cellular and population growth in treated 
HUVEC, an inhibition that may well be compensated for by a 
subsequent cellular and population growth recovery during 
the later stages of culture. 
9. Significant inhibition of cell colony formation in 
HUVEC in response to DEX administration was observed. 
Since cell colony experiments are conducted with a very 
low density of cells (1,000 cells/T-25 flask), it may well 
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be that low density growth of HUVEC is inhibited by 
steroid treatment, while higher density growth is 
facilitated. Alternatively, clonal assay may be a more 
sensitive method than mass culture for detecting 
suppressive effects on sensitive cells. 
10. Cytoflurometric analysis of HUVEC treated with DEX in 
the presence of heparin indicated that this treatment 
increased cellular size and increased the number of EC in 
the S and/or G2-M phases of the cell cycle in early 
passage HUVEC. 
Our experiments utilizing corticosteroids and 
heparin in cultures of EC demonstrated that treatment did 
not always decrease proliferation as postulated on the 
basis of in vivo findings (Folkman et al., 1983; Crum et 
al., 1985); by contrast DEX and HC sometimes caused an 
increase in proliferation. It might well be that the 
mechanism for inhibition of angiogenesis by angiostatic 
steroids observed in vivo does not involve inhibition of 
endothelial cell proliferation, but rather entails some 
alternative process, such as the induction of capillary 
basement membrane dissolution, as suggested by Ingber et 
al. (1986). But even in their work, it was not possible 
to conclude definitively that basement membrane 
alterations were a primary, rather than secondary effect; 
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basement membrane degradation might be a primary effect of 
corticosteroid treatment, or perhaps secondary to the loss 
of endothelial cell viability, the latter effected by 
steroid-induced growth inhibition. studies such as the 
present one, designed to elucidate the effect of heparin­
corticosteroid administration on the proliferation of 
HUVEC, hopefully may have assisted in clarifying their 
point to a somewhat greater degree. 
It is unknown whether cellular migration in HUVEC is 
affected by corticosteroid treatment. Since endothelial 
cellular migration precedes proliferation both in vitro 
(Shelley et al., 1977) and in vivo (Shelley et al., 1984), 
factors which affect endothelial cellular migration may 
indeed by important in determining the response of HUVEC 
to heparin-corticosteroid treatment. Although both 
heparin and ECGF have been found to be chemotactic for 
HUVEC (Maciag et al., 1984), the effect of corticosteroids 
upon directed migration of EC has not been studied. 
Migration assays utilizing various corticosteroids as 
possible chemotactic stimuli would provide information 
regarding any steroid mediated mechanisms involving 
endothelial cellular movement, which could greatly 
influence cellular proliferation in vitro. 
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Also, in this vein, it is known that vasodilation 
precedes both migration and proliferation of EC during in 
vivo angiogenesis (Folkman, 1984). Perhaps the inhibition 
of prostacyclin (a potent vasodilator) activity in 
cultured EC by corticosteroids (Lewis et al., 1986; 
Deuterina & Walker, 1986) may be partially responsible for 
the anti-angiogenic effect of these steroids observed in 
vivo. 
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Additional studies, designed to elucidate further 
the role of corticosteroids upon either endothelial 
cellular growth or the endothelial basement membrane 
integrity, could provide answers to these remaining 
questions concerning corticosteroid mediated modifications 
in the vascular system, and offer more rationale for the 
use of corticosteroids in diseases where angiogenesis is a 
prominent feature. 
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Figure la. Effect of dexamethasone (DEX) on the growth of 
HUVEC (alcohol solvent). T-25 flasks were plated at standard 
density (1.25 x 105 cells/flask). Cells in the first through 
third passage were used. The cultures were fed with medium 
containing DEX dissolved in EtOH on the second and fourth or 
fifth day after plating. The final concentration of EtOH in 
the steroid containing media was 0.2% for 1 pM DEX and 0.1% 
for 0.5 ).1M DEX; For each experiment, cells were harvested 
and counted in quadruplicate in a hemocytometer on the 
seventh day after plating. The results shown are the 
combined pool of four separate experiments: each bar 
represents the cell counts from 12 flasks, with the standard 
error of the mean (SEM) drawn above the bar. Dexamethasone 
treatment has resulted in an inhibition of cellular growth. 
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Figure 1 a. Effect of Dexa methasone on Growth of HUVEC 
(Alcohol Solvent) 
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Figure lb. Effect of dexamethasone on population growth 
(alcohol solvent). These bar graphs demonstrate the 
population doubling characteristics of HUVEC for the 
corresponding steroid doses and cell number data found in 
Figure la. Each bar represents the mean population doubling 
level from 12 flasks from four separate experiments, with the 
SEM above the bar. 
* Significantly different from control, 0.2% ETOH, and 0.1% 
ETOH, (p < 0.05). 
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Figure 1 b. Effect of Dexamethasone on Population Growth 
(Alcohol Solvent) 
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Figure 2a. Effect of hydrocortisone (HC) on growth of HUVEC 
(alcohol solvent). T-25 flasks were plated at standard 
density (1.25 x 105 cells/flask). Cells in the first through 
third passages were used. The cultures were fed with media 
containing HC dissolved in EtOH on the second and fourth day 
after plating. The final concentration of EtOH in the 
steroid containing media was 0.2%. For each experiment, 
cells were harvested and counted in quadruplicate with a 
hemocytometer on the seventh day after plating. The results 
shown are the combined pool of three separate experiments. 
Each bar represents the mean cell counts from nine flask 
determinations, with the SEM drawn above the bar. 
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Figure 2a. Effect of Hydrocortisone on Growth of HUVEC 
(Alcohol Solvent) 
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Figure 2b. Effect of hydrocortisone (HC) on population 
growth (alcohol solvent). The bars indicate the growth 
characteristics of HUVEC for the corresponding steroid doses 
and cell number data given in Figure 2a. Each bar represents 
the mean population doubling value from nine separate 
determinations, with the SEM drawn above the bar. The 
population growth inhibition effected by HC was not 
significant. 
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Figure 2b. Effect of Hydrocortisone on Population Growth 
(Alcohol Solvent) 
Population Doub Ii ng s 
3.0 
2.5 
2.0 
1.5 
1.0 
0.5 
0.0 
Control .2% ETOH 
Treatment 
,.-.,, ..... � .. ·;I 
,,.:: ·' . .  . :.·.·-.·. .· .. -1· 
·�; ' -
'···1 
/ ... -·-.·, · .. '·, .. I 
J,l,, . 
'�,. . 
125 
Figure 3a. Effect of dexamethasone (DEX) on growth of HUVEC 
(DMSO solvent). T-25 flasks were plated at standard density 
with second or fourth passage HUVEC. On the second day after 
plating, the culture media was removed and replaced with 
fully supplemented media (CM 199) containing DEX dissolved in 
dimethylsulfoxide (DMSO) at the dosages indicated. The final 
media concentration of DMSO for DMSO control and all steroid 
treated cultures was 0.1%. Cells were harvested and counted 
at seven days. The results shown are the combined pool of 
two experiments; each bar represents the mean cell counts 
from six separate determinations, with the SEM above the bar. 
Growth enhancement is evident. 
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Figure 3a. Effect of Dexa.rnethasone on Growth of HUVEC 
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Figure 3b. Effect of dexamethasone on population growth 
(DMSO solvent). This graph depicts the growth 
characteristics of HUVEC for the corresponding steroid doses 
and cell number data given in Figure 3a. Each bar represents 
the mean population doubling value calculated from six 
separate determinations, with the SEM above the bar. A non­
dose response increase in population growth was effected by 
all doses of DEX employed. * Significantly different from 
DMSO control, p < 0.05. 
128 
Figure 3b. Effect of Dexamethasone on Population Growth 
(DMSO Solvent) 
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Figure 4a. Effect of hydrocortisone (HC) on growth of HUVEC. 
(DMSO solvent). T-25 flasks were plated at standard density 
with second or fourth passage HUVEC. On the second day after 
plating, the culture media was removed and replaced with 
fully supplemented media (CM 199) containing HC dissolved in 
DMSO at the dosages indicated. The final media concentration 
of DMSO for DMSO control and all steroid-treated cultures was 
0.1%. Cells were harvested and counted at seven days. The 
results shown are the combined pool of two experiments; each 
bar represents the mean cell counts from six separate 
determinations, with the SEM above the bar. An increase in 
cellular growth occurred with all HC doses employed. 
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Figure 4a. Effect of Hydrocortisone on Growth of HUVEC 
(DMSO Solvent) 
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Figure 4b. Effect of hydrocortisone (HC) on population 
growth (DMSO solvent). This graph depicts the growth 
characteristics of HUVEC for the corresponding steroid doses 
and cell number data displayed in Figure 4a. Each bar 
represents the mean population doubling level calculated from 
the six separate determinations, with the SEM above the bar. 
A non-dose response enhancement of cellular growth was 
detected by all HC doses employed. 
* Significantly different from DMSO control, p < 0.05. 
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Figure 4b. Effect of Hydrocortisone on Population Growth 
(DMSO Solvent) 
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Figure 5a. Effect of DHEA on growth of HUVEC (DMSO solvent). 
T-25 tissue culture flasks were plated at standard density 
using second or fourth passage HUVEC. On he second day after 
plating, the culture media was removed and replaced with 
fully supplemented media (CM 199) containing DHEA dissolved 
in DMSO at the dosages indicated. The final concentration of 
DMSO for DMSO control and all steroid treated cultures was 
0.1%. Cells were harvested and counted at seven days. The 
results shown are the combined pool of two such separate 
experiments; each bar represents the mean cell counts from 
six separate determinations, with the SEM above the bar. 
Again steroid-induced enhancement of cellular growth is seen. 
Figure Sa. Effect of DHEA on Growth of HUVEC 
(DMSO Solvent) 
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Figure 5b. Effect of DHEA on population growth (DMSO 
solvent). This graph depicts the growth characteristics of 
HUVEC for the corresponding steroid doses and cell number 
data given in Figure 5a. Each bar represents the mean 
population doubling value calculated from six separate 
determinations, with the SEM above the bar. The increase in 
population growth was significant in three of the doses 
employed. * Significantly different from DMSO control, p < 
0.05. 
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Figure Sb. Effect of DHEA on Popu lotion Growth 
(DMSO Solvent) 
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Figure 6a. Effect of dexarnethasone (DEX) on growth of HUVEC 
(unabsorbed vs. absorbed FBS). The graphs compare the 
effects of media containing charcoal filtered (absorbed) FBS 
with those of media containing unfiltered (unabsorbed) FBS. 
T-25 culture flasks were plated at standard density with 
fourth passage HUVEC. On the second day after plating, CM-
199 was replaced with either CM-199 made from absorbed FBS or 
CM-199 made from unabsorbed FBS, plus the appropriate DEX 
dosage. For both absorbed and unabsorbed media, the final 
concentration of DMSO in control or steroid groups was 0.1%. 
Cells were harvested and counted on the seventh day. The 
bars represent the mean cell counts of triplicate flasks, 
given along with the SEM. The increased growth with 
unabsorbed FBS-containing media is obvious. Also observed is 
a decreased growth in steroid treated cultures when absorbed 
FBS was used. 
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Figure 6a. Effect of Dexamethasone on Growth of HUVEC 
(Absorbed vs. Unabsorbed F BS) 
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Figure 6b. Effect of dexamethasone on population growth 
(unabsorbed versus absorbed FBS). The graphs compare the 
effects of unabsorbed and absorbed FBS containing media on 
the population doubling characteristics of HUVEC for the 
corresponding to the data given in Figure 6a. Each bar 
represents the population doubling determined from triplicate 
flasks at the indicated FBS parameter, with the SEM above the 
bar. Note the greater difference between the control and 
DMSO control group when absorbed FBS was used. Also, fewer 
population doublings were achieved with the absorbed FBS in 
comparison to the unabsorbed FBS. 
* Significantly different from unabsorbed DMSO control, 
p < o.os. 
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Figure 6b. Effect of Dexa methasone on Population Growth 
(Absorbed vs. Unabsorbed F BS) 
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Figure 7a. Effect of dexamethasone (DEX) on growth of HUVEC 
(absorbed FBS). The cell counting experiments graphed in 
Figure 6a were repeated with DEX in a non-comparison 
experimental paradigm; only absorbed FBS was used. Second 
passage HUVEC were plated in T-25 flasks at standard density 
using regular CM-199. On the second day after plating, 
cultures were fed with culture media made from FBS from which 
endogenous steroids had been removed by double charcoal 
filtration, plus DEX dissolved in DMSO at the dosages 
indicated. The final concentration of DMSO in the DMSO 
control and all steroid flasks was 0.1%. The cells were 
harvested and counted on the seventh day. The bars represent 
the mean cell counts of triplicate determinations, with the 
SEM above the bar. 
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Figure 7a. Effect of Dexamethasone on Growth of HUVEC 
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Figure 7b. Effects of dexamethasone (DEX) on population 
growth (absorbed FBS). The graph indicates the growth 
characteristics of HUVEC grown in absorbed FBS-containing 
media for the corresponding steroid doses and cell number 
data given in Figure 7a. Each bar represents the mean 
population doubling determined from triplicate flasks, with 
the SEM above the bar. Neither the population doubling 
inhibition effected by the higher DEX doses (5 J,IM, 1 }lM) nor 
the population growth enhancement effected by the lower DEX 
doses (0.5 .)lM, 0.1 µM) was significant. The relatively 
greater difference between the control and DMSO control group 
when absorbed serum was used is again noted. 
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Figure 7 b. Effect of Dex a metha so ne on Popu lotion Growth 
(Absorbed FBS) 
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Figure Sa. Effect of hydrocortisone (HC) on growth of HUVEC 
(absorbed FBS). The cell counting experiments using absorbed 
serum graphed in Figure 6a were repeated with HC in a non­
comparison paradigm; only absorbed FBS was used. Second 
passage HUVEC were plated in T-25 flasks at standard density. 
On the second day after plating, cultures were fed with 
culture media made from FBS from which endogenous steroids 
had been removed by charcoal filtration, plus DEX dissolved 
in DMSO at the dosages indicated. The final concentration of 
DMSO in the DMSO control and all steroid flasks was 0.11. 
Cells were harvested and counted on the seventh day. The 
bars represent the mean cell counts of triplicate 
determinations, with the SEM above the bar. All doses led to 
growth facilitation. 
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Figure Ba. Effect of Hydrocortisone on Growth of HUVEC 
(Absorbed FBS) 
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Figure Sb. Effect of hydrocortisone (HC) on population 
growth (absorbed FBS). The graph depicts the growth 
characteristics of HUVEC grown in media with absorbed FBS 
corresponding to the given in Figure Ba. Each bar represents 
the population doubling determined from triplicate flasks, 
with the SEM above the bar. In contrast to DEX, all four 
doses of HC employed effected growth enhancement. A 
relatively greater difference (n.s.) between the control and 
DMSO control group is again recognized. * Significantly 
different from DMSO control, 
p < o.os. 
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Figure Sb. Effect of Hydrocortisone on Population Growth 
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Figure 9a. Effect of DHEA on growth of HUVEC (absorbed 
serum). The cell counting experiments using absorbed serum 
graphed in Figure 6a were repeated once again with DHEA in a 
non-comparison experimental paradigm; only absorbed serum was 
used. Second passage HUVEC were plated in T-25 flasks at 
standard density. On the second day after plating, cultures 
were fed with culture media made from FBS from which 
endogenous steroids had been removed by charcoal filtration, 
plus DHEA dissolved in DMSO at the dosages indicated. The 
final concentration of DMSO in the DMSO control and all 
steroid flasks was 0.1%. Cells were harvested and counted on 
the seventh day. The bars represent the mean cell counts of 
triplicate determinations, with the SEM above the bar. The 
effect of CHEA on cellular growth when absorbed serum was 
used is negligible. 
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Figure 9b. Effect of DHEA on population growth (absorbed 
FBS). The graph depicts the growth characteristics of HUVEC 
grown in media containing absorbed FBS corresponding to the 
data given in figure 9a. Each bar represents the PD 
determined from triplicate flasks, with the SEM above the 
bar. As with OEX and HC above, the relatively greater 
difference between control and DMSO control groups when 
absorbed serum is used is noted. The effect of DHEA on 
population growth in HUVEC when absorbed serum was used is 
not significant. 
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Figure lOa. Effect of dexamethasone (DEX) on growth of HUVEC 
(female cells). Second passage female HUVEC were plated in 
T-25 flasks at standard density. on the second day after 
plating, cultures were fed at a wider range of DEX doses as 
indicated. The final concentration of the DMSO solvent in 
the DMSO control and all treatment groups was 0.1%. Cells 
were harvested and counted on the sixth day. The bars 
represent the mean cell counts of triplicate flask 
determinations, with the SEM above each bar. Although not 
significant, the trend in female HUVEC was for higher doses 
of DEX to effect slight growth inhibition, while lower doses 
appeared to cause slight growth enhancement, compared to the 
DMSO control group. 
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Figure lOb. Effect of dexamethasone (DEX) on population 
growth (female cells). These bars illustrate the population 
doubling characteristics of steroid-treated female HUVEC 
corresponding to the data given in Figure lOa. Each bar 
represents th� mean population doubling from triplicate flask 
determinations, with the SEM above the bar. The population 
growth response was variable, but there was a trend for 
higher doses of DEX to cause slight growth inhibition, and 
the lower doses, enhancement in female cultures of HUVEC. 
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Figure lla. Effect of dexamethasone (DEX} on growth of HUVEC 
(male cells). Second passage male HUVEC were plated at 
standard density. On the second day after plating, cultures 
were fed with DEX at the six dosages indicated. The final 
concentration of the DMSO solvent in the DMSO control and all 
treatment groups was 0.1%. Cells were harvested and counted 
on the sixth day. The bars represent the mean cell count of 
triplicate flask determinations, with the SEM above the bar. 
Lower doses of DEX caused slight growth enhancement, much the 
same as for female cells (Figure 10a), except for the slight 
inhibition at 0.002 )lM DEX. Slight growth enhancement, 
rather than inhibition, occurred with higher steroid doses. 
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Figure 11a. Effect of Dexamethasone on Growth of HUVEC 
(Male Cells) 
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Figure llb. Effect of dexamethasone (DEX) on population 
doublings (male cells). These bars illustrate the population 
doubling characteristics of male HUVEC, corresponding to the 
data given in Figure lla. Each bar represents the population 
doubling from triplicate flask determinations, with the SEM 
above the bars. Although one dose of DEX (0.01 jlM) effected 
a significant ·population growth enhancement, a lower dose 
(0.002 JlM) was inhibitory. Also, high doses of DEX caused an 
enhancement of cellular growth. * Significantly different 
from DMSO control, control, and DEX at doses of 0.5 J1M and 
.002 JlM, p < 0.05. 
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Figure 11 b. Effect of Dex a methasone on Popu lotion Grow th 
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Figure 12a. Effect of dexamethasone (DEX) on growth of HUVEC 
(1% FBS). The bars depict the effect of six doses of DEX 
upon the growth of HUVEC when a reduced serum component in 
the culture medium was employed. Second passage HUVEC were 
plated in T-25 flasks at standard density using media made 
with 1%, instead of 20% FBS. All other media components were 
identical to CM-199. on the second day after plating, the 
cultures were·fed with the appropriate DEX doses. The final 
concentration of DMSO solvent was 0.1% for DMSO control and 
all steroid flasks. Cells were harvested and counted on the 
seventh day. The bars represent the mean cell counts of 
triplicate flask determinations, with the SEM above the bar. 
Cellular growth inhibition occurred with all doses employed 
when 1% FBS was used in the culture media. 
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Figure 12b. Effect of dexamethasone (DEX) on population 
growth (1% FBS). The bars illustrate the growth 
characteristics of HUVEC corresponding to the data given in 
Figure 12a. Each bar represents the population doublings 
(PD) from triplicate flask determinations, with the SEM above 
the bar. There was a significant inhibition of population 
growth with all but one DEX dose (0.5 JJM) when reduced serum 
was employed in the culture media. 
* Significantly different from DMSO control, p < 0.05. 
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Figure 13a. Effect of dexamethasone (DEX) on the growth of 
HUVEC (1% vs. 20% FBS). These bars compare the effects of 
DEX in media containing reduced serum (1%) or a full serum 
component (20%). Fourth passage HUVEC were plated in T-25 
flasks at standard density using media made with the 
designated serum concentrations. On the second day after 
plating, the cultures were fed with either 0.1 }lM DEX or 0.01 
}lM DEX in the appropriate media. In either medium, the final 
concentration of DMSO in the DMSO control and DEX treated 
flasks was 0.1%. Cells were harvested and counted on the 
seventh day. The bars represent the mean cell counts of 
triplicate flask determinations, with the SEM above the bar. 
The decreased growth that occurred with the reduced serum 
component in the culture media is noted. Slight inhibition of 
cellular growth occurred in media with 1% FBS,, while an 
enhancement of cellular growth occurred in media with 20% 
FBS. 
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Figure 13b. Effect of dexamethasone (DEX) on population 
growth (1% vs. 20% FBS). The bars compare the effects of 1% 
and 20% FBS-containing media on the growth characteristics of 
steroid-treated HUVEC for the steroid doses and cell number 
data given in Figure 13a. Each bar represents the population 
doubling determined from triplicate flasks. In the reduced 
serum medium, DEX caused slight population growth inhibition, 
while the full serum supplement media caused a significant 
population growth enhancement. This finding was consistent 
for many experiments when full CM 199 was employed as the 
culture medium. * Significant from DMSO control, 20% FBS. (p 
< 0.05). 
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Figure 14a. Effect of dexamethasone (DEX) on growth of HUVEC 
(1% vs. 20% FBS). A comparison of the effects of media 
containing reduced serum with fully supplemented media was 
again performed with a wider DEX dose range. Third passage 
HUVEC were plated in T-25 flasks at standard density, using 
media with either 1% FBS or 20% FBS. On the second day after 
plating, the cultures were fed with the appropriate media 
containing DEX at the doses indicated. The final 
concentration of DMSO solvent was 0.1% in the DMSO control 
and all experimental flasks. Cells were harvested and 
counted on the seventh day. The bars represent the mean cell 
counts of triplicate flask determinations, with the SEM above 
the bars. The decreased cellular growth that occurred with 
the reduced serum component is again noted. The effect of 
DEX in the reduced media is inconstant; cellular growth 
enhancement occurred when 20% FBS containing media was used. 
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Figure 14a. Effect of Dexamethasone on Growth of HUVEC 
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Figure 14b. Effect of dexarnethasone (DEX) on population 
growth (1% vs. 20% FBS). The bars compare the growth in 1% 
FBS and 20% FBS-containing media for the corresponding 
steroid doses and cell number data given in Figure 14a. Each 
bar represents the population doubling value determined from 
triplicate flasks. As found previously (Figure 13b), 
population growth enhancement occurred when medium with a 
full (20%) serum supplement was used. The previously found 
growth inhibition with 1% FBS media is not demonstrated here. 
* Significantly different from DMSO control, p < 0.05. 
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Figure 14b. Effect of Dexamethasone on Population Growth 
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Figure 15. Effect of dexamethasone (DEX) on colony formation 
by HUVEC. These bar graphs illustrated the number of 
colonies of HUVEC achieved with two different doses of DEX 
using three different variations on attachment and growth. 
For all variations, seventh passage HUVEC were plated in T-25 
flasks at colony formation density (1,000 cells/flask). 
After four hours, cultures were washed and then fed with 
steroid or control media according to the variation employed. 
Cultures were fed twice more at three day intervals with the 
appropriate steroid, DMSO control, or control media, and 
fixed and evaluated on the ninth day. The final 
concentration of DMSO solvent for DMSO control and all 
experimental flasks was 0.1%. Variation 1: To test the 
effect of DEX on growth only, cells were plated in CM-199 
without steroids, and refed three times as described above 
with the appropriate DEX containing medium or DMSO control 
medium. Vari�tion 2: To test the effect of DEX on 
attachment alone, HUVEC were plated with steroid containing 
or DMSO control medium, and then refed three times with CM-
199 without steroids or DMSO. Variation 3: To test the 
effect of DEX on both attachment and growth. HUVEC were both 
plated and subsequently refed three times with the 
appropriate steroid containing or DMSO control medium. Bars 
represent in the mean colony counts from triplicate flask 
determinations, with the SEM above the bar. Colony formation 
is significantly inhibited by growth in DEX; plating in 
steroid media does not lead to colony formation inhibition 
unless subsequent feedings are with steroid containing media 
as well. * significantly different from Variation 1 DMSO 
control group, p < .05. ** Significantly different from 
Variation 3 DMSO control group, p < .05. 
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Figure 16. This plot shows the light scatter analysis of 
control HUVEC. HUVEC were plated in T-2 5 tissue culture 
flasks at standard density (1.2 5 x 10 5 cells/flask). They 
were fed with fully supplemented media on the second and 
fourth day after plating. Cell harvest was on the seventh 
day. 
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Figure 17. This plot demonstrates the light scatter analysis 
of HUVEC with 0.2% EtOH added to the culture media. HUVEC 
were plated in T-25 tissue culture flasks at standard 
density. The cultures were fed with media containing 0.2% 
EtOH on the second and fourth day, with cell harvest on the 
seventh day. 
Figure 17 
128 
ONE PARAMETER ANALYSIS 
138 
C18P3-18-48 221 8185 11=82 
lP-256 LS 
4983 
BU ,u 
178 
179 
Figure 18. This plot shows the light scatter analysis of 
HUVEC treated with 0.5 µM DEX. HUVEC were plated in T-25 
tissue culture flasks at standard density. The cultures were 
fed with fully supplemented media containing 0.5% J.lM DEX 
dissolved in EtOH on the second and fourth day, with cell 
harvest on the seventh day. The final concentration of ETCH 
in the steroid containing media was 0.1%. 
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Figure 19. This plot demonstrates the light scatter analysis 
of HUVEC treated with 1 )lM DEX. HUVEC were plated at 
standard density in T-25 tissue culture flasks. The cultures 
were fed with fully supplemented media containing 1 µM DEX 
dissolved in EtOH on the second and fourth day after plating, 
with cell harvest on the seventh day. The final 
concentration of EtOH in the steroid continuing media was 
0.2%. 
Figure 19 
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Table 1. Effect of dexamethasone (DEX) on growth 
characteristics of HUVEC (second steroid feeding) -
Experiment I. This table illustrates the effect of a second 
steroid feeding upon the cellular and population growth of 
HUVEC. Second passage HUVEC were plated in T-25 flasks at 
standard density. On the second and fourth day after 
plating, cultures were fed with DEX dissolved in DMSO at the 
doses indicated. The final concentration of the DMSO solvent 
in the DMSO control and all the treatment groups was 0.1%. 
Cells were harvested and counted on the seventh day. Values 
represent the mean cell counts or corresponding mean 
population doublings of triplicate flask determinations, and 
are given with the SEM. Although not significant, there was 
a trend toward cellular and population growth inhibition with 
all four doses of DEX employed. 
Table 1 
Effect of Dexamethasone on Growth Characteristics of HUVEC 
(Second Steroid Feeding) - Experiment I 
Treatment 
0.1% DMSO Control 
1.0 µM DEX 
0.5 µM DEX 
0.1 µM DEX 
0.01 µM DEX 
Cell Number + SEM Population Doublings 
+ SEM 
9.13 + .20 X 105 3.25 + .03 - -
6.38 + .34 X 105 2.74 + .08 - -
6.86 + .80 X 105 2.83 + .16 - -
7.38 + .80 X 105 2.93 + .16 -
7.30 + 1.18 X 105 2.89 + .24 - -
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Table 2. Effect of dexamethasone (DEX) on growth 
characteristics of HUVEC (second steroid feeding) -
Experiment II. This table illustrates the effect of a second 
steroid feeding upon the cellular and population growth of 
HUVEC. Fourth passage HUVEC were plated in T-25 flasks at 
standard density. On the second and fourth day after 
plating, cultures were fed with DEX at the doses indicated. 
The final concentration of DMSO solvent in the DMSO control 
and all the treatment groups was 0.1%. Cells were harvested 
and counted on the seventh day. Values represent the mean 
cell counts or mean population doublings of triplicate flask 
determinations, and are given with the SEM. An increase in 
cellular and population growth with all steroid doses was 
noted. The increase in population growth was significant for 
1.0 µM, 0.5 µM, and 0.01 µM DEX. The much greater growth 
overall is apparent, compared to Table 1. 
Table 2 
Effect of Dexamethasone on Growth Characteristics of HUVEC 
(Second Steroid Feeding) - Experiment II 
Treatment Cell Number + SEM Po12ulation Doublings 
+ SEM 
0.1% DMSO Control 1.04 + .07 X 106 2.90 + .03 - -
1.0 JlM DEX 1.33 + .03 X 106 *3.26 + .04 - -
0.5 }lM DEX 1.24 + .04 X 10
6 *3.16 + .04 - -
0.1 µM DEX 1.16 + .01 X 106 3.0E + .01 - -
0.01 }1M DEX 1.26 + .07 X 106 *3.18 + .08 - -
* Significantly different from DMSO controls (p < .05). 
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Table 3. Effect of dexamethasone (DEX) on growth 
characteristics cf HUVEC (four day counts) - Experiment I. 
The table illustrates the effect of DEX upon the cellular and 
population growth in a four day growth assay. The purpose of 
this experiment was to determine if growth inhibition or 
enhancement occurred at an earlier time period, an effect 
that might have been masked in a seven day assay. Second 
passage HUVEC were plated in T-25 flasks at standard density. 
on the second day after plating only, cultures were fed with 
DEX at the doses indicated. The final concentration of the 
DMSO solvent for the DMSO control and all treatment groups 
was 0.1%. Cells were harvested and counted on the fourth 
day, two days after steroid administration. The values 
represent the mean cell counts or corresponding mean 
population doublings of triplicate flask determinations, and 
are given with the SEM. An early cellular and population 
growth inhibition was observed with the DEX doses employed. 
The decrease in population growth was significant for 1.0 pM 
and 0.1 }lM DEX. 
Table 3 
Effect of Dexamethasone on Growth Characteristics of HUVEC 
(Four Day Counts) - Experiment I 
Treatment Cell Number + SEM Po:gulation Doub lings 
+ SEM 
0.1% DMSO Control 3.35 + .28 X 105 1.80 + .13 - -
1.0 pM DEX 2.48 + .11 X 10
5 *1.37 + .06 - -
0. 5 µM DEX 2.68 + .26 X 10
5 1.48 + .14 - -
0.1 pM DEX 2.52 + .22 X 10
5 *1.39 + .13 - -
0.01 µM DEX 2.94 + .14 X 105 1. 62 + .07 - -
* Significantly different from DMSO Controls (p < .05 ). 
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Table 4. Effect of dexamethasone (DEX) on growth 
characteristics of HUVEC (four day counts) - Experiment II. 
The table illustrates the effect of DEX upon the cellular and 
population growth of HUVEC in a four day growth assay. The 
purpose of the experiment was to determine if growth 
inhibition or enhancement occurred at an earlier time period, 
an effect that might have been masked in a seven day assay. 
Fourth passage HUVEC were plated in T-25 flasks at standard 
density. On the second day after plating only, cultures were 
fed with DEX dissolved in DMSO at the doses indicated. The 
final concentration of the DMSO solvent in the DMSO control 
and all treatment groups was 0.1%. Cells were harvested and 
counted on the fourth day, two days after steroid 
administration. The values represent the mean cell counts or 
the corresponding mean population doublings of triplicate 
flask determinations, given with the SEM. Although cellular 
and population growth inhibition occurred, it was not 
significant for the four doses of DEX employed. Again, there 
was relatively less inhibition of growth with the lowest DEX 
dose. 
Table 4 
Effect of Dexamethasone on Growth Characteristics of HUVEC 
(Four Day Counts) - Experiment II 
Treatment Cell Number + SEM PoQulation Doublings 
+ SEM 
0.1% DMSO Control 6.23 + .43 X 105 2.16 + .11 -
1.0 pM DEX 5.17 + .84 X 10
5 1. 86 + .23 - -
0.5 µM DEX 4.77 + .31 X 10
5 1.78 + .09 - -
0.1 pM DEX 4.74 + .21 X 105 1. 77 + .06 - -
O. 01 pM DEX 6.16 + .34 X 105 2.15 + .08 - -
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Table 5. Effects of dexamethasone (DEX) upon endothelial 
cell cycle kinetics. The table illustrates the effect of 
dexamethasone on the percent of cells in the various phases 
of the cell cycle as determined by cytofluorometry. Second 
passage HUVEC were plated in T-25 flasks at standard density. 
On the second and fourth day after plating, cultures were fed 
with DEX dissolved in EtOH at the doses indicated. The final 
concentration of EtOH solvent in both the EtOH control and 1 
pM DEX treatment group was 0.2%, and in the 0.5 pM DEX 
treatment group, 0.1%. Cells were harvested and processed 
for flow cytometry on the seventh day. DEX at 0.5 pM caused 
an increase in the percentage of cells in the s phase, while 
at a higher dose (1 pH), effected an increase in the 
percentage of cells in the G2-M phase. 
Table 5 
Effects of DEX on Endothelial Cell Cycle Kinetics 
Culture Treatment Qo-G1 Q Q2-M 
Control 49.6% 36.9% 13.5% 
Control 0.2% EtOH 44.2% 40.1% 15.7% 
0.5 pM DEX 25.2% 56.9% 17.9% 
1 pM DEX 41% 34.9% 24.1% 
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Introduction 
The aim of the present study is to explore the 
possibility that there are differences regarding the 
expression of in vitro senescence between male and female 
cultures of human umbilical vein endothelial cells 
(HUVEC). The objective is to provide a clearer 
understanding of the senescent process in this culture 
system. The fact that primary age-associated cellular 
changes occur in the endothelium in vivo engenders 
relevance to the study of cellular senescence in cultured 
endothelial cells (EC) (Mueller et al., 1980). The study 
of the growth characteristics and proliferative life span 
of EC in vitro may be related to diseases such as 
atherosclerosis and metastatic cancer (Levine and Mueller, 
1979). Human EC are characterized by finite life spans 
and low frequencies of spontaneous transformations (Levine 
et al., 1983). Altered proliferative or functional 
capacities in aging endothelium would have very serious 
consequences for the organism in question. Since the 
endothelium occupies a very unique and strategic location 
within the body, it acts as a highly selective barrier for 
substances entering and leaving the blood. The 
endothelium is an essential component in wound healing and 
is the site of synthesis of a wide variety of 
1 
metabolically active compounds (Levine et al. 1983). 
Because of its distribution in practically all tissues, 
the study of endothelial cellular aging can be said to 
reflect a study of aging of the body as a whole. 
This review is divided into four sections. The 
first section describes the results of studies which have 
explored the phenomenon of endothelial cellular senescence 
in vivo. The second section outlines senescence of EC in 
vitro, with emphasis on cultured endothelial cells as an 
appropriate model for in vitro senescence. The third 
section details male-female differences in the endothelium 
that may affect endothelial aging or the expression of the 
senescent cell phenotype in experimental model systems. 
The fourth and final section, a summary, explores the 
role of the endothelium in atherogenesis. 
Endothelial senescence in vivo 
The occurrence of large, multinucleated cells 
characteristic of aging EC in cultures have in vivo 
correlates and have been described by a number of authors 
(Lautsch et al., 1953; Short 1954; McGovern 1955; Scott 
1956). Multinucleated giant cells were found in the aorta 
of aging humans (Lautsch et al., 1953), over venous 
intimal thickenings in aged humans (Short, 1953), and in 
2 
the veins of aging rats (McGovern, 1955). McGovern 
regarded multinucleated cells as evidence of regeneration 
following injury; cellular injury may play a role in 
senescent cell expression in vivo. These large cells were 
uncommon, but could be found, in young human subjects, 
indicating that they were not solely a phenomenon in aged 
individuals. It is plausible that senescent cells occur 
in all persons, their number increasing as a function of 
age. 
Scott (1956) described multinucleated cells 
overlying organized thrombi in vessel walls of humans. 
Hicks et al. (1983), examining Fischer rats, reported an 
increase in the cytoplasmic areas of EC, and an increase 
in the cross sectional areas of the basement membrane. 
Cell organelles may also undergo _changes with aging. 
Miranov and Miranov (1985) found that the aortic 
endothelial cell cytoskeleton in rats became more highly 
structured with aging, an adaptive reaction which 
increased the intracellular contacts and cell adhesion to 
the underlying substrate. The functional ramifications of 
this observation were not outlined. Multiple factors, 
including anatomical and hemodynamic differences, 
influence the organization of the endothelial cell 
cytoskeleton in situ (White et al. 1983). 
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Poole et al. (1958) mechanically injured the aorta 
of young rabbits and found that within three days, large 
cells, containing up to ten or more nuclei in their 
cytoplasm, appeared in the edges of the denuded area. 
They hypothesized that giant cells, with multiple nuclei, 
represented a syncytium which failed to break up into 
individual cells, the nuclei remaining in a conglomerate 
within the center of the cells. Exactly why this happened 
was not entirely clear. Lautsch et al. (1953) observed 
that the nuclei tended to be grouped centrally within the 
endothelial cell cytoplasm, and that two or more groups of 
nuclei could be seen within the confines of one giant 
cell. Stehbens (1965), studying endothelial cell repair 
following mechanical trauma to rabbit veins, found an 
increased number of multinucleated EC in the region of 
injury three days after the mechanical insult. In contrast 
to the above, Reidy et al. (1983) measured regrowth in 
denuded rat and rabbit arteries and reported that 
endothelial cellular regeneration stopped before regrowth 
was complete, and that cell senescence was not 
responsible. 
Aside from the knowledge that senescent cells occur 
with greater frequency in aged individuals and that they 
can be found in proximity to mechanically wounded areas of 
the endothelium in vivo, little is understood regarding 
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their significance and function. The literature suggests 
that these cells do play some role in the related 
processes of senescence and repair. 
Senescence in Cultured Endothelial Cells 
The phenomenon of age associated cellular changes 
that takes place in the endothelium in vivo makes the 
study of cellular senescence in cultured EC particularly 
relevant. Cells in the body extend across a range from 
rapidly and continuously dividing (epithelium, hemapoietic 
cells) to fixed, post mitotic, highly differentiated 
(neurons, muscle fibres). Since the vascular endothelium 
is an intermediate class of cells which exhibits a slow 
turnover in vivo, cellular senescence in endothelial cells 
might have unique characteristics and consequences for the 
organism. 
With repeated passage, cultured endothelial cells 
(EC) undergo morphological and proliferative changes which 
are similar in many respects to the changes observed in 
aged or senescent EC in vivo. The basic cause of the 
senescent process in vitro is unknown, although Grove and 
Cristafalo (1977) viewed cellular aging as being due to a 
transition from a rapidly proliferating state through a 
series of progressively slower cycling ones, to a 
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condition in which the cells were arrested or were 
proliferating so marginally so as to be incapable of 
repopulating the culture vessel. Whether the decline in 
proliferating capacity is due to a uniform increase in the 
generation time of the cells or to an increase in 
heterogeneity in the culture (resulting in a mixed 
population in which some cells divide normally, while 
others are incapable of division) remains unknown. The 
latter theory, that of a mixed cell population, is 
plausible on empirical grounds but has not been proven 
definitively (Cristafalo, 1972). Heterogeneity of the 
cell population was supported by Schwartz et al. (1981), 
who felt that the limitations to replicative lifespan 
manifested in cell culture might have been a result of 
random distribution of proliferative potential in the 
culture, rather than a true limitation of the ability of 
individual cells to have divided. 
In general, all non-transformed cell cultures 
undergo a natural history which includes three phases. 
The first phase consists of the primary culture up to the 
first confluence. The second phase is characterized by 
rather luxuriant cell growth necessitating subcultivation. 
The third and final phase marks the period of cellular 
aging, senescence, loss of growth potential, and eventual 
cell death. (Haymark, 1976). It is of interest that the 
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transition between Phase II and Phase III may be rather 
abrupt in EC in comparison to other cell lines -
fibroblasts, for example (Grove and Cristafalo, 1977). A 
limitation which must be kept in mind, however, in 
evaluating aging, is the fact that all well-documented 
reports of in vitro senescence are based upon paradigms 
where subculturing is via enzymatic dissociation 
(trypsin), which introduces a major source of artifact in 
the experimental process (Ruben and Rafferty, 1978). 
Cellular aging probably has multiple components, and in 
vitro methodology should reflect, as best as possible, the 
interaction of cells with hormones and other factors in 
their environment, a process that occurs in vivo 
(Cristafalo, 1976). 
A number of researchers have documented the 
expression of the senescent phenotype and lowered growth 
rate with aging in various human and animal endothelial 
cell cultures. Mueller et al. (1980) found a replicative 
life span of approximately 80 cumulative population 
doublings (CPD) in BAEC; growth rates decreased and cell 
size increased as the CPD increased. Rosen et al. (1981) 
extended these studies and suggested that cellular 
senescence in EC may contribute to the genesis of 
atherosclerosis and the process of tumor invasion and 
metastasis. 
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Weber et al. (1984) studied cultured BAEC and found 
that senescent cells appeared at approximately the eighth 
passage. The senescent cells were often multinucleated 
and two to three times larger than regular EC; they had 
vacuoles present in the perinuclear regions; and contained 
giant or irregular mitochondria, abundant RER, and 
occasional Weibel-Palade bodies. The Weibel-Palade body, 
a rod shaped cytoplasmic inclusion, is an endothelial­
specific organelle and as such can be used as an 
identifying marker for EC (Gimbrone, 1976). The curious 
longitudinal fibers observed running parallel to the long 
axis of the, cell often bridged over the nucleus, these 
fibers were hypothesized to be ''stress" fibers not related 
to cellular motility (Weber et al., 1984). 
Pursuant to this, it has been speculated that the 
giant cells may form as a result of some type of repair 
process, obtained through cell spreading. The origin of 
senescent cells was felt by Wright (1972) to be due to 
mitosis occurring in some instances without cytoplasmic 
division, giving rise to the giant multinucleated cells. 
Either process might possibly explain the thin, veiled 
cytoplasmic cords (see below) frequently seen in senescent 
cells. Duthu and Smith (1980), supporting the findings 
of Weber et al. (1984), remarked on the increase in the 
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number of pinocytotic perinuclear vacuoles in EC in 
confluent BAEC cultures, a phenomenon even more striking 
in senescent cells. 
Rosen et al. (1981) depicted senescent BAEC as 
having increased cellular areas and volumes, and 
increased protein content. Senescent cells, however, 
qualitatively retained their ability to express Factor 
VIII antigen, corroborating their earlier study (Mueller 
et al., 1980). A large proportion of their cells were 
rapidly dividing until 75% of their life span was 
completed; also at this point an increase in cell 
attachment area paralleled a decrease in the number of 
labeled nuclei in a (3HJ thymidine study. However, the 
cells still could achieve confluent monolayers until 90% 
of their life span was completed. Bierman and Schwartz 
(1984) documented increased binding and degradation of low 
density lipoproteins in BAEC, and suggested that this 
finding played a role in arterial wall changes that 
occurred with age in vivo. There was a gradual decrease 
in glycosaminoglycans and collagen in cultured porcine EC 
with age (Bihari et al. 1981). 
Bowersox and Sorgente (1982), studying the 
chemotactic response of BAEC to fibronectin and 
endothelial cell mitogens, such as endothelial cell growth 
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factor (ECGF) and tumor extracts, demonstrated that cells 
from later passages (i.e. after 15-16 in vitro 
subculturings), were less responsive to chemotactic 
stimulation when compared to early passage cells. Johnson 
& Longenecker (1982) described senescence in BAEC; the 
onset of Phase III in these cells could be delayed if the 
cells were maintained under fibroblast growth factor (FGF) 
dependent conditions. They believed that in vitro studies 
should focus on a cell type which begins its cultured life 
span expressing its differentiated phenotype and which 
also is known to be involved with an age-related pathology 
in vivo. HUVEC meet these criteria. 
Although most studies of in vitro senescence have 
been performed on BAEC, current perspective has included 
the exploration of senescence in human endothelium in 
culture as well. The question of whether cellular density 
at plating may be a factor in the senescence of human 
endothelial cell cultures was raised by Glassberg et 
al. (1982) who cultured human iliac artery EC and reported 
that the cells became senescent and lost viability after 
8-10 passages when passed at a 1:3 split ratio. According 
to Cristafalo (1976), there is a tendency for HUVEC to 
grow differently and senesce at different rates depending 
on the split ratio at passage (1:5 vs. 1:10 split ratios, 
for example). Cells passed at a greater density (i.e., a 
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lower split ratio) may be affected by contact inhibition 
and not proliferate as rapidly as cells passed at a 
somewhat lower density (Maciag et al., 1981). In cell 
culture, the "split ratio" used in passage procedures 
could effect the total number of population doublings 
achieved in a given assay. 
Duthu and Smith (1980), in examining culture 
conditions for BAEC, found that the effect of FGF upon 
cell proliferation in BAEC was inoculation density 
dependent. The cell division rate was significantly 
increased at inocula less than 1 x 104 cells/cm2 , but 
there was no effect at higher densities. Glassberg et al. 
(1982), in comparing HUVEC to iliac artery EC, felt that 
species differences regarding growth and function might be 
more apparent than differences between arteries and veins, 
or diversities between adult and newborn vessels. Since 
it is possible to correlate the replicative ability in 
HUVEC cultures with cell density at the time of plating 
(Henriksen et al., 1975), this parameter is also important 
in examining the growth patterns and senescent expression 
in HUVEC. 
Mayurna (1963), the first author to report the 
isolation of HUVEC in culture, described many binucleated 
and multinucleated cells in his primary cultures. 
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Although not all binucleated EC in culture are senescent 
cells, the majority of the multinucleated cells do exhibit 
the characteristics of the senescent phenotype. Fryer 
(1966), in an early discussion of "atypical cells" in 
HUVEC, described large, circular, sometimes multinucleated 
cells, that increased in number with increasing age of the 
culture. The cells contained abundant fat droplets, and 
showed a greater affinity for india ink stain than normal 
EC. Gimbrone et al. (1973) mentioned a morphologically 
distinct subpopulation of large cells in HUVEC, 
occasionally multinucleated, which could be separated from 
certain primary cultures. Maciag et al., (1981) described 
the occurrence of large, multinucleated senescent cells in 
HUVEC, adding that they were occasionally found in primary 
cultures. 
This senescent phenomenon can be observed repeatedly 
in long term culture of HUVEC. It is of interest that 
similar, large senescent veiled cells have been observed 
in the edge of intimal lesions and in the aorta of aging 
humans (Haudenschild et al., 1975). These authors wrote 
of large multinucleated "veil'' like cells seen in their 
cultured HUVEC, starting after the second passage. In 
senescent cells, the cytoplasm takes on a curious webbed 
appearance; cytoplasmic spokes will appear to extend from 
the nucleus(i) in radial fashion, much like broad spokes 
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on a wheel. Senescent cells are commonly five to ten 
times larger than typical EC in culture, contain fewer 60-
70 A filament bundles in the cell periphery, and lack 
specific endothelial granules, or Weibel-Palade bodies 
(WPB) (Haudenschild et al., 1975). Gimbrone et al. 
(1973) rendered an account of cells significantly larger 
than normal HUVEC, lacking WPB, but containing cytoplasm 
filled with myofibrillar elements and fusiform densities. 
Another in vivo correlation was provided by Weber et al. 
(1984), who remarked that while the arteries of children 
were covered by a homogeneous sheet of small to medium 
sized EC, adult arteries displayed a polymorphic luminal 
surface due to the presence of large, giant EC which 
tended to accumulate in areas of repeated endothelial 
injury or high cell turnover. 
Gospodarowicz et al. (1978), studied HUVEC and 
corroborated the earlier descriptions of senescent cells 
in these cultures, noting that the use of FGF and thrombin 
in the culture media could prevent precocious senescence. 
They noted that in the umbilical veins, the vascular cells 
may be pre-programmed to senesce rapidly after birth, 
although there was no evidence that the expression of 
senescence in culture differed as a function of the 
different sources of origin of cells, or among species. 
In conclusion, Gospodarowicz et al. (1978) warned that 
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studies performed on cell populations with excessive 
senescence might lead to misleading conclusions regarding 
the actual capability of the cells in reference to the 
function or behavior in question. 
Grinspan et al. (1981) further characterized the in 
vitro senescence of human umbilical vein endothelial cells 
(HUVEC) in culture. After continued subculture, the 
proliferation rate of EC slows and harvest cell densities 
decrease. Morphological changes ensue which are typical 
of in vitro senescence: cells become larger and have an 
increased cytoplasmic to nuclear ratio; the attachment 
area of individual cells increases; and large, 
multinucleated cells with veil-like cytoplasm appear in 
the culture. They also raised the question of whether 
culture life span was limited by the number of cell 
division (genomic time) or by a fixed amount of 
chronological "metabolic" time. Since a wide variety of 
human tissues of fetal, neonatal, or adult origin are 
incapable of unlimited proliferation, it has been thought 
that the phenomenon of limited life span must be 
programmed in some way. In addition, Cristafalo (1972) 
felt that the aging of fixed post-mitotic cells (i.e. 
neurons) quite probably proceeds by a different mechanisms 
compared to that observed in proliferating tissues (i.e. 
epithelium). What remains obscure is the relationship, if 
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any, between the observed programmed limit of population 
doublings for a particular cell line, and the actual 
events that limit cellular functions during senescence in 
vivo. 
Evidence for a pre-programmed process of senescence 
can be found in HUVEC. Subcultures of HUVEC tended to 
exhibit increasing pleomorphism of cells, with increased 
numbers of veil-like cells. Also, the tendency to form 
confluent monolayers was decreased with cell passage 
(Maciag et al., 1981). Although the large, multinucleated 
cells typically appeared in greater numbers in later 
passages of EC (Haudenschild et al., 1975), the fact that 
large veil-like cells can occasionally be found in primary 
HUVEC cultures suggests that senescence of EC is a 
preprogrammed event. 
Knaver and Cunningham (1983) grew HUVEC on a 
fibronectin matrix, using ECGF to potentiate the growth of 
the cells. They found that there was a change in the 
gross morphological appearance of the cells between early 
and late passages; cells in the latter were larger in size 
and more irregular in shape. They estimated the incidence 
of multinucleated "veil" cells as comprising one to two 
percent of cells in early cultures and 10-12% of the total 
cells by passage 16. It was suggested that in all culture 
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systems, there were deficiencies which resulted in the 
gradual decrease in the differentiated state of the 
culture. 
That the substratum-matrix upon which cells grow in 
culture can be an integral factor in determining 
proliferative rates of EC was underscored by Furcht et al. 
(1986) who found that there were different substratum 
requirements for microvascular EC and large vessel EC. 
This differential phenotypic behavior of EC from different 
sources regarding their response to matrix or basement 
membrane components exemplifies the fact that many factors 
are influential in promoting or inhibiting endothelial 
cell growth in culture. However, the suggestion that 
basement membrane components may modulate the cellular 
phenotype of the endothelial cell indicates the 
possibility of these entities influencing the expression 
of senescence in some way. Cristafalo (1972) hypothesized 
that the many and varied environmental effects by which 
the cell life span could be influenced were superimposed 
on an existing program for a preset life span, thus 
perhaps modifying its duration, but in the end, not its 
ultimate disposition. 
Maciag et al. (1981) carried HUVEC cultures through 
34 population doublings, but not to the end of their life 
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span. He was one of few authors to attempt a quantitative 
assessment of senescer.t cells in HUVEC. starting in the 
eighth passage, giant, multinucleated cells with broad, 
veil like cytoplasm appeared in culture. Their initial 
density was one/10 3 cells, but by the fourteenth passage, 
they increased in number, achieving a density of one/10 2 
cells. The authors called for detailed studies of 
cellular senescence in HUVEC, to see if EC growth rates 
indeed did decline at later stages, as did the doubling 
rates of adult (Schwartz, 1978) and fetal (Rosen et al., 
1981) bovine aortic endothelial cell cultures. 
Kan et al. (1985), using fibroblast conditioned 
medium, cultured HUVEC through 50 population doublings but 
did not specifically address the senescence phenomenon. 
In this study, medium conditioned from human diploid 
fibroblast cultures markedly enhanced the division of 
HUVEC at low seeded density. They defined the end of a 
proliferative life span as that cumulative population 
doubling at which the EC density did not double beyond the 
inoculation density (2 x 10 4 cells/35 mm dish) after two 
weeks. Rosen et al. (1981) suggested three weeks at the 
above inoculation density as a criteria for judgment as to 
when "end of life span" ensues. 
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In summary, quantitative assessment of in vitro 
senescence in EC has not been comprehensively reported in 
the literature. Many studies regarding endothelial 
cultures pool the results from numerous cell passages, 
although it has recently been demonstrated that there is a 
significant variability in properties of and growth 
characteristics during in vitro propagation (Goldsmith et 
al., 1984). This variability should be entertained when 
exploring properties of subcultured endothelium. 
Male-Female Differences in EC 
Exploring the male-female differences in growth and 
senescence of HUVEC is of strong relevance, since no 
studies have addressed this aspect in vitro. Balconi et 
al. (1983) examined factors which affected success rates 
of primary HUVEC cultures; the sex of the newborn did not 
significantly influence the successful establishment of 
primary cultures of HUVEC. Unfortunately, secondary and 
later passage cultures were not studied. 
On a functional level, male HUVEC synthesized more 
PGI2 and PGE2 than female HUVEC when the cells were 
stimulated with thrombin (Batres and Dupont 1986). The 
sex steroids 17 beta estradiol and testosterone were found 
to stimulate PGI2 secretion in female, but not male, 
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piglet EC in culture (Seillan et al., 1983). In addition, 
female, but not male EC could convert testosterone into 
the estrogens estriol, estrone, and estradiol. The fact 
that 17 beta estradiol induces stimulation of the 
production of PGI2, which inhibits platelet aggregation, 
could provide a partial explanation for the beneficial 
role generally attributed to naturally occurring estrogens 
in preventing cardiovascular diseases (Seillan et al., 
1983). Lennon and Poysner (1986), studying the effect of 
age on the vascular prostaglandin production in male and 
female rats, found that PGI2 production decreased in males 
and in aged rats, and linked this process to the 
difference in vascular disease incidence in males and 
females. Cunard et al. (1986) outlined the response of 
ring pulmonary artery preparations to the synthetic 
endoperoxide analog U46619, and reported that in denuded 
vessels, a significantly lower U46619-elicited maximum 
tension occurred in female vs. male rat preparations. 
Nordoy et al. (1978) studied the inhibitory effects 
of a monolayer of HUVEC and PGI2 upon platelet 
aggregation, and found less of an inhibitory effect of a 
monolayer of HUVEC or PGI2 upon ADP or collagen induced 
platelet aggregation in females than males. Karanian et 
al. (1981) studied whole thoracic aorta preparations in 
the rabbit and rat and found that the maximum contractile 
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response to various prostaglandins was greater in male 
specimens than female specimens; prostaglandin receptors 
in the thoracic aorta appeared to be gender related. A 
further link to gender differences in incidence and 
expression of cardiovascular diseases could be made if 
additional studies indicated parallel gender differences 
in the growth and senescence of endothelial cells. 
It is believed that exposure of the vascular 
endothelium to increases in shear stresses, as typically 
occurs in hypertension, creates an increased demand on the 
normal cellular mechanisms involved in anchorage of the 
cells to the substratum. These cellular mechanisms 
include microfilamints containing both actin and myosin; 
these "stress fibers" are seen much more frequently in 
arterial, rather than, venous, endothelium (White et al. 
1983). These authors reported that the proportion of EC 
containing stress fibers in the descending aorta was 
significantly greater in males vs. females in both normal 
and spontaneously hypertensive rats. Also, in male rats, 
the stress fibers were thicker and had more prominent 
striations. 
Male/female differences in senescent phenotypic 
expression have not been studied previously. Experiments 
examining gender differences in HUVEC regarding in vitro 
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senescence will augment the knowledge of the aging process 
of male and female EC in this culture system. Also, it 
seems likely that continued experimentation with EC in 
vitro will suggest pertinent questions to be asked 
regarding in vivo pathologies, and serve as a ground for 
exploring methodology that can be used in answering these 
questions. 
The Role of EC in Atherosclerosis 
Age related changes in the endothelium lining the 
blood vessels are believed to be significant events which 
are integral in the expression of two major pathologic 
processes: atherosclerosis and tumor invasion and 
metastasis (Mueller and Levine 1979; Grinspan et al. 
1981). It is well known that the incidence of 
atherosclerosis and thrombosis is higher in males than in 
females (Batres and Dupont 1986). Atherosclerotic lesions 
tend to occur more frequently in hypertensive individuals, 
and in areas of the vascular system subject to hemodynamic 
stress, such as the aortic bifurcation (Clarkson et al., 
1985). Sauer et al. (1981) described the age-related 
intimal alterations, including endothelial cellular 
changes, in spontaneously hypertensive rats. They 
demonstrated a proliferation of organelles in EC, most 
notably in Weibel Palade bodies, in contrast to previous 
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in vitro findings {Haudenschild et al. 1975, Weber et al. 
1984a). Haudenschild et al. (1981) compared intimal 
changes in normal, spontaneously hypertensive, and 
deoxycortisone/salt treated rats and found the latter two 
groups to exhibit an overall increased number of EC, and 
to contain a greater number of EC with bizarre shapes, 
nuclear folding, and nuclear bulging toward the lumen. 
These changes were observed in aged normotensive animals, 
but to a lessor extent and with slower progression. 
Scannning electron microscopy of these changes revealed EC 
with a raised appearance and irregular surfaces. 
Ross and Glomset (1976) in a detailed two part 
report outlined the then current theories of the 
pathogenesis of atherosclerosis. They described the early 
lesion of atherosclerosis as being the fatty streak, a 
focal accumulation of smooth muscle cells {SMC) surrounded 
by lipid deposits. Macrophage derived foam cells were a 
major constituent of this early pathological entity. 
These fatty streaks come to cover a significant percentage 
of the intimal surface as a person ages. The fibrous 
plague, a more advanced lesion, consisted of an 
accumulation of intimal, lipid laden SMC and collagen, 
elastic fibers, and proteoglycans. This fibrous cap 
covered a large, deeper deposit of free extracellular 
lipid and cellular debris. Long standing lesions were 
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characterized by fibrous caps altered by hemorrhage, 
calcification, and mural thrombosis. 
The role of EC in this process was unclear, but some 
role indeed was entertained, since the endothelium 
separates the blood from the endothelial substratum and 
underlying connective tissue, the latter areas known to be 
involved in the development of the atherosclerotic 
pathology. Ross and Glomset (1976), in implicating the 
vascular endothelium, were among the first authors to 
propose the endothelial cellular injury hypothesis as a 
major event leading to atherosclerotic lesion 
manifestation. Basically, areas in the vessel wall, 
subject to the mechanical stresses of hypertension and 
the proposed desquaminative effects of hyperlipidemia, 
were subject to endothelial barrier disruption. Platelets 
adhering to the subendothelial connective tissue at the 
sites of injury released a factor which was capable of 
promoting the proliferation of SMC. Eventually, a fatty 
streak developed, and the cascade of events leading to the 
full blown clinical presence of the atherosclerotic plaque 
ensued (Ross and Glomset, 1976). EC of the vessel wall 
were thought to exhibit diminished activity with aging, 
eventually affecting the endothelial barrier by reduced 
reparative ability. The injury theory of plaque formation 
lent support to the additional hypothesis that endothelial 
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injury occurred more frequently and/or was repaired less 
efficiently or completely with increasing age (Levine et 
al. 1983). The older an organism, the much more likely it 
was that a significant degree of endothelial injury had 
been sustained. 
The theory came to be refined as knowledge 
concerning the contributing factors increased. Basically, 
an undefined injury to the endothelium led to 
desquamination of EC, which exposed the thrombogenic 
basement membrane to the circulating blood. Platelet 
adhesion and degranulation were subsequent to release of 
platelet derived growth factor, mitogenic and chemotactic 
for SMC. It is of interest that a dying endothelial cell 
can produce in less than three days as much PDGF- like 
proteins as a healthy cell can produce over a 19 day 
period. It would appear, then, that denuded, dying EC 
would hasten or enhance growth factor release from 
platelets, thus accelerating the process of proliferation 
and infiltration of SMC. After intimal proliferation of 
SMC, the cascade of processes then continues through lipid 
accumulation and macrophage infiltration, combining to 
form the well characterized atherosclerotic plaque 
(DiCorleto and Chisolm 1986). 
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Levine and Mueller (1979) felt that injury to the 
endothelium increased vessel permeability, allowing 
extravasation of potentially atherogenic macromolecular 
substances into the arterial wall. Even subtle injury 
might promote an increase in transendothelial pinocytosis, 
thereby transporting atherogenic substances into the 
subendothelium. Also, endothelial cell injury apparently 
occurred more frequently and/or was repaired less 
efficiently with increasing age. White et al. (1983) 
proposed that the prominent microfilament bundles (stress 
fibers) observed in the aortic endothelium of hypertensive 
rats might play a part in cell contractility, thereby 
possibly affecting this altered vessel wall permeability. 
It was observed by both Lautsch et al. (1953) and 
Haudenschild et al. (1975) that large senescent cells 
occured in the edge of intimal lesions of the vascular 
system and in the aortas of aging humans. Raised levels 
of cortisol in the plasma correlated with an increased 
risk of coronary heart diseases (Jarvelainen et al. 1982). 
It was thought that cortisol acted neutrally or in a 
protective manner, attenuating endothelial cell effects 
upon SMC growth. In lesions already induced by other 
factors, it was believed that cortisol accentuated the 
atherosclerotic process due to increased formation of 
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connective tissue macromolecules in the SMC. Thus EC may 
play an indirect but vastly significant role in the 
development of this pathological lesion. However, that an 
intact endothelium was active in regulating proliferation 
of SMC was proposed by Willems et al. (1982), who 
described the inhibitory effect of media conditioned by 
confluent HUVEC monolayers upon smooth muscle cell and 
endothelial cell (3H] thymidine incorporation. Apparently 
then, HUVEC possess growth inhibitory activity which 
inhibits DNA synthesis and proliferation in EC as well as 
SMC. Their findings also lend support to the theory that 
substances released by confluent EC may contribute to the 
density dependent regulation of endothelial growth that 
has been observed by scientists studying EC in culture. 
However, it became obvious that not all features of 
the atherosclerotic lesion could be explained by the 
reaction-to-injury hypothesis (Thorgeirsson and Robertson 
1978). For example, it would be presumptive to conclude 
that endothelial cellular replication results simply from 
the disruption of the normal cell-cell contact. 
Endothelial cellular mutation leading to altered growth 
patterns may occur spontaneously or perhaps be genetically 
influenced- other concepts that should be entertained in 
exploring factors which may influence endothelial behavior 
in atherosclerosis. Also, although endothelial cell 
26 
replication may be increased in response to hypertension 
or hyperlipidemia, this does not automatically imply areas 
where the endothelium has become denuded (Schwartz et al. 
1981). A critical period or degree of denudation, and 
unique or characteristic location of the denudation injury 
may also be factors involved. 
Schwartz et al. (1981) remarked that there was no 
convincing evidence that excessive growth of the 
endothelium contributed to the atherosclerotic lesions. 
That the endothelium partakes in some way in the process 
was evident in the fact that platelet derived, endothelial 
cell derived, and macrophage derived growth factors could 
all stimulate the growth of SMC. Schwartz et al. outlined 
three ways in which endothelial cellular functions could 
lead to the proliferation of SMC: either by altered 
transport, altered platelet interactions, or altered 
control of the production and release of growth factors. 
Interestingly, though, it is not known whether the 
endocytotic process observed in cell culture of EC is the 
same as the mechanism involved in the transport of LDL 
across the vessel wall in vivo. 
DiCorelto and Chisolm (1986) admitted that although 
the response to injury hypothesis of atherosclerotic 
lesion development had a marked influence regarding 
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atherogenesis, evidence had not been produced convincingly 
that frank denudation of the endothelium occurs as an 
early event in atherogenesis. They contended that only in 
advanced plaques had regions of vessel wall without 
endothelium been identified morphologically, and that 
endothelial denudation by itself could not be used to 
identify an early vascular wall lesion. They hypothesized 
an attractive theory that called for an active role of EC 
in atherogenesis. In an activated state, EC could express 
binding sites for monocytes; secrete monocyte activators; 
secrete oxygen free radicals which could conceivably 
modify surrounding LDL; and finally synthesize and secrete 
a PDGF-like protein or other mitogens and chemoattractants 
for SMC in the media of the vessel. Since not all 
mitogens secreted by EC have been identified, it is rather 
clear that the endothelial injury hypothesis will undergo 
further modification as research unfolds in this area. 
Ross (1986) later modified his approach to the 
injury hypothesis of atherosclerosis. He felt that 
cultured endothelium was a useful yet limited model of 
endothelium in vivo. However, cultured confluent 
endothelial models have a low but definite rate of 
turnover, which may approximate the state of "injury" in 
vivo. Ross proposed that EC in vitro may be in an 
abnormal or "injured" state, and were continuously 
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stimulated to form and secrete growth factors, including 
PDGF. It was further postulated that in its subtle form, 
injury to the endothelium might cause no morphologic 
alterations in EC, but might be sufficient to stimulate 
the cells to form and secrete growth factors. In the in 
vivo lesion, chronic repeated bouts of injury might cause 
EC to proliferate repeatedly at the edge of intimal 
lesions, eventually undergoing senescence. Whether these 
senescent cells release mitogenic substances or other 
factors more readily or efficiently is not known, but is 
an interesting speculation in the pathogenesis of 
atherosclerosis. 
Glagov et al. (1987) emphasized that a variety of 
tissue responses occurred within atherosclerotic lesions. 
They stressed the fact that the endothelial transport 
system may undergo modification, making transport of LDL 
and other substances facilitative in atherogenesis 
development. There was no evidence that there was 
microinjury of the endothelium at sites of lesion 
formation; only when the atherosclerotic lesions became 
large did the overlying endothelium demonstrate 
intercellular separations or perforations with focal 
bridging. Also, plaques tended to occur in zones of 
relatively low flow velocity, where flow fields were 
complex, and reversed during the cardiac cycle. Perhaps, 
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they felt, the "low•• flow could favor transendothelial 
transfer of atherogenic substances into the arterial wall, 
and such interactions in the presence of an otherwise 
morphologically intact endothelium, rather than one with 
focal desquamination, could be major factors in lesion 
development. Finally, Reidy et al. {1987) removed zones 
of aortic rat endothelium with a thin, flexible nylon 
catheter, and found no replication of medial SMC and no 
intimal thickening underlying the mechanical denudation 
sites. Additional studies along these parameters will 
illuminate the many factors involved in atherosclerotic 
plaque progression. 
In summary, large, senescent multinucleated EC have 
been described in both in vivo and in vitro experimental 
systems, but their exact significance and role in normal 
or pathologic processes has not been established. Since 
these senescent cells are associated with atherosclerotic 
lesions in humans and animals, and have been found with 
increasing frequency with aging in both in situ and 
culture conditions, their relevance to aging and systemic 
changes in the vascular tree needs further clarification 
and definition. Also, due to the pronounced differences 
in incidence and severity of atherosclerotic disease in 
males and females, basic gender differences may play some 
role. 
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Materials and Methods 
Experimental Methodology 
Culture of HUVEC. Harvest of EC from umbilical cord veins 
was based on the method of Gimbrone et al. (1974). Term 
umbilical cords were obtained from the Department of 
Obstetrics and Gynecology at the Medical College of 
Virginia. Using sterile technique, unclamped umbilical 
cord segments at least 10 cm. long were cannulated at both 
ends using one-way stopcocks and the blood flushed by 
perfusion of 200-400 ml. of phosphate buffered saline 
solution (PBS- pH 7.2). The lumen of the vein was filled 
with 0.1% collagenase (Clostridium histolyticum, type I, 
Sigma Chemical Company, St. Louis, MO) in PBS with calcium 
and magnesium [CaC12 (anhyd), 0.10 gm/L, and Mgcl2·6 H2o. 
0.10 gm/LJ, and the stopcocks closed. The cord segment 
was then incubated in a bath of PBS at 37 degrees C for 15 
minutes. The collagenase solution was collected in a 
conical centrifuge tube with an equal volume of Hank's 
Balanced Salt Solution (HBSS) without calcium or 
magnesium. The EC were then pelleted by centrifugation at 
200 x g for 5 minutes. 
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Defined fetal bovine serum (FBS, Hyclone 
Laboratories, Logan, UT) was used. Other media and 
reagents were from Gibco Laboratories (Grand Island, NY) 
or Meloy Laboratories (Springfield, VA). The pelleted EC 
were resuspended in complete Medium 199 (CM 199) 
containing Earle's Salts, L-glutamine, 100 U/L 
penicillin, 100 pg/ml streptomycin, 0.25 y.g/ml Fungizone, 
20% FBS, 90 µg/ml heparin (sodium salt, grade 1, from 
porcine intestinal mucosa, Sigma Chemical Co., St. Louis, 
MO), and 20 ug/ml endothelial cell growth factor (ECGF, 
tissue culture grade, Meloy Laboratories, Springfield, VA 
or a generous gift from Dr. Thomas Maciag of the American 
Red Cross, Rockville, MD). Thornton et al. (1983) have 
described the use of such concentrations of ECGF when 
heparin is used in the medium, the heparin potentiating 
the effects of the ECGF. Cultures were grown in gelatin 
coated T-25 flasks. Gelatin (0.2% wt/vol) promotes the 
attachment and growth of HUVEC (Gordon et al., 1983; 
Folkman et al., 1979; Thornton et al., 1983; Walker et 
al., 1984). Except for periods of time when passing or 
other experimental manipulations were being performed, 
cultures were incubated continuously at 37 degrees C in a  
humidified atmosphere of 95% air, 5% co2. 
Identification of HUVEC. The endothelial nature of the 
cultured cells was determined by observing the typical 
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"cobblestone" morphological appearance of the monolayer 
when viewed under phase contrast microscopy (Nikon 
Inverted Phase Contrast Microscope, Model M}, and by 
irnrnunofluorescent staining for the factor VIII antigen. 
Staining for factor VIII antigen was performed on selected 
confluent cultures. 
Identification of Senescent HUVEC. Senescent EC were 
readily identified by their morphological appearance under 
phase contrast microscopy. Using a 200 x magnification, 
senescent cells demonstrated large cytoplasmic areas 
(larger than non-senescent EC) and a thin, veiled 
cytoplasm. Senescent cells were often multinucleated, the 
nuclei clustering centrally. Senescent HUVEC frequently 
displayed indistinct borders under phase constrast 
microscopy. If a particular mono-nucleated cell was 
equivocal concerning size, the presence of veiled 
cytoplasm was the criterion upon which a cell was judged 
senescent. Text Figures 1 and 2 demonstrate senescent 
cells in female and male cultures respectively. 
Fixation of EC. At selected times after plating, 
depending on the experimental paradigm, cultures were 
fixed using the following procedure. After removal of the 
medium, the cells were washed twice in fresh PBS (pH 7.2) 
with calcium and magnesium in order to remove the residual 
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Text Figure 1. C57 PlO. This contrast photomicrograph shows 
female HUVEC in the tenth passage. Primary cultures of 
female HUVEC were passed at a 1:10 split ratio for the first 
three passages. Starting with the fourth passage (P4), the 
cultures were passed at a 1:5 split ratio. The cells are in 
a typical swirled configuration, showing darkened, granular 
cytoplasm, with paler nuclei and prominent nucleoli. Cells 
still formed a crowded swirled monolayer seven days after the 
tenth passage. x 260. 
Text Figure 2. C58 PlO. This phase contrast photomicrograph 
shows male HUVEC in the tenth passage. Primary cultures of 
male HUVEC were passed at a 1:10 split ratio for the first 
three passages. Starting with the fourth passage (P4), the 
cultures were passed at a 1:5 split ratio. The cells 
demonstrate changes typical of in vitro senescence, with 
increased cellular size, larger cytoplasmic/nuclear area 
ratio, a greater accumulation of peri-nuclear cytoplasmic 
granules, and veil-like cytoplasm. A characteristic 
multinucleated veiled senescent cell can be seen (arrow) with 
its large area and "spoke wheel'' cytoplasmic cords extending 
radially from the nuclei to the cell border. At seven days 
after the tenth passage, the monolayer is less crowded and 
swirled in appearance when compared to tenth passage female 
HUVEC. (Text Figure 1). x 260. 

serum containing medium. Each flask was washed 
individually and then immediately fixed, as PBS caused 
cells to round up and detach if left on the cells after a 
few minutes. After each flask was washed, 2.5% 
glutaraldehyde in O.lM Na cacodylate buffer (pH= 7,3) was 
added, and the flask was incubated at room temperature for 
one hour. After incubation, the glutaraldehyde fixative 
was removed and the flasks were rinsed once with 0.1 M Na 
cacodylate (pH= 7.3) containing 7% sucrose. The cultures 
were then stored in the sucrose cacodylate buffer at 4 
degrees c until further processing and evaluation were 
undertaken. Selected fixed flasks were photographed under 
phase microscopy using 35 mm Pan X film and a Nikon EFM 
camera system. 
Assessment of Male-female senescent patterns. To assess 
male and female senescent patterns, selected male-female 
culture pairs from the same desired passage were grown for 
seven days and fixed as described above. In certain 
cases, cultures were fixed at four days after passage. 
Cellular counting to determine the percentage of veiled 
(senescent) cells was done with the aid of a 25 cm2 etched 
glass plate aligned to the bottom of the culture flask. 
The glass plate divided the culture surface of the flask 
into 25 separate squares, each measuring one square 
centimeter. In order to eliminate experimental bias 
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during flask evaluation, counting was performed using a 
single blind method. The flasks were coded by someone 
other than the evaluator after identifying labels were 
removed from the flask. In this way, the origin, gender, 
and passage number of the cells were unknown to the 
evaluator during the counting process. The experimental 
code was not broken until all flasks from a particular 
experiment had been evaluated. 
Cellular counting was performed with the aid of an 
ocular grid in combination with a lOx widefield ocular and 
a 20 x objective lens on a Nikon binocular phase contrast 
microscope. With this 200x magnification, the area 
encompassed by the grid was 0.117649 sq. mm. Sixteen grid 
areas per flask, within 16 of the 25 large (1 cm2 squares, 
were evaluated (please see the Senescent Data Assessment 
Form in the Appendix). Within all 16 grids, all senescent 
cells were counted (S). In four of the sixteen grids 
(grids 1,6,11,and 16), all non-senescent cells were 
counted (N) and multiplied by a factor of four (4N). The 
total number of cells (T) in the 16 grids was estimated as 
4N + s. The percentage of senescent cells was equal to 
the sum of senescent cells in the 16 grids divided by the 
total number of cells in the grids, or S/T x 100. From 
this information, the cellular density of the flask 
(number of cells per cm2) was calculated. By multiplying 
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cellular density by the percentage of senescent cells, the 
senescent cell density was derived. For each flask at 
each passage, the data were expressed according to the 
following three parameters: the percentage of senescent 
cells, the senescent cellular density, and the total 
cellular density. 
Experimental Designs 
Effect of Culture Gender on Senescent Expression and 
Passage Number (1:5 split ratio). In order to determine 
the effects of gender and passage number on the percentage 
of senescent cells and cellular density, three different 
male-female culture pairs were used. Each male-female 
culture pair was begun on the same day. The culture pairs 
were fed with CM-199 every two or three days and passaged 
on a weekly basis at the split ratios indicated below. 
Beginning at selected passage numbers, cultures from the 
male-female culture pairs were fixed on the seventh day 
after passage and the percentage of senescent cells in the 
cultures determined as described above. Cellular density, 
i.e. the number of cells per square centimeter, was also 
determined. The male-female differences, if present, were 
also related to the cell passage number, so that variation 
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in the amount of senescence could be determined as the 
culture increased in age. 
The C 57(F) - C 58(M) culture pair (Pair I) was 
passed at a 1:10 split ratio through the fourth passage 
(Pl-4). Beginning with P5, the cultures were passed at a 
1:5 split ratio. The rationale for the early passage at a 
higher split ratio lay in the fact that premature 
confluence and overcrowding ensued if primary and early 
passage cultures were passed at a 1:5 split ratio. At 
each passage for Pair I, four or five female and four or 
five male flasks were plated, and the cultures refed with 
CM 199 every two or three days. On th� seventh day after 
plating, a male and female flask were selected to continue 
the cell line and passed at the desired split ratio. The 
cultures were carried in this manner through the twentieth 
passage. Beginning with PlO and continuing through P20 
inclusive, a male and a female flask from each passage 
were glutaraldehyde-fixed weekly on the seventh day after 
plating and stored in sucrose-cacodylate buffer at 4 
degrees c and subsequently evaluated for senescent 
expression. Thus, the three parameters of senescence 
expression (percentage of senescent cells, senescent 
cellular density, and total cellular density) for each of 
22 flasks (11 female and 11 male) from 11 passages (Pl0-
20 inclusive) comprised the data for C 57(F) and c 58(M). 
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The primary cultures of the Pair II, c 59(F) and C 
60(M) were passed weekly at a 1:10 split ratio through the 
third passage (Pl-P3). Beginning with P4, the cultures 
were passed weekly at a 1:5 split ratio. The cultures 
were fed with CM 199 every two or three days. The culture 
pair was continued in this manner through the nineteenth 
passage. Beginning with P9 and continuing through P19 
inclusive, a male and female culture from each passage 
were glutaraldehyde fixed weekly on the seventh day after 
plating, stored in sucrose cacodylate buffer at 4 degrees 
C and subsequently evaluated for senescent expression. 
The three parameters of senescent expression for each of 
22 flasks (11 female and 11 male) from 11 passages (P9-19 
inclusive) comprised the data for C 59(F) - C 60(M). 
In order to assess senescent expression in HUVEC at 
an earlier point in the culture life span, the primary 
cultures of Pair III, C 63(F) and C 64(M), were passed 
weekly at a 1:10 split ratio through the third passage 
(Pl-P3). Beginning with P4, the cultures were passed 
weekly at a 1:5 split ratio. Cultures were fed with CM 
199 every two or three days. The culture pair was 
continued in this manner through the ninth passage. 
Beginning with Pl and continuing through P9 inclusive, a 
male and female culture from each passage were 
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glutaraldehyde fixed weekly on the seventh day after 
plating, stored in sucrose-cacodylate buffer at 4 degrees 
C and subsequently evaluated for senescent expression. 
The three parameters of senescent expression for each of 
the 18 flasks (nine female and nine male) from nine 
passages (Pl-9 inclusive) comprised the data for Pair III. 
Effects of Culture Gender and Passage Number on Senescent 
Expression (standard density). In order to determine the 
effects of gender and passage number on senescent 
expression in HUVEC plated at standard density (1.25 x 10 5 
cells/flask), a male female culture pair (C 67(F) and C 
68(M)) was begun on the same day. The primary cultures of 
this pair were trypsinized and passed at standard density 
at seven days. At weekly intervals, one male and one 
female culture per culture pair were used to plate flasks 
at standard density for each succeeding passage. Passage 
was repeated until terminal senescence, defined as failure 
of the cultures to double in population in seven days. 
Beginning with P2 and continuing through P16 inclusive, a 
male and a female flask from each passage were 
glutaraldehyde-fixed on the seventh day after plating, 
stored in sucrose buffer, and then evaluated for senescent 
expression. The three parameters of senescent expression 
for each of the 30 flasks (15 female and 15 male) from 1 5 
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passages (P2-16) comprised the data for this phase of the 
study. 
In the above experiments, when the flasks were fixed 
at seven days after plating, most of the cultures so 
evaluated tended to be confluent or subconfluent, 
especially in earlier passages. Since crowding may affect 
the number of senescent cells in a given culture, it was 
decided to evaluate male and female cultures at five days 
after plating. In order to assess senescent expression at 
this earlier time, the same male-female culture pair (C 
67(F) -c 68(M)) was used. Beginning with P2 and 
continuing through P14, a male and female culture from 
each passage were glutaraldehyde-fixed weekly on the fifth 
day after standard density plating, stored in sucrose 
buffer, and subsequently evaluated for senescent 
expression. The three parameters of senescent expression 
for each of the 26 flasks (13 female and 13 male) from 13 
passages (P2-14 inclusive) comprised the data for the five 
day assessment. Enough culture flasks were plated at 
standard density each week to run both the five and seven 
day assessments concurrently. 
Effect of Plating Density on Senescent Expression. It has 
been our observation that cultures plated at a 1:10 split 
ratio actually showed more sustained proliferative ability 
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than those passed at a 1:5 ratio. In order to maintain 
the cell turnover, thereby "aging" the culture at a more 
rapid rate, the primary cultures of a male-female pair (C 
69(F) - C 70(M)) were passed weekly at a 1:10 split ratio 
through the ninth passage (Pl-9). Cultures were fed with 
CM-199 every two or three days. Beginning at PlO, the 
cultures were trypsinized and passed at standard density 
(1.25 x 105 cells/flask) at weekly intervals. Passage was 
repeated until the cell number failed to double within 
seven days. The female cultures were carried through P19, 
and the male cultures through P17. Beginning with P6 and 
continuing through P17, a male and female culture from 
each passage (except PlO) were glutaraldehyde-fixed on the 
seventh day after passage, stored in sucrose buffer, and 
subsequently evaluated for senescent expression. The 
three parameters of senescence expression for each of the 
22 flasks (11 female and 11 male) from 11 passages (P6-17, 
exclusive of PlO) comprised the data. It should be 
reiterated that flasks fixed and evaluated from P6-9 were 
from a 1:10 split ratio passage, while flasks fixed and 
evaluated from Pll-17 were from a standard density 
passage. 
Effect of a 1:4 vs. a 1:16 Split Ratio on Senescent 
Expression. In order to ascertain if cultures plated at 
higher density express a greater degree of senescence than 
43 
cultures plated at a lower density, the following 
experiment was done. The primary cultures of a male­
female pair (C 75(F) - C 76(M)) were passed weekly at a 
1:10 split ratio through the third passage (Pl-P3). At 
P4, three male and three female cultures were plated at 
four times standard density (5 x 10 5 cells/flask). The 
cultures were fed with CM 199 every two or three days. 
Beginning with P5, the cultures were passed weekly at a 
1:4 split ratio. For comparison, cultures were plated at 
a lower density as follows. Using the same male-female 
pair, three male and three female cultures were plated at 
P4 at standard density. Beginning with P5, the cultures 
were passed weekly at a 1:16 split ratio. The cultures 
were fed with CM 199 every two to three days. Cultures 
plated at both densities were carried through the 
sixteenth passage. Two male and two female flasks from 
each passage were glutaraldehyde-fixed on the seventh day 
after plating, stored in sucrose buffer, and subsequently 
evaluated for senescent expression. A total of 96 flasks 
were assessed: 48 male flasks (24 at a 1:4 split and 24 at 
a 1:16 split) and 48 female flasks (24 at a 1:4 split and 
24 at a 1:16 split). Comparisons regarding senescent 
expression were thus made for both gender and split ratio. 
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Results 
Effect of Culture Gender and Age on Senescent Expression 
(1:5 split ratio) 
The purpose of these experiments was to determine if 
culture gender and age had an effect on senescent 
expression in HUVEC. Three separate male-female culture 
pairs were used. In these and all experiments described 
in this study, even numbered cultures were female EC, and 
odd-numbered cultures were male EC. The primary cultures 
were passed at a 1:10 split ratio from Pl-4 for the C 57-
C 58 pair (I), and from Pl-3 for the c 59 - C 60 pair 
(II), and at a 1:5 split ratio for both thereafter. Table 
1 illustrates the total cells, the total senescent cells, 
and the percentage of senescent cells, generated in a cm2 
area over ten passages (Pl0-19). The percentage of 
senescent cells is also illustrated by bar graphs in 
Figure 1. Chi square analysis, using the total number of 
senescent cells and the total number of non-senescent 
cells generated in a cm2 area, was the test statistic 
used to compare the percentages of senescent cells in this 
and all subsequent experiments. Likewise, for all 
experiments, the Wilcoxon Rank Sum Test was the test 
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statistic employed to compare the total cells generated in 
a cm2 area over the passages indicated. In this results 
section, and the discussion section that follows, total 
senescent cells and total cells always signify the number 
of senescent cells or total cells generated in a cm2 area 
over the passages indicated. 
Table 1 and Figure 1 show that for ten passages 
(Pl0-19), in both Pair I and Pair II, male HUVEC showed a 
significantly greater percentage of senescent cells and 
significantly fewer total cells than female HUVEC. In 
Pair I, male flasks generated almost three times as many 
senescent cells over ten passages as female flasks. The 
number and percentage of senescent cells for male cultures 
increased with increasing passage number, yet the total 
cell number was significantly lower than that for female 
cultures. In Pair II, these same relationships held true. 
As in Pair I, male cultures had a significantly greater 
total senescent cell number and percentage of senescent 
cells than females, yet significantly fewer total cells. 
The bar graphs in Figure 1 demonstrate the percentage of 
senescent cells for the two culture pairs; the 
significantly greater percentage of senescent cells in the 
male cultures compared to female cultures should be noted. 
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Table 2 is a comparison of senescence in the five 
earli8r passages (Pl0-14) versus the five later passages 
(PlS-19) for the male-female culture pairs described in 
Table 1. The percentage of senescent cells for each 
culture and passage series are shown by bar graphs in 
Figure 2. Table 2 and Figure 2 demonstrate that the male­
female differences in percentage of senescent cells are 
sustained for both culture pairs for both the earlier 
(Pl0-14) and later (P15-19) passages. There was a 
significantly greater number of total cells in the Pl0-14 
passages than the P15-19 passages for female cultures. 
However, this was not true for male cultures (C58 and 
C60). Table 2 also shows that when female cultures were 
compared to male cultures regarding total number of cells 1 
there was a significant difference for the Pl0-14 passages 
but not the Pl5-19 passages. This implies, then that 
most of the male-female difference regarding cumulative 
cellular density occurred during the first five passages 
(Pl0-14). However, the percentage of senescent cells did 
not differ significantly between Pl0-14 and Pl5-19 for any 
of the culture pairs, although there was a trend toward an 
increase in later passages. Again, comparing earlier and 
later passages, the sum of senescent cells increased while 
the total number of cells decreased. 
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In order to assess senescent expression in HUVEC 
earlier in the culture life span, male-female culture Pair 
III (passed at a 1:10 split ratio until P4, then at a 1:5 
split ratio through P9), was studied in passages Pl-9. 
Table 3 compares total cells, sum of senescent cells, and 
the percentages of senescent cells for passages Pl-4 with 
those for passages P5-9. Although the percentages of 
senescent cells were higher in male than in female 
cultures, these differences were not statistically 
significant. However, the percentages of senescent cells 
were significantly greater for later passages (P6-9) 
compared to earlier passages (Pl-4) for both male and 
female cultures. Note that this was not the case for Pair 
I or Pair II. Whether the increase in senescent 
expression in Pair III (C 63 - c 64) during P6-9 over that 
observed in Pl-4 was due to the higher density (1:5 vs. 
1:10 split ratio) of plating cannot be ascertained 
definitively; a later experiment (Table 7) addresses this 
question more specifically. Since Pair III was not 
continued beyond P9, it is not possible to determine if 
the increase in senescence which occurred during P6-9 
would have been moderated in later passages (i.e. Pl0-19), 
as in the first two culture pairs studied. Table 3 also 
shows that there was a significantly greater total number 
of cells in Pl-4 vs. P6-9 for female cultures, but not for 
male cultures. 
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In summary, when primary cultures of HUVEC were 
passed initially at 1:10 split ratios followed by a longer 
series of passages at 1:5 split ratios, there was a 
significantly greater expression of senescence in male 
cultures than in female cultures. Concerning the total 
number of cells generated over an equal number of 
passages, a significant difference between earlier and 
later passage groups was found for female cultures but not 
for male cultures. 
Effect of Culture Gender and Passage Number on Senescent 
Expression (standard density plating) 
In the previous experiments, primary cultures that 
were cobblestone in appearance and confluent were passed 
at 1:10 split ratios followed by 1:5 split ratios. The 
purpose of the next set of experiments was to correct for 
possible differences in confluent cell density between 
male and female primary cultures. This was done by 
plating at a standard density (SD- 1.2 5 x 10 5 cells/flask) 
in all passages. As in the previous experiments, two 
passage series were compared to determine the effect of 
passage number, as well as gender, on senescent 
expression. Both five day and seven day assessments were 
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performed, and the results are depicted in Tables 4 and 5 
and in Figure 3. 
Table 4 compares total cells, sum of senescent 
cells, and percentages of senescent cells for three series 
of four passages each for male and female cultures in a 
five day assessment. There was no significant difference 
in senescent expression between female (C 67) and male (C 
68) cultures for any of the three passage series compared. 
Nor were there significant differences in percentages of 
senescent cells among the three passage series for male or 
female cultures. Note that in the male cultures, the 
percentage of senescent cells �as greater in earlier 
passages (P2-5) than later passages (P6-9 or Pl0-13), a 
finding which is somewhat unexpected. In the later 
passages, there was a trend for female cultures to show a 
greater percentage of senescent cells than male cells, but 
the difference was not significant. 
Regarding total number of cells generated over the 
passages indicated, the only significant difference 
between male and female cultures was in the Pl0-13 group 
(Table 4). In the SD study, in contrast to earlier 
findings, the difference in total cells generated during 
early (P2-5) passages vs. later passages (P6-9, Pl0-13) 
was significant for male cells but not for female cells. 
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In fact, in contrast to male-female culture pairs passed 
at a 1:5 split ratio, Table 4 shows that the total number 
of cells increased during passages 6-9 compared to 2-5 for 
both females and males, although significant only in the 
latter. This is paradoxical, since one would have 
expected the total number of cells to decrease in 
succeeding passages. However, since this was a five day 
assessment, cultures evaluated at seven days might not 
show this "reverse" phenomenon. Indeed, this increase in 
total cell number generated in later passages was not true 
for the seven day assessment (see Table 5). 
Table 5 compares total cells, sum of senescent 
cells, and the percentages of senescent cells for three 
series of four passages each for the same male and female 
cultures described above, this time in the usual seven day 
assessment. Again it is seen that there was no 
significant difference in percentages of senescent cells 
between males and females for any of the three passage 
series studied. The percentages of senescent cells 
increased in succeeding passage groups for both male and 
female cultures. For female cultures, the percentage of 
senescent cells was significantly greater in the later 
passage series (Pl0-13) compared to either the P2-5 or the 
P6-9 series; a similar trend in the male cultures was not 
significant. 
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When the total cells generated in the three passage 
series were compared, no significant differences were 
found between male and female cultures for any of the 
three series. In fact, the three series parallelled each 
other, with similar decreases in cumulative cellular 
density as the culture age progressed (Table 5). For both 
male and female cultures, there were significantly more 
total cells generated in P2-5 than in Pl0-13. This 
finding contrasted with earlier experiments (1:5 split 
ratio), in which only the female cultures displayed a 
similar significant difference. 
When one compares the five and seven day assessments 
(Tables 4 and 5, Figure 3), some interesting patterns are 
noticed. There were no significant differences between 
five and seven day assessments regarding percentages of 
senescent cells generated over the three passages series 
for either female or male cultures. However, Figure 3 
reveals a trend toward greater percentages of senescent 
cells in cultures assessed at five days vs. seven days. 
This was true for all three passage series in female 
cultures and for the P2-5 series in male cultures. Since 
multinucleated veiled (senescent) cells have not been 
observed to proliferate in cultures of HUVEC, these cells 
would be passed along at a relatively fixed number, 
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increasing only slightly as a result of terminal 
differentiation in each passage. The relatively constant 
number of senescent cells would then constitute a higher 
percentage of the total cell population at five days than 
they would at seven days, when a continued proliferation 
of non-senescent cells would have increased the total cell 
number. 
In comparing total cells at five versus seven days, 
the increase at seven days was significant only for 
earlier passages (P2-5) for both male and female cultures 
(Tables 4 and 5). In fact, there was a decrease in total 
cells generated in later passages at seven days for male 
cultures but not female cultures (Tables 4 and 5). 
In summary, when cultures of HUVEC were passed at 
standard density, there was no significant difference in 
total cells, sum of senescent cells, or percentages of 
senescent cells between male and female cultures. This 
was true for both five day and seven day assessments. 
There was a trend for the percentage of senescent cells to 
be greater in cultures assessed at five days than at seven 
days, but the difference was not significant. There was a 
significant decrease in the total cells generated between 
early and later passages for both male and female 
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cultures, in contrast to earlier experiments where this 
difference was significant for female cultures only. 
The total cells generated at five days for later passage 
male cultures was actually greater than that found at 
seven days. 
Effect of 1:10 Split Ratio Passage Followed by SD Passage 
The purpose of the next set of experiments was to 
compare senescent expression between male and female 
cultures that had been ''aged" in terms of population 
turnover by repeatedly passing the cultures at a low 
density (1:10 split ratio). In these experiments, a 
primary male-female culture pair (P 69 and P 70) was 
passed at a 1:10 split ratio up to and including P9, then 
subsequently at standard density. Table 6 compares the 
total cells, sum of senescent cells, and the percentages 
of senescent cells for two series of four passages (P6-9, 
Pll-14) and one series of three passages (P15-17) for male 
and female cultures. There were no significant 
differences in the percentages of senescent cells between 
male and female cultures for any of the three passage 
series studied (Table 6 and Figure 4). However, there was 
a larger, albeit non-significant, difference between male 
and female cultures for P6-9, where the cultures were 
passed at a 1:10 split ratio, than there was between male 
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and female cultures for Pll-14 or P15-17, where the cells 
were passed at standard density. This is better 
illustrated by the bar graphs in Figure 4. 
As in previous experiments, differences in total 
cell number were apparent for female, but not male 
cultures. There was a significant difference in total 
cells between P6-9 and Pll-14 for female, but not male, 
cultures. As in previous experiments, the percentage of 
senescent cells increased, while total cells decreased 
with increasing passage number. 
Comp�rison of 1:4 and 1:16 Split Ratio Passage 
Although our earlier experiments with a 1:5 split 
ratio passage demonstrated a greater expression of 
senescence in male cultures than in female cultures, this 
difference was not sustained when initial cell number was 
corrected for by passage at standard density. The 
possibility of differences in passage density being a 
factor in senescent expression was examined in the present 
experiment, which was designed to determine if cultures 
passed at a higher density (1:4 split ratio) would show a 
greater degree of senescence than cultures passed at a 
lower cell density (1:16 split ratio). Male and female 
differences were also examined within this experimental 
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paradigm. Table 7 compares total number of cells, sum of 
senescent cells, and the percentages of senescent cells 
generated for male and female cultures for five earlier 
passages (P5-10) with those of five later passages (Pll-
16) for the 1:4 split ratio cultures and the 1:16 split 
ratio cultures. 
Table 7 shows that there was not a significant 
difference between male and female cultures regarding 
percentage of senescent cells for either the 1:4 split 
ratio group or the 1:16 split ratio group. When early 
(P5-10) and later passages (Pll-16) were compared, there 
was a significantly greater percentage of senescent cells 
in later passages of both male and female cultures when 
the cultures were passed at a 1:4 split ratio (high 
density), but not when they were passed at a 1:16 split 
ratio (low density). Also, the difference in number of 
senescent cells was greater for the former vs. the latter. 
Lastly, for both early and late passage series, and for 
both male and female cultures, there was a trend toward 
cultures passed at a 1:4 split ratio to show a greater 
percentage of senescent cells than cultures passed at a 
1:16 split ratio. However, this difference was 
significant only for female cultures at a later passage 
(Table 7 - C 75, 1:4, Pll-16 compared to C 75, 1:16, Pll-
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16). The percentage of senescent cells is illustrated by 
bar graphs in Figure 5. 
Table 7 demonstrates that there were significantly 
more total cells generated in earlier (P5-10) than in 
later (Pll-16) passages for both male and female cultures 
passed at high density, as well as for female cultures 
passed at low density. In comparing the high density 
cultures to the low density cultures, there was a 
significantly greater total number of cells generated for 
female cultures from later passages (Pll-16) at low 
density (1:16 split ratio) than in later passage female 
cultures at high density (1:4 split ratio). This 
difference parallels the significant difference seen in 
the percentages of senescent cells between these passage 
series. In viewing Table 7 and Figure 5, there was a 
trend for both male and female cultures passed at low 
density to generate a greater number of cells and exhibit 
fewer senescent cells for comparable passages than their 
companion cultures passed at a high density, although this 
difference was significant only for the female cultures 
mentioned above. From the above, it appears that culture 
density at passage may be at least as important in 
determining cellular senescent expression in HUVEC as 
culture gender. 
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Discussion 
The existence of multinucleated, veiled cells, 
considered to be senescent, has been known since the 
earliest successful cultures of endothelium were 
established from human umbilical veins. Mayuma (1963), 
the first author to report the successful culture of 
endothelial cells isolated from human umbilical veins, 
described senescent cells in his cultures. Since in vitro 
aging is now a recognized phenomenon in cultures of human 
EC (Levine and Mueller, 1979), the present study was begun 
to document quantitatively the occurrence and expression 
of senescence in cultures from male and female cords, in 
early and late passages, and at various passage densities. 
Since our initial observations suggested that there was a 
difference between male and female cultures of HUVEC 
regarding the incidence and progression of endothelial 
cellular senescence, experiments were undertaken to 
determine quantitatively if cellular gender was a 
significant factor in the expression of endothelial 
cellular senescence. Male-female differences in senescent 
phenotypic expression have not been addressed previously 
in the literature. The working hypothesis of this study 
was that possible gender differences regarding expression 
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of in vitro senescence might help to explain the 
variations in growth and culture life span observed in 
cultures from different umbilical cords (previously of 
unknown sex). 
The major findings of this paper can be summarized 
as follows: 
1. When primary cultures of HUVEC are passed at a 1:10 
split ratio for the first three or four passages, and 
subsequently passed at a 1:5 split ratio, there was a 
significant difference in senescent expression between 
male and female cultures. This difference was expressed 
for both the Pl0-14 and the P15-19 passage series, 
suggesting that gender differences in senescent expression 
were sustained through the passages studied. Under these 
passage conditions, there was a significant difference in 
total number of cells generated over equal numbers of 
passages between earlier (Pl0-14) and later passage (Pl5-
19) groups for female, but not male, cultures. 
2. When cultures of HUVEC are passed at standard 
density, there were no significant differences in total 
cells, total senescent cells, or percentages of senescent 
cells between male and female cultures. This phenomenon 
was true in both five day and seven day assessments. 
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There was a significant decrease in the total cells 
generated between early and later passages for both male 
and female cultures, in contrast to earlier experiments 
where this difference was significant for female cultures 
only. The total cell generated at five days for later 
passage male cultures was actually greater than that found 
at seven days. 
3. When cultures of both male and female HUVEC were 
passed at high density (1:4 split ratio), significantly 
greater senescence expression occurred in later passages 
vs. earlier passages, an effect not seen when the cultures 
were passed at a lower density (1:16 split ratio). This 
suggested a hastening of the senescent rate when cultures 
are passed at a higher density, an effect which appears to 
be gender independent. 
4. There was a trend for both male and female cultures 
passed at a lower density to generate a greater number of 
cells, fewer senescent cells, and exhibit a lessor 
percentage of senescent cells over comparative passage 
series when contrasted with male and female cultures 
passed at a higher density. 
Our results demonstrated that when primary cultures 
of HUVEC are passed at low density (1:10 split ratio) for 
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the first several passages and subsequently passed for a 
longer period at high density (1:5 split ratio), male 
cultures developed a significantly greater percentage of 
senescent cells than female cultures. However, when 
initial cell numbers were standardized by passing the 
primary cultures at a uniform density, significant 
differences in senescent expression between male and 
female cultures did not occur. Further experiments 
suggested that cultures passed consistently at a low 
density exhibited a lessor degree of senescent expression 
than cultures passed at a higher density, and that this 
effect was apparently gender-independent. This implied 
that cellular density at passage might be more important 
than gender in the expression of senescence in HUVEC. 
When cultures of HUVEC were passed at standard 
density, there were no significant differences in 
senescent expression or total cells generated between male 
and female cultures (Tables 4 and 5; figure 3) at either 
the five day or the seven day assessment. At five days, 
the percentage of senescent cells was greater in earlier 
passages (P2-5) than later passages (P6-9 or Pl0-13) in 
the male cultures, and this finding was accompanied by 
significantly fewer cells generated at earlier passages 
than at later passages, which might explain the greater 
senescent expression in the earlier passage male cultures. 
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Another factor might be that the number of senescent cells 
did not increase appreciably during later passages for 
male cultures assessed at five days (Table 4). It is 
possible that male cultures exhibited slower growth during 
later passages (P6-9, Pl0-13) at seven days; total cells 
actually decreased in later passage male cultures at seven 
days compared to five days. 
The transition from Phase II to Phase III in the 
life history of a cell culture, signified by an increase 
in the number of senescent cells and a decrease in 
cellular growth, may be rather abrupt in fibroblasts 
(Grove and Cristafalo, 1977; Haymark, 1976). This appears 
to be true in the culture system using EC, particularly 
when cells are passed at standard density. Note Table 5, 
which shows an abrupt change in the total cells, total 
senescent cells, and percentages of senescent cells 
between the P6-9 passage series and the Pl0-13 passage 
series for female cultures. 
The "aging" of HUVEC by passing primaries at a 1:10 
split ratio for nine passages followed by standard density 
passing did not produce a significant difference between 
male and female cultures regarding senescent expression or 
total cells generated for any of the three passage series 
(Table 6). However, Table 6 shows that male-female 
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differences that did exist were greater for earlier 
passages (P6-9) compared to later passages (Pll-14). It 
is interesting that male-female differences in senescent 
expression tend to decrease when cultures are passed at 
standard density. This is illustrated in Table 6 which 
demonstrates that there were fewer senescent cells and a 
lower percentage of senescent cells for early passage 
female cultures (P6-9), accompanied by a greater cellular 
density, compared to early passage male cultures. 
The results in Table 6 and Figure 4 further 
encouraged the author to explore cellular density at 
passage as a possible factor in senescent expression in 
male and female HUVEC. Glassberg et al. (1982), who 
cultured EC from the human iliac artery, found that cells 
became senescent, losing viability at passages 8-10, when 
passed at a 1:3 split ratio. However, no comparisons were 
made with cultures passed under different density 
conditions. Cristafalo (1976) contended that HUVEC 
senesce at different rates, depending on the split ratio 
at passage, although he did not offer quantitative data to 
support his statement. 
It is known that senescent EC are more common in 
confluent cultures than in less crowded cultures. Since 
endothelial cellular senescence represents a form of 
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differentiation (whether it is terminal differentiation is 
currently controversial), our findings suggest that 
inhibition of expression of this differentiated phenotype 
can be done by increasing the split ratio at passage, i.e. 
passing the cultures at a lower density. This results in 
less crowding in each passage, giving the cells more room 
to grow and proliferate, thereby decreasing the chances 
for the senescent phenotype to be expressed. Passing at a 
1:16 split ratio would decrease the chances of the 
relatively fewer number of senescent cells reaching the 
next passage. This, in combination with relatively 
greater growth in the cultures passed at lower density, 
might result in a lower senescent percentage for the low 
density passage cultures. On the other hand, since the 
growth of EC is generally contact inhibited, passing the 
cultures at a high density (1:4 split ratio) would cause 
the cells to reach confluence rapidly, stop proliferating, 
and undergo senescence. Subsequently passing the cultures 
further at a 1:4 split ratio would increase the likelihood 
of the senescent cells appearing in the next passage. 
An additional factor here might be the period of 
time spent at confluence prior to culture fixation and 
evaluation. Endothelial cultures passed at high density 
(1:4 split ratio) would reach confluence sooner than 
cultures passed at lower density (1:16 split ratio), the 
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former conceivably spending a longer time in the confluent 
state than the latter. This would create a greater 
tendency for the senescent phenotype to be expressed, 
hence, the greater percentage of senescent cells in 
cultures passed at a high density. 
Confluent cultures of HUVEC will senesce rapidly if 
not passed. As total cell number decreases as the culture 
ages, the percentage of senescent cells increases. Note 
that this can occur without an appreciable increase in the 
absolute number of senescent cells from passage to 
passage. Regarding senescent expression, the culture 
density at passage may be a stronger factor in senescent 
expression than the number of population doublings that 
the culture has undergone by that same passage. 
Only a few authors have attempted to estimate 
quantitatively the incidence of senescent veiled cells in 
human umbilical vein endothelial cellular cultures. 
Knaver and Cunningham (1983) estimated the incidence of 
endothelial cellular senescence to be 1-2% in early 
cultures, and up to 10-12% at approximately Passage 16, 
although they did not indicate the cellular plating 
density or passage split ratio used. Their estimates are 
comparable to those found in this study, except that there 
was a much higher percentage (24-28%) of senescent cells 
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in later passage (P15-17) HUVEC passed at a 1:10 split 
ratio followed by standard density passage (See Table 6 
and Figure 4). Maciag et al. (1981) estimated the density 
of senescent EC in cultures of HUVEC (1/1000 cells, 0.1% 
initially increasing to 1/100, 1% by passage 14). Their 
estimates are somewhat lower than those reported in this 
research, as the percentage of senescent cells averaged 
much more than 1% by passage 14 in all passage paradigms 
that were used. 
The heterogeneity of the endothelial cellular 
culture, mentioned by Schwartz et al. (1981), might be a 
factor in senescent expression in both male and female 
cultures. Senescence observed in endothelial cells in 
vitro might be the result of the random distribution of 
senescent cells during passage of the culture, rather than 
abrupt increases in senescent cells derived from normal 
cells during that particular passage. In a like manner, 
limitations in the replicative lifespan of cultures of 
HUVEC might be due to random distribution of proliferative 
potential in the culture. 
According to Gospodarowicz et al. (1978), senescence 
in HUVEC may be a pre-programmed event. The question of 
whether human umbilical vein endothelial cells are 
programmed to die shortly after the birth of the child has 
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not been answered. Or do these cells die because the 
umbilical cord is severed, and the EC, dissociated from 
their normal connection to the placenta, then die. No one 
has kept an umbilical cord viable in situ for much longer 
than nine months, so this question remains unanswered. 
The fact that senescent cells can be found in primary 
cultures of HUVEC (Maciag et al., 1981) suggests that 
senescent cells were present in vivo in situ. Since the 
umbilical cord forms and degenerates within nine months, 
senescent cells in primary cultures may be due to the 
"accelerated aging" in human umbilical vein endothelium, 
or alternatively, the cells may became senescent or 
undergo senescent-like changes when they are plated. It 
is clear that factors which would affect senescent 
expression in primary and early passage cultures of HUVEC 
need further study and exploration. 
Are multinucleated cells evidence of attempted 
regeneration following cellular injury? There is the 
possibility that enzymatic dissociation, as occurs when 
the cultures are passed, may play a role in senescent 
expression in HUVEC (Ruben & Rafferty, 1978). In vitro 
senescence is typically evaluated in cultures of EC where 
subculturing methods are via this enzymatic dissociation 
(collagenase for primaries, trypsin for secondary and 
subsequent subculturing). The actual effect of repeatedly 
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breaking the bonds between cells and their extracellular 
substrate upon senescence, as occurs during trypsinization 
and passing, is unknown. 
The question of whether senescent cells represent a 
syncytium, where an endothelial cell divides but fails to 
break up into individual cells, the nuclei remaining 
within the center of the senescent cell, remains 
unanswered. Why this would specifically occur is not 
known. Future research might employ "wounding" an aged 
culture, and then exploring the leading edge of the 
migrating, dividing EC and determining the effect on 
senescent patterns. 
The role of the senescent endothelial cell in the 
process of tumor invasion and metastasis constitutes a 
largely unexplored area of research. By nature of its 
structure, the senescent cell, with its veiled, thread­
like cytoplasmic extensions bridging the nucleus and its 
large area, might be more susceptible to the ability of an 
attached tumor cell to invaginate the endothelial cell, 
thus making the senescent cells more susceptible to 
transendothelial intravasation or extravasation of primary 
or metastatic tumor cells respectively. However, this is 
purely speculative at this time. 
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Rosenthal et al. (1981) suggested that cellular 
senescence in EC may contr.ibute to the genesis of 
atherosclerosis. Haudenschild et al. (1975) remarked that 
veiled, senescent endothelial cells are commonly observed 
on the edge of intimal lesions in vivo. Weber et al. 
(1984) suggested that endothelial cellular senescence in 
vivo may be the result of either high cell turnover or 
repeated endothelial injury. High cell turnover is a 
likely possibility when one considers that the incidence 
of senescent endothelial cells increases with cell passage 
number. However, repeated endothelial injury, although 
not sufficient to mechanically denude the vessel wall, may 
encourage endothelial cellular turnover. If, however, 
the cells are prevented from proliferating due to lack of 
room in which to divide, as in confluent cultures of EC in 
vitro, division may occur without cytoplasmic separation, 
with senescent cells ensuing. Whether the senescent 
phenotype is more apt to be expressed in areas of 
endothelial cellular microinjury is unknown. However, it 
should be remembered that confluent EC have a low but 
definite rate of cell turnover, which may approximate the 
state of "injury'' in vivo. In the in vivo situation, 
chronic repeated bouts of subtle endothelial ''injury" 
might cause the EC to proliferate repeatedly at the edge 
of intimal lesions, which can result in senescent cells. 
However, the data from the 1:4 and 1:16 comparison 
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experiment would refute the concept that simple continuous 
cell turnover in EC, as would occur to a greater degree in 
the 1:16 split ratio passage cultures, would increase the 
number of senescent cells present. In fact, this study 
has suggested that passage at the 1:16 split ratio reduces 
senescent expression compared to higher density passage, 
where proliferation is less. Maciag et al. (1981) 
reported that endothelial cells passed at a greater 
density may be affected by contact inhibition, and may not 
proliferate as rapidly. This might well affect the 
expression of endothelial cellular senescence. 
It can be recalled that in any culture system, there 
will be deficiencies in the media or procedural components 
of cellular culture, perhaps contributing to the gradual 
differentiated state of the culture in question. How much 
of the senescent process in vitro can be attributed to the 
culture environment and how much to senescent phenotypic 
expression of the cells themselves is an unsettled 
question. 
Do the senescent cells secrete or promote activation 
of growth factors of other substances which enhance the 
proliferation of smooth muscle cells and/or induce 
alterations in the endothelial substrata? Or are the 
senescent cells the result of the transformation induced 
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in the endothelium by the atherosclerotic lesion itself? 
Presumably, an expanding mural lesion would stretch the 
overlying EC, perhaps making them more likely to express 
their senescent phenotype. 
The translation of information obtained from the in 
vitro situation to the events observed in vivo is not 
always easy, and in many cases purely speculative. 
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However, the above questions and additional courses of 
inquiry concerning senescent expression of HUVEC afford 
attractive future avenues of study of this remarkable process. 
Bibliography 
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Figure 1. Effect of culture gender on senescent expression 
in HUVEC passed at a 1:5 split ratio (PlO - Pl9). The C 
57(F) and c 58(M) culture pair and the C 59(F) and C 60(M) 
culture pair were passed weekly. A male and a female flask 
from each culture pair were fixed and evaluated weekly. The 
bar graphs illustrate the percentage of senescent cells
2 calculated by dividing the sum of of senescent cells/cm 
generated during PlO - P19 by the total number of cells/cm2 
generated during these passages. F = female; M = male. a 
significantly different from b and c from d, p < 0.001. 
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Figure 1. Effect of Culture Gender on Senescent Ex press ion 
in HUVEC Passed at a 1 :5 Split Ratio (P1O-P19) 
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Figure 2. Effect of culture gender and passage number on 
senescent expression in HUVEC (1:5 split ratio). The same 
male-female culture pairs described in Table 1 and Figure 1 
were used to compare senescent percentages for five earlier 
passages (PlO - Pl4) with those of five later passages (Pl5 -
Pl9). The bar graphs show the percentage of senescent cells 
exhibited by each culture, calculated by dividing the sum of 
senescent cells generated during the passages indicated by 
the total number of cells generated during the same passages. 
a significantly different from c; b from d; e from g, all p < 
0.001. f significantly different from h, p < 0.01. 
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Figure 2. Effect of Culture Gender 8c Passage Number 
on Senescent Expression in HUVEC (1 :5 Split Ratio) 
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Figure 3. Effect of culture gender and passage number on 
senescent expression in HUVEC (standard density). Comparison 
of a five day vs. seven day assessment. The primary cultures 
of c 67(F) and c 68(M) were passed weekly at standard density 
(1.25 x 105 cells/T 25 flask) through Pl4. From P2 through 
P14, a male and female flask were fixed and assessed each 
week at both five days and seven days after plating. The bar 
graphs compare the percentages of senescent cells between 
male and female cultures for three series of four passages 
each: P2-5, P6-9, and Pl0-13. a significantly different from 
c, p < 0.01; b significantly different from c, p < 0.05 . 
Figure 3. Effect of Culture Gender 8c Passage Number 
on Senescent Expression in HUVEC (Standard Densit y) 
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Figure 4. Effect of 1:10 splits followed by SD plating on 
senescent expression in male and female HUVEC. The primary 
cultures of C 69(F) and C 70(M) were passed weekly as 
described in Table 6. A male and female flask were fixed 
weekly from P6 through P9, and from Pll through P17 (At PlO, 
all available cells were used to plate subsequent flasks at 
standard density. The bar graphs compare the percentages of 
senescent cells between male and female cultures for two 
groups of four passages each (P6-9, Pll-14) and one group of 
three passages (P15-17). Senescent expression did not differ 
significantly between male and female cultures in this 
experiment. 
Figure 4. Effect of 1:10 Spli ts Followed by SD Plating 
on Senescent Expression in Male 8c Female HUVEC 
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Figure 5. Effect of 1:4 vs. 1:16 splits on senescent 
expression in early vs. late passage HUVEC. Comparison of 
male and female cultures. The primary cultures of C 75(F) 
and C 76(M) were passed weekly as described in Table 7. At 
each passage from P4 through Pl6 inclusive, two male and two 
female flasks from each split ratio were fixed and evaluated. 
Senescent expression parameters as outlined in this figure 
are the result of the mean of two such flask determinations 
for each culture and passage number. The bar graphs compare 
the percentages of senescent cells between male and female 
cultures for five earlier passages (P5-10) with those of five 
later passages (Pll-16) for the 1:4 and the 1:16 split ratio 
groups. a significantly different from b, p < 0.01; d 
significantly different from e, and b significantly different 
from c, p < 0.05. 
Figure 5. Effect of 1:4 vs 1:16 Splits on Senescent 
Expression in Early vs. Late Passage HUVEC 
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Table 1. Effect of culture gender on senescent expression in 
HUVEC passed at a 1:5 split ratio (PlO - Pl9). The primary 
cultures of c 57(F) and c 58(M) were passed weekly at a 1:10 
split ratio through P4, and then at a 1:5 split ratio 
beginning with P5 and extending through P 20. The primary 
cultures of C 59(F) and c 60(M) were passed weekly at a 1:10 
split ratio though P3, and then at a 1:5 split ratio 
beginning with P4 and extending through Pl9. A male and 
female flask were fixed weekly from PlO to Pl9 inclusively. 
The sums of total cells/cm2 and total senescent cells/cm2 
generated from PlO - Pl9 (ten passages inclusive) are 
illustrated in the table. The percentages of senescent 
cells, calculated by dividin� the sum of senescent cells/cm
2 
by the sum of total cells/cm for each culture, is 
illustrated in the last column. F= female; M= male. 
Table 1 
Effect of Culture Gender on Senescent Expression 
in HUVEC Passed at a 1: 5 Split Ratio (P 10 - P 19) 
Culture Total Cells* Senescent Percent 
Cells* 
C 57 (F) a3,99 X 105 13594 
e3,41 
C 58(M) b2 ,06 X 105 34812 
f16.90 
C 59 ( F) C5 ,51 X 105 7792 
gl. 40 
C 60 (M) d2.25 X 105 19696 ha.75 
*generated over 10 passages in a cm
2 area. 
a significantly different from b, c from d, and a from c, 
p < 0.05 ; e significantly different from f, and g from h, 
p < 0.001. 
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Table 2. Effect of culture gender and passage number on 
senescent expression in HUVEC (1:5 split ratio). Using the 
same male-female culture pairs described in Table 1, Table 2 
compares both the total cell number and the sum of senescent 
cells generated in five earlier passages (Pl0-14) with those 
in five later passages (PlS-19). The percentages of 
senescent cells for each culture and passage group, 
calculated as described in Table 1, are compared in the last 
column. 
Table 2 
Effect of Culture Gender and Passage Number on Senescent 
Expression in HUVEC (1: 5 Split Ratio) 
Culture 
C 57(F) 
p 10-14 
p 15-19 
C 58(M) 
P 10-14 
P 15 -19 
C 59(F) 
P 10-14 
P 15-19 
C 60(M) 
P 10-14 
P 15-19 
Total Cells* 
a2.32 X 105 
bl.64 X 105 
Cl. 10 X 105 
d9.70 X 104 
e3.07 X 105 
f2.44 X 105 
gl. 08 X 105 
hl. 12 X 105 
Senescent 
Cells* 
5450 
8144 
13716 
21096 
2810 
4982 
8948 
10748 
Percent 
i2.35 
j4_97 
m.92 
08.29 
q9_ 59 
*generated over the indicated number of passages in a cm2 
area. 
a significantly different from b, a from c, e from f, and 
e from g, p < 0.01; i significantly different from k, j 
from 1, and m from o, p < 0.001; n significantly different 
from q, p < 0.01. 
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Table 3. Effect of culture gender and passage number on 
senescent expression in HUVEC - 1:10 followed by 1:5 split 
ratio. The primary cultures of C 63(F) and C 64(M) were 
passed weekly at a 1:10 split ratio through P3, and then at a 
1:5 split ratio from P4-9. A male and female flask were 
fixed weekly from Pl-9. The table compares the total cell 
number and sum of senescent cells generated for four earlier 
passages (Pl-4) with those of four later passages (P6-9). 
The percentages of senescent cells for each culture and 
passage group are compared in the last column. 
Table 3 
Effect of Culture Gender and Passage Number on Senescent 
Expression in HUVEC- 1:10 Followed by 1:5 Split Ratio 
(P 1 - P 9) 
Culture 
C 63 (F) 
p 1-4 
p 6-9 
C 64(M) 
P 1-4 
P 6-9 
Total Cells* 
a3.89 X 105 
bl. 77 X 105 
3.2 8 X 105 
1. 08 X 105 
Senescent 
Cells* 
182 9 
7875 
4274 
10337 
Percent 
c. 47 
d4 .45 
f9_ 57 
*generated over the indicated number of passages in a cm
2 
area. 
a significantly different from b, p < 0.05; c 
significantly different from d, p < 0.01; e significantly 
different from f, p < 0.001. 
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Table 4. Effect of culture gender and passage number on 
senescent expression in HUVEC - five day assessment (standard 
density). The primary cultures of C 67(F) and C 68(M) were 
passed weekly at standard density (1.25 x 105 cells/ T 25 
flask) through P14. Flasks from each culture were fixed and 
assessed at five days after plating. The table compares the 
total cell number and sum of senescent cells generated for 
three series of four passages each: P2- 5, P6-9, and Pl0-13. 
The percentages of senescent cells for each culture and 
passage series are compared in the last column. 
Table 4 
Effect of Culture Gender & Passage Number on Senescent 
Expression in HUVEC - Five Day Assessment 
(Standard Density) 
Culture 
C 67 (F) 
p 2-5 
p 6-9 
p 10-13 
C 68(M) 
P 2-5 
P 6-9 
P 10-13 
Total Cells* 
1.56 X 105 
2.10 X 105 
al. 29 X 105 
C2.36 X 105 
d2.02 X 105 
Senescent 
Cells* 
6476 
10321 
12822 
7791 
7505 
9078 
Percent 
4.15 
4.91 
9.94 
5.12 
3.18 
4.49 
*generated over the indicated number of passages in a cm
2 
area. 
a significantly different from d, b from c, and b from d, 
p < 0.05. 
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Table 5. Effect of culture gender and passage number on 
senescent expression in HUVEC - seven day assessment 
(standard density). The primary cultures of c 67(F) and c 
68(M) were passed weekly at standard density through Pl4. A 
male and female flask were fixed weekly from P2 through Pl3. 
The table compares the total cell number and sum of senescent 
cells generated for P2-5, P6-9, and Pl0-13 as in Table 4. 
The percentages of senescent cells for each culture and 
passage series are compared in the last column. 
Table 5 
Effect of Culture Gender & Passage Number on Senescent 
Expression in HUVEC - Seven Day Assessment 
(Standard Density) 
Culture 
C 67 (F) 
p 2-5 
p 6-9 
p 10-13 
P 68(M) 
P 2-5 
P 6-9 
P 10-13 
Total Cells* 
a2.85 X 105 
2.76 X 105 
bi. 62 X 105 
c2.57 X 105 
2.25 X 105 
dl. 86 X 105 
Senescent 
Cells* 
6752 
8058 
13416 
6043 
8762 
10888 
Percent 
e2.37 
f3 .11 
g8.28 
2.50 
3.89 
5.85 
*generated over the indicated number of passages in a cm
2 
area. 
a significantly different from b, c from d, and f from g, 
p < 0.05 ; e significantly different from g, p < 0.01. 
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Table 6. Effect of 1:10 splits followed by standard density 
(SD) plating on senescent expression in male and female 
HUVEC. The primary cultures of C 69(F) and C70(M) were 
passed weekly at a 1:10 split ratio through P9, and then at 
standard density beginning at PlO and extending through Pl7. 
A male and female flask were fixed weekly from P6-P9 and from 
Pll-Pl7. The table compares the total cell number and sum of 
senescent cells generated for two series of four passages 
each (P6-9, Pll-14) and one series of three passages (Pl5-
17). The percentages of senescent cells for each culture and 
passage series are compared in the last column. 
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Table 6 
Effect of 1:10 Splits Followed by Standard Density 
Plating on Senescent Expression in Male and Female HUVEC 
Culture 
C 69 (F} 
p 6-9 
p 11-14 
p 15-17 
C 70 (M} 
P 6-9 
P 11-14 
P 15-17 
Total Cells* 
al.63 X 105 
bi. 02 X 105 
4.50 X 104 
1.19 X 105 
1.10 X 105 
4 .90 X 104 
Senescent 
Cells* 
8316 
11691 
11086 
11076 
112 54 
13794 
Percent 
5.10 
11. 46 
24.64 
9.31 
10.2 3 
2 8.15 
*generated over the indicated number of passages in a cm
2 
area. 
a significantly different from b, p < 0.05. 
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Table 7. Effect of 1:4 or 1:16 split ratio passage on 
senescent expression in early vs. late passage HUVEC. 
Comparison of male and female cultures. The primary cultures 
of C 75(F) and C76(M) were passed weekly at a 1:10 split 
ratio through P3. At P4, both male and female cultures were 
either plated at standard density or four times standard 
density (5 x 105 cells/flask). Beginning with PS and 
extending through P16, the flasks plated at four times SD 
were passed weekly at a 1:4 split ratio, and the flasks 
plated at SD were passed at a 1:16 split ratio. Beginning 
with P4 and continuing through P16 inclusively, two male and 
two female flasks from each passage and from each split ratio 
were fixed and evaluated. The raw data consisted of the mean 
of two determinations for both male and female cultures at 
each passage. The table compares both the total cell number 
and sum of senescent cells generated for five earlier 
passages (PS-10) with those of five later passages (Pll-16) 
for the 1:4 split ratio group and the 1:16 split ratio group. 
The percentages of senescent cells for each male-female 
culture pair, split ratio, and passage series, calculated as 
described in Table 1, are compared in the last column. 
Table 7 
Effect of 1:4 or 1:16 Split Ratio Passage on Senescent 
Expression in Early vs. Late Passage HUVEC 
Comparison of Male and Female Cultures 
Culture Total Cells* Senescent Percent 
Cells* 
C 7 5(F) 1:4 
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p 5 -10 a2 .35 X 105 20792 98.80 
p 11-16 
C 76(M) 1:4 
P 5-10 
P 11-16 
C 75(F) 1:16 
P 5-10 
P 11-16 
C 76(M) 1:16 
P 5-10 
P 11-16 
bi. 38 X 105 
C2 .33 X 105 
dl. 40 X 105 
2.47 X 105 
1. 56 X 105 
26710 
13181 
17454 
14673 
1692 1 
12 988 
11093 
h19. 35 
4.70 
k9.oo 
5.26 
7 .11 
*generated over the indicated number of passages in a cm
2 
area. 
a significantly different from b, c from d, g from h, and 
i from j, p < 0.01; e significantly different from f, b 
from f, and h from k, p < 0.05. 
104 
Senescent Data Assessment Form 
Code No. ------- Flask No. -------- Male Female_ 
I 2 3 4 
17 18 19 
5 6 7 8 
20 21 22 
9 no I 2 
23 24 25 
13 P4 5 6 
NON 
AREA NON-SENESCENT SENESCENT AREA SENESCENT SENESCENT 
7 
2 8 
3 9 
4 10 
5 11 
6 12 
NON 
AREA NON-SENESCENT SE'<ESCENT AREA SENESCENT SENESCENT 
13 19 
14 20 
15 21 
16 22 
17 23 
18 24 
25 
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Senescent Data Assessment Form 
Calculation of Percentage of Senescent Cells 
Cllde No. ----- Flask No. _______ _ Male __ Female __ 
Sum of numbers of non-senescent cells in areas 1,6,11&16 • N • ____ _ 
Calculated number of non-senescent cells in areas 1-16 
Sum of numbers of senescent cells in areas 1-16 
Total number of cells in areas 1-16 • 4N + S 
Percentage of senescent cells 
Calculation of Cellular Density 
Same flask as above 
2 
At 200X, the area of each sample grid• 0.117649 mm 
•4N • -----
• s • -----
• T • -----
% •S/T• ========= 
Mean of total cell numbers iq areas 1,6,11&16 • ____ _ 
2 
Number of cells per cm 
100 mm
2 
0.117649mm2
X Mean 
849.986 X Mean 
Vita 
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